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Brain regeneration through stem cell transplantation studies holds the potential to enhance 
functional recovery of the damaged brain. Most of the positive effects fostered by 
transplanted stem cells are believed to be fuelled by their multipotency to differentiate into 
neurovascular cells, their propensity to release neurotrophic factors to interact with host 
neurovascular unit (NVU) and trigger immune modulation. Pericytes are a subtype of 
mesenchymal stem cells (MSCs) that are embedded within the walls of capillaries, including 
those in the brain. Pericytes are multipotent cells that can interact with NVU and regulate 
brain homeostasis by maintaining the blood-brain barrier (BBB). They can support brain 
endothelium and exhibit trans-differentiation capacity into vascular and neuronal cells in the 
context of both development and disease. Although in vitro studies have demonstrated the 
stem cell potential of pericytes, the fate of the pericytes transplanted in vivo and the 
subsequent effects within the grafted niche is not known. The current study aims to 
understand what happens to the isolated and purified brain cortical pericytes after grafting 
within the mouse motor cortex. Mouse brain pericytes were isolated, cultured, and 
characterized for their positive expression of pericyte specific markers (platelet-derived 
growth factor receptor-Beta (PDGFR-β), neuronal glia (NG2) and alpha-smooth muscle actin 
(α-SMA)) and negative expression of astrocyte marker (Glial-fibrillary acidic protein 
(GFAP)). The cortical pericytes were enriched in regular DMEM and pericyte specific 
medium (PM) and purified by fluorescence-activated cell sorting (FACS) for 
CD140b/PDGFR-β+ pericytes to obtain maximum enrichment efficiency. The purified 
pericytes were then lentivirally transduced with the iRFP reporter gene and FACS sorted 
based upon iRFP to enrich for iRFP expression. iRFP expressing pericytes allowed us to 




grafted into the brain. The iRFP+ pericytes were grafted (unilateral injections in mouse motor 
cortex, 50000 cells/µL) into naïve mice motor cortex and monitored for their survival, 
integration, differentiation and immunomodulation (glial cell activation).  
The mRNA and protein expression results revealed that the isolated cortical pericytes were 
initially heterogeneous in their pericyte marker expression, where the cultures displayed a 
positive expression of both pericyte ( PDGFR-β, NG2, α-SMA) and astrocyte markers 
(GFAP).  The PM-enriched pericytes showed increased expression of PDGFR-β+ & NG2+ and 
decreased expression of α-SMA+ single-labelled cells. Importantly, they contained the highest 
percentage (82%) of  PDGFR-β NG2++ double labelled cells and demonstrated a decrease in 
triple labelled population (PDGFR-β NG2 α-SMA+++) after the 7-day cultures were passaged 
twice (7P2). The 7P2 cultures were selected for subsequent purification, iRFP transduction 
and grafting experiments. Imaging of 96h post-graft tissues revealed successful grafting of 
iRFP+ pericytes as observed by their integration into host vasculature. The success of grafting 
was further reiterated by the coexpression of iRFP PDGFR-β++ expression. Interestingly, the 
grafted iRFP+ pericytes acquired an α-SMA (iRFP α-SMA++) expression phenotype, even 
though very few of the injected pericytes expressed α-SMA at the time of injection. The 
iRFP+ pericytes did not differentiate into glial cells at 96h. However, pericyte grafting 
resulted in immunomodulatory responses in the form of microglial activation and astrogliosis 
compared to the vehicle.  
In summary, the current work reports the successful grafting of pericytes, where the grafted 
cells at 96h post-grafting exhibited the properties of survival, integration into the existing 
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1.1 Stem cells and brain regeneration 
Improper recovery of the brain following trauma and disease is associated with long-term 
consequences that impair essential body functions. Revascularization and vascular 
normalization of the brain are necessary for adequate delivery of oxygen and nutrients 
required to sustain the high metabolic demands of the brain. Under normal physiological 
conditions, neuronal regeneration and axonal growth are extremely limited in the adult 
mammalian brain (He and Jin, 2016, Tran et al., 2018). As a result of disease or trauma, the 
adult brain loses the regeneration ability by developing a hostile environment which are the 
major obstacles to neurological recovery (Schwab and Gargett, 2007, Liu et al., 2010, 
Geoffroy and Zheng, 2014, Tedeschi and Bradke, 2017). Stem cells have the potential to 
differentiate into multiple cell types. The regenerative ability of the adult brain encompasses a 
series of coordinated cellular processes, which includes neural progenitor cell proliferation 
and migration to injury sites, neuronal differentiation, survival, and the integration of the new 
neurons into existing neural circuits (Dibajnia and Morshead, 2013). However, the 
regeneration efficiency of neurons in the injured mammalian brain is extremely low. Hence, 
efforts are being made to address the ongoing issue of brain regeneration by isolating stem 
cells like neural stem cells (NSCs), mesenchymal stem cells (MSCs), and endogenous brain 
pericytes. Among the aforementioned stem cells, brain pericytes are recently becoming cells 
of interest due to their multipotency as well as their specialised function to maintain 
homeostasis at the blood-brain barrier (BBB). They are a type of MSCs, whose properties and 







1.2 Mesenchymal stem cells  
1.2.1 Origin  
During the 1960s, the Russian scientist Friedenstein identified a population of adult cells 
within the rodent bone marrow that were adherent to plastic, formed clonal colonies, and had 
the appearance of fibroblasts in vitro. These cells were capable of osteogenic differentiation 
and could also generate bone when implanted (Friedenstein et al., 1966, Friedenstein et al., 
1970, Friedenstein et al., 1974) and could generate heterotopic bone tissue in serial implants 
suggesting their self-renewal capability (Owen and Friedenstein, 1988). Since then, numerous 
researchers have shown that cells with similar abilities can be differentiated in vitro into a 
variety of mesenchymal cell types such as osteoblasts, chondrocytes, adipocytes, and 
myoblasts (Caplan, 2007, Bianco et al., 2008).  
   
Figure 1.1 Diagrammatic representation of multipotency of mesenchymal stem cells (MSCs).  
MSCs are heterogenous multipotent adult stem cells that are identified by a specific panel of surface 
markers capable of being cultured as colony forming units (CFU) in vitro and are non-immunogenic. 




The isolated cells from the bone marrow of rodents were later coined mesenchymal stem cells 
or MSC by Caplan (Caplan, 1991). A statement in 2006 was produced by The International 
Society for Cellular Therapy (ISCT), suggesting minimum criteria required to define MSC 
(Dominici et al., 2006). The cells must be  
• Adherent to plastic 
• Express the cell surface antigens CD105, CD73 and CD90 
• Should not express the cell surface antigens CD45, CD34, CD13, CD11b, CD19, or 
HLA-DR. 
• Differentiate into osteoblasts, adipocytes, and chondroblasts in vitro. 
Unfortunately, the extensive use of in vitro properties to characterize MSCs hindered the 
validation of their native identity. Besides, the culture conditions affect the expression of 
some cell surface molecules. For example, cultured human BM-derived MSCs (BM-MSCs) 
downregulates the expression of CD146 during hypoxia and upregulates it during normoxia 
(Tormin et al., 2011). It has been shown that human BM-MSCs, human retinal CD146+ 
pericytes, and human fibroblast cell lines share cell morphology and the expression of 22 
different cell surface molecules and the capacity to differentiate toward osteogenic, 
adipogenic, and chondrogenic lineages in vitro. This leads to the conclusion that they are 
identical cells (Covas et al., 2008). But it has also been shown that fibroblasts have a global 
transcription profile that is distinct from MSCs and pericytes and that these cell types are not 
coincident (Covas et al., 2008).  
Distinct niches exist within the bone marrow to support hematopoietic stem cell (HSC) 
survival and growth by providing the requisite factors and adhesive properties to maintain 
their viability (Janowska-Wieczorek et al., 2001). Specifically, endothelial cells (ECs), 




progeny are the primary cellular components of the marrow stroma (Castro-Malaspina et al., 
1984, Wang and Wolf, 1990). It is within this dynamic and cellular microenvironment where 
MSCs are presumed to exist.  
Multilineage capacity and proliferation in vitro were interpreted as indicative of in vivo 
multipotency and self-renewal, the hallmarks of 'stemness' (Caplan, 1991). MSCs are 
regarded as a clinically attractive reagent for regenerative medicine applications due to their 
unique combination of characteristics, as mentioned above. The adult multipotent stem cell 
type can be isolated and expanded in a dish from the most easily available tissue sources, such 
as fat and bone marrow into therapeutic quantities. 
In addition to multilineage potential, MSCs also possess the capacity to migrate to the injured 
sites in response to environmental signals. Promote tissue regeneration mediated by the 
release of paracrine factors with pleiotropic effects (Salgado et al., 2010). A study using 
neonatal stroke rat model showed that intranasal delivery of bone marrow MSCs reduces 
infarct size, gray-white matter loss and motor deficits (Velthoven et al., 2013). MSCs can 
inhibit the immune system, promote cell survival or induce angiogenesis. MSCs confers 
resistance to rejection by the host immune system after transplantation. The adult multipotent 
stem cell type can be used for therapeutic as they are most easily available from tissue 
sources, such as fat and bone marrow and can be rapidly expanded on a large scale for clinical 
use (Escacena et al., 2015). This allows us to produce a patient-specific autologous medicinal 
product within a therapeutic time window. 
1.2.2 MSCs as a therapeutic tool 
Recent studies have shown that BM-MSCs can self-renew in vivo showing that the progeny of 
a single murine CFU-F (colony-forming unit Fibroblastic) (Figure 1.1) can generate bone 




and secondary recipients (Sacchetti et al., 2007, Mendez-Ferrer et al., 2010). Therefore, these 
cells fulfill the criteria of stem cells by generating fully developed descendants in vivo 
(multipotency) and producing cells that are identical in phenotype and potency to those 
explanted (self-renewal). An important criterion used to identify stem cells is their capacity to 
self-renew, their capacity to differentiate into different cell lineages and colony-forming 
ability (Metcalf, 2007). Stem cell lineages are often described as starting with a stem cell and 
a progenitor (Szilvassy, 2003). The progenitor continues to proliferate and differentiate into a 
transitional cell phenotype, which then further differentiates into a specialized cell. Easy 
access to MSCs provides prospects for human regenerative medicine without the need for 
immunosuppression and minimal risk for neoplastic formations (Vedenko et al., 2018) and 
can be readily transplanted between the tissues.  
MSC transplantation promotes therapeutic effects in a variety of diseases, including 
cardiovascular, musculoskeletal, immunologic and age-related disorders. It was originally 
thought that their regenerative effects were based on canonical stem cell mechanisms of 
action, whereby transplanted MSCs engraft, differentiate and directly regenerate healthy cells 
in the host tissue. Their effects were recognized as primarily indirect and operated as 
reservoirs of growth factors, nucleotides, and mitochondria (Vedenko et al., 2018).  
MSC transplantation in the neonatal hypoxic-ischemia (HI) model promotes endogenous 
neuronal repair. MSC transplantation 10 days after induction of neonatal HI, the gene 
expression profile in the brain shifts toward a growth-promoting environment (Velthoven et 
al., 2013). MSC treatment increases cell proliferation for at least 28 days post-MCAO. There 
is a time window of administration for MSC to be effective. A study has shown in a murine 
model that a second dose of MSC at 17 days post-HI has no additive effect on top of a first 
dose at 10 days post-HI, whereas 2 doses at 3 and 10 days post-HI effectively reduce HI brain 




1.2.3 MSCs in Brain 
A recent idea that broadens the concept of MSC actions is that they secrete biologically active 
molecules that exert beneficial effects on other cells (Caplan and Dennis, 2006). This property 
significantly increases the range of MSC therapeutic applications, even if they do not 
differentiate or engraft into tissue-specific cells (da Silva Meirelles et al., 2009). Pericytes are 
adhering cells, unlike blood cells that are generally considered to be in suspension. As 
mentioned in the introduction, pericytes are found around vasculature in order to help in 
vascular stability and homeostasis in vivo. In vitro, the non-attachment of pericytes would 
lead to cell death. Therefore, engraftment into the host tissue is the first step for a cell to adapt 
and acclimatise to the tissue and environment. Hence, cell engraftment is very much essential 
to understand its long term therapeutic potential. Several factors influence the ability of MSCs 
to preferentially gather at sites of injured tissues. This is one of the regenerative properties of 
MSCs, as it increases the likelihood of systemically delivering cells to areas where their 
paracrine effects are needed the most (Karp and Leng Teo, 2009).  These paracrine effects can 
be divided into trophic (nurturing), immunomodulatory, anti-scarring and chemoattractant (da 
Silva Meirelles et al., 2009). One example of a chemoattractant molecule is monocyte 
chemoattractant protein-1, which recruits circulating monocytes to injured sites, where they 
can differentiate into ECs (Fujiyama et al., 2003, Kinnaird et al., 2004) 
The finding that MSCs administration to patients produced recovery through trophic and 
immunomodulatory effects have prompted the development of numerous clinical trials, that 
may hopefully lead to new healing therapies (Caplan, 2009, Sadan et al., 2009, Hoogduijn et 
al., 2010, Yagi et al., 2010). MSCs are prime candidates in the field of regenerative medicine 
with considerable interest in characterizing these cells as well as optimizing, harvesting and 
expansion techniques for their use in injury and tissue repair (Murray et al., 2014). The 




goal of regenerative medicine, which is the replacement of the lost cells in the damaged tissue 
with new healthy ones, which are also specific for that tissue. 
These observations paved the way for the concept of a perivascular niche for MSCs. 
Mesenchymal stem cells and vasculature association allows them to function as a source of 
new cells for physiological turnover and makes them available for repair and regeneration of 
local lesions. When there is damage to any tissue, MSCs will be released from their 
perivascular site and divides, which secretes immunomodulatory and trophic bioactive factors 
(da Silva Meirelles et al., 2008). Recent work has extended this concept to several other 
tissues in addition to bone marrow and dental pulp and provided further support to the notion 
that pericytes are a source of MSCs (Crisan et al., 2008a, Crisan et al., 2008b). Consequently, 
the pericyte emerges as a possible in vivo source for locally therapeutic MSCs.  
Importantly, extensive damage to the vascular integrity of the brain occurs due to the loss of a 
population of mural cells called the perivascular cells/ pericytes that communicate with the 
neuronal niche. Transplantation of pericytes as a means to stimulate neurovascular recovery 
has lately been hypothesized to ameliorate vascular integrity as well as neuronal degeneration 
of the brain. Although a few in vitro studies have highlighted the regenerative properties of 
pericytes, the fate of pericytes post-transplantation has not been emphasized, and their 
regulation of the vascular and neuronal niche is yet unclear and has received less attention. 
Before determining the fate of transplanted pericytes, it is imperative to briefly understand the 
history of their ontogeny, morphological and functional characteristics in detail.  
1.3 The Pericyte 
Perivascular cells or perivascular mural cells, namely pericytes, were initially described by 
Rouget in 1873, and hence were initially named as Rouget cells. All vessels have an inner 




smooth muscle cells) and hence pericytes are termed as vascular mural cells. However, in 
1923, Zimmermann renamed them as pericytes for their unique localization in the 
perivascular space of brain vessels (i.e., surrounding ECs) (Abbott, 2002). The ontogeny of 
pericytes is heterogeneous, and much remains to be deciphered. Chick-quail chimera analysis 
(Etchevers et al., 2001, Korn et al., 2002) and genetic lineage tracing experiments using 
neural crest-specific Cre-mediated reporter line demonstrated that pericytes of the face, brain, 
and thymus were derived from the neural crest (Korn et al., 2002, Foster et al., 2008, Muller 
et al., 2008, Yamanishi et al., 2012). Also, by genetic lineage tracing experiments, the origin 
of pericytes of gut, lung, and liver in mice have been traced to the mesothelium (Wilm et al., 
2005, Que et al., 2008, Asahina et al., 2011). While the epicardial mesothelium gives rise to 
coronary pericytes and vascular smooth muscle cells (VSMCs) in the heart (Mikawa and 
Gourdie, 1996, Dettman et al., 1998, Zhou et al., 2008), some endocardium also contributes to 
coronary pericytes (Chen et al., 2016). Most commonly, their origin was best described and 
understood to be from mesenchymal stem cells (Zuckerwise et al., 2016). Therefore, these 
studies indicate that the origin of pericytes is heterogeneous in tissue as well as context-
dependent manner. 
The developmental sources of pericytes are heterogeneous. A series of genetic lineage tracing 
experiments using a Cre-mediated fluorescent reporter line demonstrated that a fraction of 
pericytes in the developing skin and brain was derived from myeloid progenitors, where 
mutant mice in the absence of myeloid lineage lead to a defective pericyte development. 
Moreover, transforming growth factor-beta (TGF-β) stimulates the differentiation of myeloid 
progenitors into pericytes in vitro and in vivo (Yamazaki et al., 2017). Similarly, some CD31+ 
F4/80+ macrophages give rise to cerebrovascular pericytes during embryogenesis (Yamamoto 
et al., 2017). Insight into the origin of pericytes can have useful applications in terms of 




tissue engineering models. It remains to be determined whether pericytes of different origins 
have different functions in these tissues. 
It is intriguing to evaluate whether pericytes of heterogeneous origins at embryonic stages 
remain in adults. Either a subtype of pericytes may become dominant in adults or adult tissue-
resident progenitors may contribute to pericytes, in pathological conditions. Indeed, MSCs 
were shown to generate pericytes after radiation therapy (Wang et al., 2016), while tumors 
such as bone and soft tissue sarcomas of mesenchymal origin can be derived from pericytes 
(Sato et al., 2016). Stem cells within a glioblastoma were reported to generate pericytes to 
support tumor growth (Cheng et al., 2013). Tracking the origin of adult tissue pericytes 
requires the development of a cell-type-specific inducible Cre recombinase line. Transient 
Cre activity generates cells with an endogenous fluorescent reporter at a specified 
developmental time point, which then allows the tracking of their progeny in adults. Also, the 
inducible lineage tracing experiment allows us to follow the differential contribution of 
heterogeneous pericytes to the neovasculogenesis in pathological conditions such as tumor 
angiogenesis and wound healing. 
1.3.1 Morphology 
Studies by electron microscopy defined the morphological characteristics of pericytes as cells 
that possess a cell body with a conspicuous nucleus and a small amount of cytoplasm and 
have long extending processes covering the wall of the endothelium (Yamazaki and 
Mukouyama, 2018). From the available reports, it is well known that the pericyte density, 
morphology, function and molecular signature vary across the vascular beds of all organs 
(Birbrair et al., 2013). The pericyte-endothelium interaction helps in enhancing the assembly 
of the basement membrane. The presence of a prominent round nucleus in pericytes differs 




come out of the cytoplasmic projections encircle 30-70% of the capillary wall. A basement 
membrane (BM) separates the majority of the pericyte endothelial interface. The contacts are 
of peg-socket type, in which pericyte cytoplasmic fingers (pegs) are inserted into endothelial 
invaginations (sockets). The sites that contain fibronectin and resemble adherence junctions 
consist of N-cadherin based connections and are formed between ECs and pericytes (Gerhardt 
et al., 2000, Gerhardt and Betsholtz, 2003). It has also been reported in vitro, but not in vivo, 
that gap junction-like structures occur between ECs and pericytes (Diaz-Flores et al., 2009). 
Direct gap junction mediated communication among pericytes and other vascular elements 
plays a key role in vasomotor response propagation (Oku et al., 2001, Ivanova et al., 2017, 
2019). Electrical pulses propagate radially along the network of pericytes and endothelial cells 
in the isolated retina vasculature (Zhang et al., 2011). The vasomotor response tends to 
propagate stronger upstream of the irrigating vascular branch following focal stimulation, a 
phenomenon observed in multiple systems including the retina, olfactory bulb, cerebral cortex 
and skeletal muscles (Kovacs-Oller et al., 2020).  
1.3.2 Types of pericytes 
Depending upon the appearance of their projections, pericytes are categorized into different 
types. The ensheathing pericytes are alpha-smooth muscle actin (α-SMA)-positive, occupy 
proximal branches of penetrating arterioles and almost entirely cover the vessel (Grant et al., 
2019). The pre-capillary arterioles are defined as the microvessels occupied by ensheathing 
pericytes that possess a protruding oval cell body and a more elongated shape. In contrast, the 
other two types of pericytes, mesh, and thin-stranded pericytes are called the capillary 
pericytes (Grant et al., 2019). These pericytes are α-SMA-negative, longer in total cell length, 
and bear processes of varying complexity that cover the vessel partially. The capillary 
pericytes occupy the capillaries occurring after the α-SMA terminus (Grant et al., 2019). The 




a large continuous surface of the vessel. Some of the pericyte processes may also form finger-
like projections that surround a finite portion of the vessels. The third pattern of the pericyte 
orientation in the microvessels involve a retraction of projections, and this represents a 
migrating pericyte (Dore-Duffy et al., 2000). These pericytes also extend along the long axis 
of the capillary, which represents longitudinal migration and is commonly seen during 
angiogenesis. The differences in these patterns represent the functional differentiation of 
pericytes. Their molecular marker expression varies along the vasculature and depends on 
species, organ, type of blood vessel, location, and developmental stage (Birbrair et al., 2013). 
1.3.3 Distribution 
Pericytes appear ubiquitously on the pre-capillary arterioles, capillaries, and post-capillary 
venules of many organs, but not generally in lymphatic capillaries (Petrova et al., 2004). They 
are more frequently found on the microvessels of the retina and brain. In the brain, the 
pericytes are located outside of the microvessels and are ensheathed by basal laminae 
separating them from the endothelium and astrocyte end-feet. The distribution of pericytes 
can vary between different areas, particularly the capillary bed, with higher densities often 
observed at vessel branch points. The endothelial to pericyte ratio varies between 1:1 and 
10:1, and the abluminal (away from the endothelial abluminal surface) coverage ranges 
between 70% and 10% (Sims, 1986). These differences are in part organ-specific and depend 
on pericyte density that correlates with endothelial barrier properties (brain, lung, muscle) 
(Sims et al., 1994, Diaz-Flores et al., 2009). The ECs and pericytes co-exist and interact in 
CNS vasculature with a coverage ratio of  1:1 – 3:1 with 30% coverage restricted to the 




1.4 Identification of pericytes 
Although the morphological features were well studied, pericytes are relatively poorly defined 
in terms of markers for identification (Armulik et al., 2011a). The current 
immunohistochemical approaches identify pericytes using antibodies against the proteins, 
depending on tissue and microvessel types and also with their classic ‘bump on a log’ 
morphology. No marker has been defined as pericyte-specific due to the heterogeneous 
distributions and functions of these cells (Bergers and Song, 2005, Armulik et al., 2010a, 
Trost et al., 2016). It should be highlighted that the markers present in pericytes are not 
restricted to pericytes but also exist in other cell types, including perivascular fibroblasts, 
macrophages, and VSMCs (Table 1.1).  
Table 1.1 Table enlisting markers for pericyte identification, origin and their function 
MARKER FUNCTION REFERENCES 
PDGFR-β (Platelet-derived 
growth factor-β receptor)  
Receptor tyrosine kinase; a 
useful marker for brain 
pericytes, helps in recruiting 
pericytes during 
angiogenesis. 
(Lindahl et al., 1997b), 
(Winkler et al., 2010b) 
α-SMA (alpha-smooth 
muscle actin) 
Structural protein; quiescent 
pericytes do not express α-
SMA whereas, ensheathing 
pericytes do express α-SMA.  
Expression in pericytes is 
commonly upregulated in 





tumours and inflammation 
NG-2 (Neuron glial-2 or 
Chondroitin sulphate 
proteoglycan 4)  
Integral membrane 
chondroitin sulphate 
proteoglycan; expressed at 
higher density during 
development and in tumour 
pericytes; involved in 
pericyte recruitment to 
tumour vasculature. 
(Huang et al., 2010) 
CD13 (Alanyl membrane 
aminopeptidase)   
Type-II membrane zinc-
dependent metalloprotease; a 
useful marker for brain 
pericytes 
(Kunz et al., 1994b) 
Desmin Structural protein; pericyte 
marker outside skeletal and 
cardiac muscle 
(Nehls et al., 1992) 
RGS5 (Regulator of G-
protein signalling 5) 
Regulate heterotrimeric G 
proteins by activating 
GTPase activity; angiogenic 
pericyte marker. 
(Bondjers et al., 2003) 
3G5  Cell surface ganglioside 
antigen; Specific marker for 
pericytes in 





Nestin Intermediate filament 
protein; predominantly 
expressed in nerve cells 
(Armulik et al., 2011b) 
1.4.1 PDGFR-β/CD140b 
PDGFR-β, along with PDGFR-α, is a cell surface tyrosine kinase receptor (RTK) for 
members of the PDGF family. These receptors dimerize and trigger intracellular signalling 
cascades that lead to cellular responses such as proliferation and migration. PDGFR-β helps in 
the recruitment of pericytes during angiogenesis (Heldin and Westermark, 1999, Thijssen et 
al., 2018). Therefore, this marker should be used with caution in the identification of pericytes 
and should be used alongside a vascular marker to confirm that pericytes are located on the 
vasculature. The PDGF family is a subfamily of the PDGF/vascular endothelial growth factor 
(VEGF) superfamily. Members of this family contain cysteine knots, which are special 
stabilizing structural motifs characterized by eight conserved cysteine residues (Ball et al., 
2007). 
PDGFR-β is a widely used marker for pericytes. However, the expression of this protein is 
not unique to pericytes. Other cells such as fibroblasts, neurons and macrophages also express 
PDGFR-β (Heldin and Westermark, 1999, Riew et al., 2018). Therefore, this marker should 
be used with caution in the identification of pericytes. PDGFR-β is also called CD140b which 
is a receptor for the ligand PDGF-BB. The antibody CD140b used in the FACS experiments 




1.4.2 Alpha smooth muscle actin (α-SMA)  
Actin is a highly conserved cytoskeletal protein found in all eukaryotic cells, and it 
participates in a variety of important cellular processes. Six isoforms of actins have been 
discovered in mammals and are divided into three subgroups: alpha, beta and gamma actins. 
The beta and gamma isoforms are present in non-muscle cells, where they serve as a part of 
the cytoskeleton and mediate internal cell motility (Gerhardt et al., 2000). Alpha actins are 
found in smooth-muscle cell lineages and are part of the contractile apparatus. α-SMA is one 
pericyte marker which is non-uniformly expressed at different stages and circumstances. 
Pericytes are negative for α-SMA in their capillary location; however, transition pericytes 
express 10-40% of α-SMA adjacent to pre-capillary arterioles (Alarcon-Martinez et al., 2018). 
During a pathological insult like traumatic brain injury (TBI), the expression of α-SMA 
drastically increases, leading to constriction of blood vessels and hypoperfusion. α-SMA is 
also expressed in pericytes as a marker for differentiation (Alarcon-Martinez et al., 2018). 
Freshly isolated pericytes cultured for more than 7 days acquire a muscle actin phenotype, 
which was a consequence of differentiation rather than proliferation. α-SMA is probably the 
best characterized and most frequently used marker for differentiating pericytes (Dore-Duffy, 
2008). The reason for the pericyte cultures acquiring an α-SMA phenotype is a sign of 
pericyte differentiation. Hence, the amount of α-SMA+ pericytes used in a grafting experiment 
must be kept to a minimum, especially since TBI is known to increase pericytes with an α-
SMA phenotype in the brain (Cai et al., 2017). 
1.4.3 Neuron-glial 2 (NG2) 
NG2 also called a high-molecular-weight melanoma-associated antigen; HMWMAA is a cell 
surface chondroitin sulphate proteoglycan, which is expressed in mural cells during normal 




interacting with basic fibroblast growth factor (bFGF), and platelet-derived growth factor-AA 
(PDGF-AA) in signal transduction pathways that mediate cell spreading and motility 
(Ozerdem and Stallcup, 2004). NG2 is useful for identifying but is not specific for pericytes 
since it can also be found in neural cells (glial progenitor cells, oligodendrocyte progenitor 
cells and neurons). It is often seen as a marker for pericytes in vessels undergoing 
remodelling, since the expression of NG2 in the brain decreases as the vessel mature, and its 
expression becomes stable and quiescent (Nishiyama et al., 1996). 
1.4.4 Desmin 
Desmin is a muscle-specific intermediate filament found in skeletal, cardiac and smooth 
muscle cells of vertebrates. Desmin is expressed near the Z line in sarcomeres in striated 
muscle and associated with dense bodies in smooth muscle cells. Although Desmin is 
expressed by immature and mature pericytes, a subpopulation of smooth muscle cells 
associated with developing or mature arteries also expresses this marker. Even though desmin 
is sometimes used as a pericyte marker, its expression is unfortunately not restricted to 
pericytes. When co-labelled with α-SMA, the desmin showed a characteristic filamentous 
staining pattern entirely confined to large vessels, probably arterioles (Daneman et al., 2010c, 
Hu et al., 2017, Jung et al., 2018b, Smyth et al., 2018). Desmin is most prominently present in 
muscle cells (Li et al., 1997). 
1.4.5 Cluster of Differentiation (CD13) 
CD13, also called pericytic aminopeptidase N (pAPN), is a zinc-dependent ectoenzyme 
involved in the degradation of extracellular matrix (ECM) molecules and non-ECM molecules 
such as growth factors and neuropeptides. It mostly localizes to the plasma membrane of the 
non-endothelial side of the cell soma. CD13 has proven to be extremely useful for the 




(Kunz et al., 1994a). CD13 has been shown to be expressed on capillary pericytes but is also 
detected on α-SMA positive vascular smooth muscle cells. Fluorescent NeuroTrace 500/525 
brightly labels brain capillary pericytes separate from other brain cells and could be used as an 
unambiguous marker for capillary pericytes that do not express α-SMA (Damisah et al., 
2017b). 
1.4.6 Other markers 
Several other proposed pericyte markers are listed below (Dore-Duffy et al., 2006) (Nayak et 
al., 1988a). 
• Kir6.1 (ATP- sensitive potassium-channel, Kcnj8) 
• SUR2B (sulfonylurea receptor 2, Abcc9) 
• DLK1 (delta homologue 1) 
• Nestin 
• Vimentin 
• VCAM-1 (vascular cell adhesion molecule 1) 
• OX-42 (integrin αM) 
• 3G5-defined ganglioside 
During development and in pathological conditions, the lineage of pericytes can be traced 
with the help of genetic mouse models, including fluorescent reporters such as nuclear β-
galactosidase reporter, transgenic markers, and lineage tracing lines using the promoter of 
PDGFRβ, NG2, and Tbx18 (a transcription factor specific to pericytes and VSMCs) that 
function as valuable tools. Also, brain pericytes could specifically be labelled with a 
fluorescent Nissl dye, which enables the imaging in the live mouse (Damisah et al., 2017a). 
Molecular definitions of the principal classes of brain vascular cells were provided through 




1.5 Pericytes in the Brain 
In the mammalian brain, pericytes exist among a complex unit of cells called the 
neurovascular unit (NVU), interacting and communicating with a plethora of cell populations 
including ECs, astrocytes, and microglia. Electron microscopy studies have revealed the 
existence of two populations of brain pericytes that are granulous and filamentous. The latter 
contains microfilaments resembling actin- and myosin-containing muscle fibers and express 
α-SMA, a protein that regulates their contractile properties (Le Beux and Willemot, 1978, 
Toribatake et al., 1997). To meet the demand for oxygen and nutrients in the healthy brain, 
these properties are crucial for the coordination of increased neuronal activity with changes in 
blood flow. Granulous and filamentous types of pericytes are very much needed to maintain 
the contractility of the blood vessel. Pericytes containing α-SMA help in the vessel 
contractility through which the demand for oxygen and nutrients required to the nearby cells 
in tissues are met (Alarcon-Martinez et al., 2018). The role of brain pericytes is better 
understood by knowing their spatial distribution and how they interact with their surrounding 
niche, as detailed below.  
1.5.1 Neurovascular unit (NVU) 
The pericyte population in the brain is heterogeneous (Dias Moura Prazeres et al., 2017). The 
NVU plays a vital role in maintaining brain function by forming a BBB and also in regulating 
cerebral blood flow by connecting the brain parenchyma to the cerebral vasculature (Muoio et 
al., 2014). The NVU includes neurons, interneurons, astrocytes, and microglia that interact 
with vascular cells, i.e., pericytes on capillaries, vascular smooth muscle cells on arteries, and 
ECs (McConnell et al., 2017) (Figure1.2). The pericytes in NVU are considered to be crucial 
for intercellular communication between different groups of cells due to their location at the 





Figure 1.2 Diagrammatic representation of Neurovascular unit:  
Neurovascular unit (NVU) representing capillary pericytes interacting with a plethora of neuronal 
(astrocytes, neurons, microglia, oligodendrocytes and interneurons) and vascular cells (ECs and 
vascular smooth muscle cells (VSMC)). 
 
1.5.2 Pericyte-endothelial cell (EC) interaction 
ECs and pericytes communicate by juxtracrine and paracrine signaling transduction pathways 
(Armulik et al., 2011a) These pathways are essential in directing vessel development and 
maturation and formation of the BBB, as well as pericyte survival and contractility (Armulik 
et al., 2011a). The importance of pericyte-EC interactions can be seen in pericyte depletion 
animal models, such as PDGFR-β knockdown mice, that display abnormal vascular growth 
and extensive EC apoptosis (Hellstrom et al., 2001). Intercommunication between pericytes 
allows the signal propagation up or down the capillary, which can assist in the control of 




signaling pathways involved in pericyte-EC interaction would help understanding in detail the 
importance of their interaction. 
1.5.2.1 PDGF-BB–PDGFRβ pathway  
The platelet-derived growth factor (PDGF) family contains four ligands (PDGF-A, B, C & 
D), which bind to two receptors (α and β) (Heldin, 2013). Among different PDGF ligands that 
bind differentially to its receptors (PDGFRs), PDGF-BB, secreted by ECs, has high-affinity 
binding towards PDGFRβ (Heldin, 2013), a receptor on pericytes (Winkler et al., 2010a) and 
is a potent mitogen and chemoattractant for many cell types and has the ability to promote 
angiogenesis (Zhang et al., 2018). Binding of PDGF-BB to PDGFRβ activates the latter 
(Tallquist et al., 2003), resulting in the recruitment and binding of specific Src-homology 2 
(SH2) domain-containing proteins to distinct phosphorylated tyrosine residues of  PDGFRβ. 
These events induce downstream signalling, which promotes pericyte survival, proliferation, 
migration, and recruitment to the vessel wall (Tallquist et al., 2003, Winkler et al., 2011). 
Thus, PDGF-BB is considered a key regulatory factor in tissue repair and regeneration. In 
microvessels, PDGF-BB is secreted by endothelial cells, and binds to PDGFR-β on the 
surfaces of pericytes (Phipps et al., 2012).  The PDGF-BB/PDGFR-β signalling pathway is 
essential for the formation and maturation of the blood-retinal barrier through the recruitment 
of pericytes onto new capillaries (Xiang et al., 2019).  Pericytes are involved in angiogenic 
cascades, including the formation and maturation of NV. In a laser-induced model of 
choroidal neovascularization (CNV), a PDGFRβ+ scaffold limits the extent of NV formed 
before the formation of CNV lesions (Strittmatter et al., 2016).  
During embryonic development, PDGF-BB – PDGFRβ signalling is essential for endothelial - 
mesenchymal communication, blood vessel development and stabilization in CNS (Lindahl et 




allele does not result in an apparent vascular phenotype, a null mutation of Pdgfb and Pdgfrb 
are embryonically lethal in mice and lead to the development of CNS microvascular 
instability, endothelial hyperplasia, microaneurysms, and microhaemorrhages. Contrastingly, 
brain pericytes may contain a different regulatory role during postnatal development, 
adulthood, and ageing. Studies in mouse models suggested that a partial disruption of PDGF-
BB – PDGFRβ signalling, either by a mutation in the PDGF-BB retention motif (Pdgfbret/ret) 
or deficient PDGFRβ signalling, resulted in age-dependent BBB breakdown and aggregation 
of blood-derived neurotoxic proteins in the neuropil and brain interstitial fluid (Armulik et al., 
2010b, Bell et al., 2010, Daneman et al., 2010b). Deficient PDGFRβ signalling also leads to 
microvascular reductions, which, together with BBB breakdown, may contribute to secondary 
neurodegeneration (Bell et al., 2010, Winkler et al., 2012). 
In animal models of diabetic retinopathy, diminished PDGFRβ signalling resulted in retinal 
pericyte apoptosis (Geraldes et al., 2009), whereas studies of tumor angiogenesis have shown 
that pericyte loss may lead to endothelial apoptosis (Song et al., 2005). PDGFRβ signal 
transduction in pericytes also mediates pro-inflammatory responses at the BBB by 
transcriptional regulation of various chemokines that promote endothelial expression of 
monocyte chemoattractant protein-1 (MCP-1), nitric oxide (NO), interleukins IL-1, IL-6, IL-
12, and tumor necrosis factor-α (TNF-α), resulting in transvascular trafficking of 
macrophages and leukocytes into the brain, as shown in pericyte-deficient Pdgfrb+/− mice 
(Olson and Soriano, 2011). In vivo studies in Pdgfb and Pdgfrb, mutant mice reported that the 
disruption in PDGF-BB – PDGFRβ signalling upregulates vascular endothelial growth factor 
(VEGF)-A, and accelerates vascular abnormalities (Hellstrom et al., 2001). PDGF-BB – 
PDGFRβ signalling dysfunction also contributes to various CNS pathophysiologies, including 




1.5.2.2 Ephrin-Eph pathway 
Ephrin signalling pathway, via ephrin-B ligands and EphB receptors, is a critical regulator of 
angiogenesis during development and pericyte-EC interaction during assembly of the 
vasculature (Augustin and Reiss, 2003). Studies in transgenic Pdgfrb-Cre; Efnb2lox/lox mice 
revealed that ephrin-B2 – EphB4 signalling controls directional migration of pericytes and its 
adhesion to maturing vessels (Foo et al., 2006). Studies using genetically engineered mice 
have shown that ephrin-B2 is expressed in brain pericytes and ECs (Gale et al., 2001). 
Moreover, EphB4 controls blood vascular morphogenesis during postnatal angiogenesis 
(Erber et al., 2006). Therefore, ephrin signalling via ephrin-B2 and its receptor EphB4 can 
participate in vascular remodeling and different aspects of NVU formation. 
1.5.3 Pericyte-astrocyte cross-talk 
1.5.3.1 CypA–NFκB–MMP-9 cascade 
Astrocytes and pericytes interact through astrocyte-secreted apolipoprotein E (APOE) binding 
to the cell-surface low-density lipoprotein receptor-related protein-1 receptor (LRP-1) on 
pericytes. The type of APOE binding can regulate the integrity of BBB (Bell et al., 2012b). 
Binding of APOE2 and APOE3 to LRP-1 inhibits the pro-inflammatory Cyclophilin A – 
nuclear factor-ĸB-matrix metalloproteinase-9 (CypA–NFκB–MMP-9) cascade, whereas 
binding of APOE4 increases MMP-9 activity in the vessel wall, which leads to degradation of 
endothelial tight junction and basement membrane proteins causing BBB breakdown (Bell et 
al., 2012b). Increases in CypA and MMP-9 CSF levels were reported to correlate with BBB 
breakdown in human APOE4 carriers, but not in age-matched APOE2 or APOE3 carriers 
(Halliday et al., 2013). Animal Studies in APOE4 transgenic mice demonstrated that the 
breakdown of BBB results in neuronal injury and neurodegeneration (Bell et al., 2012b). The 




disease (Karch et al., 2014). Astrocyte-secreted APOE3, but not APOE4, suppressed the 
CypA–NFκB–MMP-9 pathway in pericytes through a lipoprotein receptor. CypA is a key 
target for treating APOE4-mediated neurovascular injury and the resulting neuronal 
dysfunction and degeneration (Bell et al., 2012a). Among diverse brain cell populations, 
vascular mural cells (vascular smooth muscle cells and pericytes) have been identified as a 
major cell type that expresses abundant apoE under physiological conditions (Zhao et al., 
2015). Pericytes have recently emerged as critical regulators of vascular morphogenesis, 
cerebrovascular homeostasis and NVU function (Hamilton et al., 2010, Winkler et al., 2011, 
Sweeney et al., 2016). Although astrocytic APOE4 may disrupt BBB integrity, it is likely that 
APOE4 expressed in vascular mural cells, integral components of vasculature also contribute 
to the cerebrovascular dysfunction. A study by Nation and Yamazaki et al., has proved that 
APOE4-mediated endothelial dysfunction may be significantly involved in the susceptibility 
for cognitive decline (Nation et al., 2019, Yamazaki et al., 2019). Therefore, pericytes should 
be further explored as a critical cellular population that contributes to the pathogenic 
pathways for APOE4-related neurodegeneration (Yamazaki et al., 2020). 
1.5.4 Arachidonic acid pathway 
Astrocytes regulate pericyte tone (change in the contractility of the pericyte network) and 
capillary diameter via the arachidonic acid (AA) pathway and cause capillary disturbances 
(Peppiatt et al., 2006). The presence of neuronal factors like glutamate increase the 
intracellular Ca2+ concentration of astrocytes, leading to phospholipase A2 (PLA2)-mediated 
AA generation (Sweeney et al., 2016). In vivo studies in mouse somatosensory cortex have 
shown that AA, in astrocytes, is metabolized to prostaglandin E2 (PGE2) (Takano et al., 
2006). Studies in rat cerebral and retinal slices have demonstrated that PGE2 activates its 
receptor EP4, leading to pericyte relaxation after the addition of glutamate (Hall et al., 2014a). 




hydroxyeicosatetraenoic acid (20-HETE) in pericytes, causing contraction of pericytes 
(Peppiatt et al., 2006, Sato et al., 2016). Therefore, the arachidonic acid pathway could act as 
a hemodynamic regulator, but this needs to be confirmed in vivo. A study by Mishra et.al., 
highlights the communication between astrocytes and pericytes where, astrocytes are 
important contributors to the neurovascular coupling at the capillary level and suggest that 
capillaries, which contain most of the resistance to blood flow in the brain parenchyma could 
be specifically targeted therapeutically to increase blood flow in pathological conditions 
(Mishra et al., 2016). 
1.5.5 Pericyte-neuronal interaction   
Although the pericytes and capillaries are well-positioned to receive chemical transmitters 
from activated neurons, neuronal innervation of capillary pericytes is yet to be understood 
entirely. The average distance between a neuron and a capillary is 8-23 µm in the mouse 
hippocampus (Lovick et al., 1999). The interaction of neurons and pericytes were reported to 
be orchestrated by neurotrophic factors and neurotransmitters.  
1.5.5.1 Neurotrophic factors  
A study using a murine hypothalamic GT1-7 neuronal cell line has shown that only pericyte-
derived media increases the insulin-stimulated phosphorylation of Akt in GT1-7 cells and 
insulin-dependent tyrosine phosphorylation of insulin receptor β (Takahashi et al., 2015), 
suggesting that pericytes can modify insulin sensitivity in hypothalamic neurons. Given the 
strategic location of pericytes within the NVU, pericyte-derived molecules may be distributed 
in the NVU and reach their neuronal targets by para-arterial CSF–interstitial fluid flow (Iliff 





Various in vivo and ex vivo studies have provided substantial evidence for neuronal control of 
pericyte contraction and relaxation. While norepinephrine leads to pericyte contraction and 
reduction of capillary diameter (Helbig et al., 1992, Peppiatt et al., 2006, Hall et al., 2014a), 
GABA (Peppiatt et al., 2006), adenosine (Li and Puro, 2001), glutamate (Hall et al., 2014a) 
and dopamine (Wu et al., 2001) stimulate the relaxation of pericytes. In some cases, 
neurotransmitters act directly on pericytes (e.g. adenosine) whereas other neurotransmitters 
act through an intermediary cell (e.g. glutamate on astrocytes).  Recent in vivo studies also 
demonstrated the neuronal control of capillary circulation by showing that capillaries dilate 
before arterioles in the mouse cortex in response to whisker stimulation (Hall et al., 2014a). 
1.6  Functions of Pericytes 
1.6.1 Blood-Brain Barrier (BBB) and maintenance 
The passage of various nutrients and essential components, proteins, chemical substances, and 
microscopic organisms between the bloodstream and the parenchymal tissue is regulated by 
the BBB (Armulik et al., 2010b). The anatomical constituents of the BBB are the EC, 
pericytes, and basal lamina that, together with the astrocytes, neurons, and other glial cells 
comprise the neurovascular unit (del Zoppo, 2010). A primary function of the BBB is to 
provide EC-EC integrity and various other physical interactions between ECs with other 
resident cell types in the neurovascular unit (NVU) (Kulczar et al., 2017, Lim et al., 2017). 
The NVU regulates a wide variety of other functions by coordinated cell-to-cell interactions 
that include development, BBB permeability, cerebral blood flow, and stress response. 




functions necessary for proper CNS homeostasis that includes BBB formation and 
maintenance, vascular stability and angiogenesis and capillary diameter and blood flow.  
Studies have demonstrated that the BBB forms early in embryogenesis and coincides with the 
initial pericyte recruitment but precedes astrocyte generation. Pericytes owe a critical role in 
the context of BBB homeostasis, and the identification of various aspects of pericytes' 
behavior can be a remarkable target for the acceleration of brain healing.  Molecular 
characterization has shown that pericytes contribute to BBB integrity by regulating the 
formation of tight junction proteins between ECs and trans-endothelial vesicle trafficking, 
which is also dependent upon the pericyte density (Daneman et al., 2010a). Also, pericytes 
inhibit CNS immune cell infiltration and the expression of molecules, thus decreasing 
vascular permeability during the BBB development. The first study that showed pericytes 
play a functional role in the vascular barrier was carried out in PDGFR-β deficient mice 
(Bernstein et al., 1982, D'Amore and Smith, 1993). Their data suggests that pericytes may be 
important for suppressing a 'leaky' and pro-inflammatory phenotype that is associated with 
undifferentiated cerebrovascular ECs during embryogenesis. Another recent study using 
pericyte-deficient mouse lines with genetically disrupted PDGFR-β signalling has shown that 
pericytes play an integral part in maintaining the BBB during adulthood (Armulik et al., 
2010b, Bell et al., 2010) and brain ageing (Bell et al., 2010). BBB breakdown and pericyte 
deficiency were also associated with a progressive age-dependent microvascular degeneration 
that is accompanied by the loss of cerebral capillaries (Bell et al., 2010). Their study showed 
that brain pericyte deficiency did not result in the upregulation of genes for pro-inflammatory 
molecules, nor did it result in increased CNS immune cell response in early to mid-adulthood, 
but these responses were only observed in aged pericyte-deficient mice (Bell et al., 2010). 
Additionally, astrocytes release antioxidant-associated molecules and exert a protective role 




CNS function is impaired due to the loss of brain pericytes that results in BBB breakdown 
through leakage and deposition of several potentially vascular toxic and neurotoxic blood-
derived macromolecules, including fibrin (Paul et al., 2007), thrombin (Mhatre et al., 2004, 
Chen et al., 2010), plasmin (Chen and Strickland, 1997) and hemoglobin-derived 
hemosiderin, which causes accumulation of iron and reactive oxygen species (Bell et al., 
2010). Accumulations of toxic proteins amplify microvascular degeneration and the 
development of edema obstructing capillary flow, resulting in local tissue hypoperfusion and 
hypoxia. These could result in neuronal functional and structural changes resulting in 
secondary, vascular-mediated neurodegeneration (Bell et al., 2010). Pericytes also promote 
endothelial cell survival by releasing angiopoietin-1, which binds to the Tie2 receptor on 
endothelia (Sato, 1995). 
1.6.2 Vascular development and stabilization 
Pericytes are, in general, involved in the preservation of vascular homeostasis, including 
regulation of blood flow, angiogenesis, structural stabilization of the vasculature, and vascular 
permeability. Proper vascular development and its maintenance are essential to bringing forth 
the properties of BBB. It is known that the presence of pericytes is critical for normal 
angiogenesis. PDGF-B and its receptor PDGFR-β are involved in BBB maintenance by the 
recruitment or differentiation of pericytes to sites of angiogenesis or neurovascularization 
(Gerhardt and Betsholtz, 2003). Mice deficient in PDGF-β or its receptor develop identical 
vascular phenotypes exhibiting pericyte-depleted vessels leading to neonatal lethality, 
microvascular leakage, and haemorrhage (Leveen et al., 1994, Soriano, 1994). 
Pericytes influence the local extracellular matrix (ECM) by modulating the deposition of 
basement membrane proteins to guide endothelial migration (Davis, 2011). Depending upon 




function, and that could be the reason for their heterogeneous coverage among different 
organs. For example, in the brain, the high-density pericytes prevent the fluctuations in the 
sensitive environment of the central nervous system (CNS), by tightly regulating the blood-
brain barrier as a selectively permeable fortification. In skeletal muscle, the pericyte coverage 
is meager as one pericyte for every 100 ECs (Shepro and Morel, 1993). Liver (stellate cells) 
and kidney pericytes aid parenchymal functions, which have garnered attention for their 
essential role in liver and kidney fibrosis (Humphreys et al., 2010, Schrimpf and Duffield, 
2011, Greenhalgh et al., 2013). Decreased pericyte coverage in the brain leads to 
neurodegeneration (Quaegebeur et al., 2010), which is similar to the tumor growth where 
loose pericyte coverage leads to vascular dysfunction (Gerhardt and Semb, 2008, You et al., 
2014). During tumor vascularization, pericytes contribute to angiogenesis. Loss of pericytes 
or abnormal pericyte function in tumors increases vessel permeability and decreases vessel 
integrity,  which enhances the metastatic potential of the tumor. (Cooke et al., 2012). 
The dynamics of pericytes during angiogenesis include recruitment, ECM modulation, 
paracrine signalling, and direct interactions with ECs. The vessel stabilization occurs by 
involving two essential components: the perivascular extracellular matrix, i.e., the vascular 
basement membrane and the recruitment and integration of pericytes into the vessel wall. The 
contact of single pericytes with several ECs suggests that they may mediate and integrate 
specific endothelial function (stabilization) of neighboring ECs (Gerhardt and Betsholtz, 
2003). A specialized ECM known as the vascular basement membrane (vBM) that is 
deposited around the cells within the blood vessel wall, confers stability and provides a 
scaffold for signalling proteins as the vessels develop (Kalluri, 2003, Davis and Senger, 
2005). A critical component of the vBM is the Type-IV collagen (Col-IV), where the 




pruning, or stabilization (Baluk et al., 2003, Stratman et al., 2010, Alavi et al., 2016, Dave et 
al., 2018). 
1.6.3 Vessel contractility 
Pericytes reside on the microvasculature in the absence of smooth muscle and may serve in a 
contractile capacity similar to the smooth muscle cells of larger vessels. Vasoconstriction and 
vasodilation are produced within capillary beds, where the pericytes could regulate vascular 
diameter and capillary blood flow through this contraction property (Rucker et al., 2000). The 
detection of contractile proteins, such as actin filaments in pericytes, strongly indicates their 
contractile property. It has been shown that muscle-specific actin is present only in pre- and 
post-capillary regions (arterioles and venules), while those of the actual capillaries appear to 
lack the muscle-specific form (Nehls and Drenckhahn, 1991, Boado and Pardridge, 1994), 
indicating heterogeneity within the pericyte population. A study has found that capillary 
pericytes in mice and humans do not express smooth muscle actin and are morphologically 
and functionally distinct from adjacent precapillary smooth muscle cells (SMCs) (Hill et al., 
2015). Studies using in vitro techniques support the contractile functions of these cells, but the 
studies using in vivo techniques have been difficult to prove. In situ studies using 
morphometric analysis have proven the changes in the extension of pericyte processes and 
buckling of the endothelium after application of vasoactive substances (Tilton et al., 1979, 
Buchanan and Wagner, 1990). Another study has shown that neuronal activity and the 
neurotransmitter glutamate evoke the release of messengers that dilate capillaries by actively 
relaxing pericytes. In pathology, ischemia evokes capillary constriction by pericytes which is 
followed by pericyte death, which may irreversibly constrict capillaries and damage the 




Pericytes have also been reported to display excitable properties, including the generation of 
action potentials (Helbig et al., 1992). The contraction of pericytes causes a decrease in the 
vessel diameter in the capillary beds during the contacts of the "peg-and-socket" junctions 
with the ECs. A vasoactive peptide called Angiotensin II is present in various areas of the 
brain and causes vasoconstriction. This peptide is present in some neurons and nerve 
terminals in situ and is associated with microvessels, whereas the pericytes in vitro contain 
specific angiotensin II binding sites (Rucker et al., 2000). The contractility of pericytes is also 
influenced by various metabolic factors, particularly the levels of carbon dioxide and oxygen 
(Bergers and Song, 2005).  
Additionally, vascular smooth muscle cells (vSMCs) can be further sub-classified as either 
contractile or synthetic. During both neovascularization in the embryo (Ball et al., 2010) and 
vessel development, vSMCs take on a synthetic phenotype; in adult blood vessels, these cells 
are committed to a contractile phenotype, taking on the important task of vessel stabilization 
(Owens et al., 2004). The principal function of contractile vSMCs is, as its name suggests, 
contraction. At a cellular level, the contractile vSMC phenotype is characterized by a spindle-
shaped morphology, cell quiescence, marked by the cell’s low proliferative capacity, and 
increased contractile protein expression (Beamish et al., 2010). In healthy vessels, contractile 
vSMCs wrap circumferentially rather than longitudinally around blood vessels and improves 
the mechanical properties of the vessel (Clifford, 2011). Fibroblast growth factor 9 has been 
suggested to induce wrapping of vSMC around endothelial tubes, supporting their continuous 
stabilization (Frontini et al., 2011). 
1.6.4 Glial scar Formation 
Approximately 10% of the total population of the pericyte subtype gives rise to a scar forming 




their perivascular location and acquire markers specific to fibroblasts post recruitment to the 
site of injury. They produce extensive networks of extracellular matrix proteins by forming a 
'seal' to the injured tissue, which eventually forms connective tissue and makes up the stromal 
component of scar tissue, which prevents the tissue from further damage. It has been thought 
that astrocytes were the only cells that played this role, and so it was referred to as glial scar 
(Sofroniew 2009). However, pericytes are also involved in scar formation along with 
fibroblasts and myofibroblasts or may constitute progenitors (Schrimpf and Duffield 2011, 
Dragunow 2013). 
1.6.5 Immune Function 
Several studies, mostly in vitro, show that pericytes may serve as macrophages and are 
considered as brain macrophages. These cells showed characteristics reminiscent of 
macrophages by the presence of numerous lysosomes and an efficient uptake via phagocytosis 
(Thomas 1999). Pericytes contain components that are recognized by the macrophage-
selective monoclonal antibodies such as ED2 (Balabanov, Washington et al. 1996) and class 
II major histocompatibility complex (MHC) and capacity to present antigen to T-lymphocytes 
(Graeber, Streit et al. 1992) in tissue culture. Pericytes also produce chemoattractants and 
promote transmigration to the brain of circulating immune cells, starting an inflammatory 
process. During this process, they also release inflammatory mediators such as IL-1β, IL-6, 
tumor necrosis factor (TNF) and other matrix metalloproteinases (MMP-2 and MMP-9), 
which contribute to pericyte detachment and BBB disruption (Kovac, Erickson et al. 2011). 
These immunoreactive properties of pericytes suggest the mechanisms by which they can act 
as an integral part of BBB during the brain inflammatory process (Hurtado-Alvarado, 




1.6.6 Multipotency of pericytes   
Multipotency is the ability of a cell to differentiate into discrete cell types. Recently, there has 
been increased interest in pericytes due to their multipotentiality and their emerging role in 
tissue repair in different organs.  
1.6.6.1 Pericytes exhibit mesenchymal stem cell characteristics 
The similarities between MSCs and pericytes have been well documented (Schwab and 
Gargett, 2007, Covas et al., 2008). Two interesting studies provided evidence that MSCs are 
perivascular cells, such as pericytes (Covas et al., 2008, Crisan et al., 2008a, Crisan et al., 
2008b). They have identified that pericytes in culture also exhibit the surface antigens of 
MSCs like CD44, CD73, CD90, and CD105. The similarity of MSCs in vivo as pericytes 
explains the possibility that MSCs can be cultured from all tissues and could function as a 
source of stem cells for the regeneration of local lesions (da Silva Meirelles et al., 2008). 
Pericytes have been shown to differentiate into numerous cellular population like osteoblasts 
(Doherty et al., 1998), chondroblasts, adipocytes (Farrington-Rock et al., 2004), smooth 
muscle cells (Hirschi et al., 1998), fibroblasts (Sundberg et al., 1996), cells of neuronal 
lineage (Dore-Duffy et al., 2006) and Leydig cells (Davidoff et al., 2004) and have thus been 
hypothesized to function like MSCs or perhaps precursors of MSCs in vivo (Caplan, 
2008).  Balabanov et al. have previously shown that CNS pericytes differentiate to a 
macrophage/dendritic cell phenotype in primary culture (3- to 5-day-old) and express CD80 
and CD86 costimulatory molecules in vivo (Balabanov, Washington et al. 1996).  
The exact mediators that control the differentiation of pericytes are still under investigation, 
but the multipotency of pericytes can be utilized as a target for therapeutic intervention for 
several diseases. An exciting example of pericyte multipotency is from the dental pulp, where 




example uses peripheral pericytes, and there is increasing evidence at the single-cell 
transcriptomic level that there are molecular and functional differences between brain-derived 
pericytes and pericytes residing in the periphery (Brown et al., 2019).  
1.6.6.2 Multipotentiality of pericytes in response to injury 
Regeneration of NVU components serves as a reconstructive mechanism in neuropathology. 
Pericytes isolated from ischemic areas have been reported to express stem cell markers and 
subsequently differentiated into various cell types, including microglia-like cells with 
phagocytic capacity. In response to infection, injury, or inflammation, pericytes release a wide 
variety of regulatory molecules and migrate from their vascular location into the perivascular 
space (Dore-Duffy et al., 2000). After migration in the perivascular space or primary culture, 
the CNS pericyte responds to signalling molecules that induce differentiation. Dore-Duffy et 
al. have first shown that CNS microvascular pericytes are Nestin/NG2 positive and are a 
source of adult multipotential progenitor cells (Dore-Duffy, Katychev et al. 2006). A study 
suggests that during the vessel damage or inflammation, the adult pericytes become activated 
MSCs. These activated MSCs respond by secreting a cascade of bioactive molecules that 
control the surrounding immune cells (Caplan, 2016).  
In a significant finding by Ozen et al., it was reported that pericytes robustly proliferate, 
migrate out of the vasculature and differentiate in response to ischemic brain injury. They 
demonstrated that pericytes acquired a microglial phenotype in response to hypoxia/ischemic 
conditions, both in vivo and in vitro (Ozen, Deierborg et al. 2014). Consistent with the 
phenotypic transformation of pericytes in vivo, human brain-derived pericytes exposed to 
hypoxic conditions in vitro changed their morphology, expressed microglial markers and 
upregulated mRNA for several microglial genes (Ozen, Deierborg et al. 2014). Sakuma et al. 




under pathological conditions. Under normal conditions, the quiescent pericytes are inactive. 
However, post-ischemia, they become active and acquire stemness genes like Nestin, klf4, 
cmyc, and sox-2 and can differentiate into microglia cells (Sakuma, Kawahara et al. 2016). 
In a recent study by Nakagomi et al., it was demonstrated for the first time that brain vascular 
pericytes develop stemness following ischemia/hypoxia (Nakagomi et al., 2011). They 
emphasized that pericytes retain a multipotent stem cell activity during the conditions of 
stroke/ischemia. Along with maintaining their original mesenchymal stem cell phenotype, 
they developed a complex phenotype of angioblasts and differentiated into neuronal and 
vascular lineages post-ischemia. This leads to a novel concept that brain pericytes can be 
targeted after an event of injury to promote both neurogenesis and angiogenesis (Nakagomi, 
Kubo, et al. 2015). In a more recent study, Nakata et al. demonstrated that ischemia-induced 
neural stem cells (iNSCs) (Nakata, Nakagomi et al. 2016) could be induced under conditions 
of non-lethal and lethal ischemia/reperfusion injury following transient cerebral artery 
occlusion. Also, they showed that iNSCs induced under these conditions originate from brain 
pericytes and that pericyte-derived iNSCs have the potential to produce neurons in vivo and in 
vitro. 
In a study conducted on Sprague-Dawley rats, pericytes isolated from aorta were shown to 
have pluripotent nature that could be induced to neural differentiation. When induced to 
neural differentiation with retinoic acid, the pericytes expressed pluripotent marker stage-
specific embryonic antigen-1 (SSEA-1), neural cell-specific β-tubulin, neural filament-200, 
and glial fibrillary acidic protein suggesting that pericytes undergo differentiation similar to 
neuroectodermal cells. The differentiated cells also responded with intracellular calcium 
transients to membrane depolarization by KCl, indicating the presence of voltage-gated ion 
channels and express functional N-methyl-D-aspartate receptors, characteristic for functional 




Given the above-detailed elaboration of pericyte interaction, within NVU, with adjacent 
milieu and their functional properties in maintaining brain homeostasis, they can be 
considered as a population of therapeutic efficacy. While there are not many in vivo studies 
that demonstrated pericyte transplantation in the brain, Tachibana et al. reported that brain 
implantation of in vitro-differentiated MSC-derived pericytes resulted in reduced amyloid-β 
pathology and enhanced cerebral blood flow in amyloid model mice (Tachibana et al., 2018). 
Although differentiated pericytes were transplanted, the fate of the grafted cells and the 
consequent effect on NVU was not monitored. Moreover, pericytes being heterogeneous in 
their molecular signature based on their distribution and surrounding cellular niche, their 
functions could be tissue-specific and hence their therapeutic efficacy. Also, the brain is 
considered to have the highest density of pericytes to ECs. Therefore, in the first of its kind 
study, the current work aims to transplant pure brain pericytes in the mouse cortex to 
determine the fate of the transplanted cells as well as the resultant impact on the 










1.7 Project aim and hypothesis 
In this thesis, I aimed to study the role of iRFP+ pericytes grafted into the mouse motor cortex. 
In order to graft pure pericyte populations, it was important to isolate, characterise and enrich 
the mouse cortical pericytes using pericyte positive and negative markers. The cortical 
cultures were characterised primarily by validating the pericyte positive and negative markers 
in situ and by growing in Dulbecco's modified eagle media (DMEM) and Pericyte media 
(PM) after 7 and 14 days of culturing for up to 3 passages (Chapter 3).  
To graft pure pericytes, I needed to purify the enriched pericyte culture by live FACSorting 
using FACS specific pericyte positive markers. The purified pericytes were lentivirally 
transduced to express Red Fluorescent Protein (iRFP) to distinguish between exogenous and 
endogenous pericytes. The transduced pericytes were again FACSorted based on iRFP 
expression to ensure all the grafted pericytes were iRFP+ pure pericytes (Chapter 4). 
My final aim was to graft iRFP+ pericytes into the mouse motor cortex (Chapter 5) and study 
their phenotypic changes within the injection site and also evaluating any effects of pericyte 
grafting using a forelimb specific motor behavioural test. I hypothesise that the exogenous 
pericytes integrate into the host vasculature, and to test this, the grafted tissues were labelled 
with pericyte-positive markers (PDGFR-β and α-SMA), and their expression analysed. I also 
hypothesise that pericytes transdifferentiate into glia and would provoke an immune response.  
To analyse this, the grafted cortex was labelled for the expression of Iba-1 (microglia) and 
GFAP (astrocytes) and further analysed for co-labelling of exogenous pericytes with Iba-1 
and GFAP. Since the graft is unilateral into the left motor cortex, the idea was to understand if 
the graft alters the motor behaviour of the mice. The performance of the mice was detected 




test. As future studies will be conducted in cortical stroke mice, the poor performance of these 
mice will be evaluated and hence the same cylinder behaviour test was used in this study.   
1.8 Key objectives 
• To isolate, characterise and enrich cortical pericytes by standardising the protocols and 
validating the pericyte markers. 
• To obtain pure pericyte populations using live FACSorting and further transducing 
with lentivirus to express iRFP to distinguish between exogenous and endogenous 
pericytes post grafting. 
• Molecular phenotyping of grafted pericytes and evaluating the fate of iRFP+ grafted 





































2.1 Animal Model 
A transgenic modified mouse strain Rasgrf 2-2AdCre; Camk2a-ttA; Ai78, obtained from the 
Allen Institute for Brain Science, was used for all our experiments. Triple transgenic mice that 
are positive for dCre, tTA and VSFP Butterfly genes express high levels of VSFP Butterfly 
1.2 in pyramidal neurons of cortical L2/3 driven by the TRE promoter (Empson et al., 2015, 
Madisen et al., 2015). The non-triple transgenic littermates that do not express one of the 
above genes (VSFP Butterfly non-expressers) were used for our cell culture, surgical, 
behavioural and histological experiments. All animal husbandry and ethical procedures were 
conducted under the approved guidelines of the University of Otago Animal Ethics 
Committee (AEC 12/17 and AUP-18-85). The overview of the methodology is schematically 






Figure 2.1 Schematic representation of the experimental procedure.   
The cortical tissues were collected from 4-6-week-old mice and were cultured in DMEM/ PM for 
characterization of pericytes. Enriched pericytes were obtained when the cells were cultured in PM 
and were validated by ICC and PCR. Enriched pericytes were further purified by FACSorting. The 
FACSorted cells were lentivirally transduced to express iRFP reporter. The iRFP+ pericytes were 
collected by live FACSorting and grafted into the mouse cortex. The behaviour analysis was 
performed to study the motor deficits pre and post grafting. The grafted tissues were validated by IHC 
and imaged using a confocal microscope.  
DMEM – Dulbecco's modified eagle medium; PM – Pericyte medium; ICC – Immunocytochemistry; 
PCR – quantitative polymerase chain reaction; FACS – fluorescence-activated cell sorting; LV – 





2.2 Cell culture methods 
2.2.1 Isolation of mouse brain cortical pericytes 
Mouse brains were collected from six 6-8-week-old mice. Approximately 2 g of brains were 
weighed and stored in ice-cold Hanks balanced salt solution (HBSS, ThermoFisher 
Scientific), then finely diced with a scalpel blade and transferred to an Eppendorf tube 
containing 50 mL pre-warmed HBSS. Tissue was allowed to settle for 1 min, and HBSS was 
removed. Samples were resuspended in digestion media (Figure 2.2) containing 2.5 U/mL 
papain (Worthington Biochemical Corporation, NJ, US) and 10 U/mL DNase I (Invitrogen, 
NZ) in HBSS and rotated on MACS rotor for 15 min at 37 ⁰C. The Eppendorf tube was 
removed from the incubator and titurated 5 times through a 10 mL strip pipette and rotated in 
the incubator again for 15 min. The tissue was titurated again and was allowed to settle for 1 
min before collecting the supernatant and transferred to equal volumes of warm Dulbecco's 
modified eagle medium (DMEM, ThermoFisher Scientific) supplemented with 10% 
Antibiotic-Antimycotic (100x, ThermoFisher Scientific). The complete solution was filtered 
through a 100 µm filter. The cell suspension was equally divided between the 50 mL tubes 
and was centrifuged at 1000 x g for 8 min, and the pellet was resuspended into 15 mL 
DMEM.  
2.2.2 Culturing mouse cortical pericytes 
5 mL of the suspension was plated into each of three T75 flasks, and 20 mL of DMEM was 
added to each flask to make up the volume to 25 mL. The flasks were incubated at 37 ⁰C 
overnight. The culture media for each flask was removed that contained debris and unwanted 
cells and was discarded. The adhered cells were carefully washed in 10 mL DMEM, 
transferred to a 50 mL tube and were centrifuged at 1000 x g for 8 min. The cells in the flask 




DMEM and was added to the cells and was incubated for 24h at 37 ⁰C. The culture media was 
removed after 24h and discarded. The adherent cells were carefully washed with 5 mL 
DMEM twice and discarded. Each flask then received 20 mL of fresh warm DMEM, and cells 
continued to culture for 7 and 14 days (Figure 2.2). 
 
Figure 2.2 Schematic representation of the isolation and culturing protocol.  
The isolated mixed cells from 4-6-week-old mice were cultured in DMEM for 7 and 14 days by tissue 
dissection and dissociation using dissociation mix. The cultures post 7 and 14 days were quantified 
using ICC and PCR. 
P0 – Passage – 0; DMEM – Dulbecco's modified eagle medium; PCR – quantitative Polymerase Chain 





2.2.3 Maintenance and passaging of mouse brain pericytes 
The 7/14-day cultures (P0) were washed in 10 mL Dulbecco's phosphate-buffered saline 
(DPBS, ThermoFisher Scientific) gently followed by 5 mL of 0.25% trypsin-EDTA 
(ThermoFisher Scientific) incubated for 3-4 min at 37 ⁰C. Once the cells formed ball-like 
structures, the trypsin-EDTA solution was removed and collected in a falcon tube. The flask 
with the remaining adherent cells was tapped gently onto the sides, and 10 mL of DMEM/ 
Pericyte medium (PM, iXCells Biotechnologies, San Diego, CA) was added to the flask and 
gently titurated. The suspension was pooled into the falcon tube and centrifuged at 1000rpm 
for 8 min. The supernatant was discarded, and 15 mL of DMEM/ PM was added to the pellet. 
The cells were seeded to a 1:3 ratio where, one-third of the solution (5 mL) was replated 
(Figure 2.3) for the next passage (P1) by diluting in 10 mL of DMEM/PM, other third of the 
solution (5 mL) was used for ICC in 24 well plates. The remaining solution (5 mL) was 
centrifuged again at 1000rpm for 5 min. The supernatant was discarded, and the pellet was 
suspended in an antifreeze solution consisting of growth medium (DMEM / PM), FBS and 






Figure 2.3 Schematic representation of passaging the cultures.  
The cultures were passaged thrice in both DMEM and PM in parallel for the enrichment of pericyte 
cultures. 
P0 – Passage-0; P1 – Passage-1; P2 – Passage-2; P3 – Passage-3; DMEM – Dulbecco's modified eagle 





2.3 Immunocytochemistry (ICC) to phenotype cultures 
One-third of the split cells (5 mL) was diluted in 10 mL DMEM/PM and plated onto poly-L-
lysine coated coverslips in 15 wells of a 24-well plate. After overnight incubation at 37 ⁰C, the 
culture media was removed, and the cells were fixed in 4% paraformaldehyde for 15min. The 
cells were washed in PBS with 0.1% Triton X – 100 thrice for 15 min. The cells were then 
blocked in 0.2 mL of blocking solution containing PBS, 0.2% (v/v) Triton X-100, and 10% 
normal goat serum for 1 h at room temperature on the rocker (speed 15-20rpm, VSR-50 Lab 
plus Series, PRO Scientific Inc., USA). Primary antibodies were diluted in antibody solution 
containing PBS with 0.1% (v/v) Triton X-100 and 10% normal goat serum, according to the 
dilution factors listed (Table 2.1).  The cells were incubated in 0.2 mL of primary antibody 
solution overnight at 4 ⁰C. The primary antibody solution was removed, and cells were 
washed in PBS – Triton X-100, 3 times for 10 min in order to remove any unbound primary 
antibody. The secondary antibody was diluted in antibody solution containing PBS with 0.3% 
(v/v) Triton X-100 and 10% normal goat serum, according to the dilution factors listed (Table 
2.2). The cells were incubated in 0.2 mL of secondary antibody solution for 90 min, in the 
dark. A further 3 PBS-Triton X-100 washes were carried out in order to remove any unbound 
secondary antibody. The coverslips containing cells were then mounted on a glass slide with 














Host species Dilution Source/Catalog 
PDGFR-β Pericytes Rabbit 
monoclonal 
1:500 Abcam – ab32570 
α-SMA Pericytes Mouse 
monoclonal 
1:100 ThermoFisher Scientific – 
MA5-11547 
GFAP Astrocytes Rat polyclonal 1:1000 ThermoFisher Scientific – 13-
0300 
NG2 Pericytes Guinea-Pig 
polyclonal 
1:100 Sanford Burnham, LA Jolla, 
CA (Ozerdem et al., 2001). 
 
Table 2.2 List of secondary antibodies used for ICC 
Secondary 
antibody 
Host species Dilution Source/catalog 




1:1000 ThermoFisher Scientific – A27040 




1:1000 ThermoFisher Scientific – A21422 
Alexa Fluor 488 
Donkey anti-rat 




2.3.1 Imaging fixed cells on the coverslip 
Images were obtained using a Nikon AIR confocal laser scanning microscope (Nikon Co., 
Ltd, Japan). Laser lines 448 nm, 507 nm, 561 nm, and 638 nm were used to excite and 
visualize fluorescence emitted by Alexa Flour 405, 488, 555, and 647, respectively. The 
images were scanned at 1/8 speed without averaging for a 512 x 512-pixel image size. All 
images were collected at a single optical plane using a 40x air objective from three random 
fields of a single 13 mm diameter coverslip (Figure 2.4). The passage numbers and the 
timepoints were blinded during imaging and analysis. The images were further analysed on 
Image J software, and the number of cells in each area counted manually, and a single mean 
value was generated for each culture (n=3 separate cultures). 
 
Figure 2.4 Schematic representation of imaging three fields of view from a 13mm diameter 
coverslip.  
Only 6 coverslips from 6 wells were used for quantification and the rest of the coverslips were saved 
for future use. 
DAPI - 4′,6-diamidino-2-phenylindole; GFAP – Glial fibrillary acidic protein; PDGFR-β – Platelet-





2.4 Molecular Biology to phenotype and validate ICC 
2.4.1 RNA extraction using TRIzol 
Cells were lysed by repeated pipetting in TRIzol (Invitrogen, NZ, 1 mL per 5-10x106 cells), 
after which the homogenate was incubated for 5 min at room temperature. Chloroform (80 
µL) was added to the homogenate, and the solution was shaken vigorously for 15 s then 
incubated at room temperature for 3 min. Samples were centrifuged (12,000 g for 15 min at 
4⁰C), and the colorless, upper aqueous phase containing RNA was transferred to a fresh tube 
by angling the tube at 45 ⁰ and pipetting the solution out. RNA was precipitated by mixing 
with isopropyl alcohol (200 µL) and vortexed. The samples were incubated at room 
temperature for 10 min then centrifuged (12,000 g for 10 min at 4⁰C). The supernatant was 
discarded, and the pellet was washed in 75% ethanol (400 µL) and centrifuged (7500 g for 5 
min at 4⁰C). Finally, the pellet was air-dried and then dissolved in 30 µL of RNase free water 
and incubated for 10 min at 55⁰C. A spectrophotometer at a spectrum of 230-280 nm was 
used to determine RNA concentration and protein contamination. The RNA was stored at -
80⁰C. 
2.4.2 cDNA synthesis 
RNA was treated with DNase I prior to cDNA synthesis. Three hundred nanograms of RNA 
was added to 10X DNase I buffer and 1 µL of DNase I in a 10 µL reaction. After gentle 
mixing, the reaction was incubated at room temperature for 15 min. One microliter of EDTA 
was added and incubated at 65 ⁰C for 10 min to inhibit DNase I activity.  
For cDNA synthesis, a reaction mixture (master mix) was prepared with a 25X dNTP mix, 10 
x RT buffer, 10 x RT random primer. Reverse transcriptase (1 µL) was added to each sample 




C1000TM Thermal cycler at 25 ⁰C for 10 min, 37 ⁰C for 120 min, and then 85 ⁰C for 5 min 
before cooling samples to 4 ⁰C. The resulting cDNA was aliquoted and stored at -20 ⁰C. 
2.4.3 Polymerase chain reaction (PCR) 
The reaction mixture was composed of 1 x PCR buffer (10 mM Tris-HCl and 50 mM KCl), 
1.5 mM Mg Cl2, 200 nM dNTPs, 200 nM each of forward and reverse primer and 2 U of Taq 
polymerase (Life Technologies) in a 19 µL of H2O. PCR was always performed with the 
Gapdh housekeeping gene to determine successful cDNA synthesis by acting as a normaliser 
for expression of genes of interest. Gapdh is stably and constitutively expressed at high levels 
in many tissues and cells. All the primers were ordered from Sigma which contains the 
database with exon sequences of pre-designed primers. For PCR, a standardised annealing 
temperature for each primer was set up as suggested by Sigma. The primer sequences for all 
the genes analysed are listed in Appendix 3 that were pre-designed and obtained from Sigma-
Aldrich. The size of the amplified product was identified corresponding to the size of the 
ladder loaded in a separate well. H2O and -RT were used as negative controls to rule out the 
possibility of contamination. 
The PCR protocol consisted of enzyme activation at 94 ⁰C for 3 min followed by 30 cycles of 
denaturation at 94 ⁰C for 15 s, annealing at 55 ⁰C for 15 s, extension at 72 ⁰C for 15 s and a 
final extension at 72 ⁰C for 5 min. All PCR protocols and cDNA synthesis protocols were 
performed using a Bio-RAD C1000TM Thermal Cycler.  
2.4.4 Agarose gel electrophoresis 
The PCR products were electrophoresed on 1.5% agarose gels made with 1 x TAE buffer. 
SYBR safe (3 µL; Invitrogen, NZ) was added before setting the gel in a casting tray. Loading 




kb plus DNA ladder (Invitrogen, NZ). Gels were submerged in 1 x TAE buffer and 
electrophoresed at 100 V for 30 min using a Bio-RAD PowerPac HC. When the loading dye 
had run more than half-way, the gel was removed for imaging. Gels were imaged using a Bio-
RAD DocTM XR+ system.  
2.5 Fluorescence-activated cell sorting (FACS) 
2.5.1 Cell preparation 
Once the desired cell number was achieved, and the cultures were confluent, the cells were 
subjected to FACS and analysed. Adherent cells were detached by a 4 min incubation with 
0.025% trypsin-EDTA and resuspended in 10 mL DMEM/PM and centrifuged at 1000rpm for 
8 min. The pellet was resuspended in 1 mL staining buffer, with a 10 µL aliquot taken for 
counting in a haemocytometer using Trypan blue to distinguish non-viable cells.  
2.5.2 FACS protocol 
In preparation for fluorescence-activated cell sorting (FACS), cells were resuspended at a 
concentration of 8x106 / mL and incubated with all antibodies (Table 2.3). As controls, 4x106 
cells were divided into four tubes containing 1x106 cells/tube, and the remaining cells were 
used for sorting after passing the cell suspension through a 70 µm strainer. The cell 
suspensions were incubated with the antibodies on ice and in the dark for 60 min then washed 
with staining buffer (PBS and 10% FBS) by centrifuging at 300rpm for 5 min at 4 ⁰C. The 
supernatant was discarded, and the cell pellet was resuspended in 1 mL suspension buffer 
(HBSS, 10% FBS, and 25 mM HEPES). DAPI (0.1 µg/mL) was added to cell suspension 5 
min prior to cell sorting. The FACSAria with BDFACSDiva software (BD biosciences, AU) 
and a 70 µm nozzle was used to sort cells, with assistance from the University of Otago flow 




settings were optimized using negative controls (Appendix 2). The list of antibodies used for 
FACSorting is given in Table 2.3. Unstained cells were used to account for the 
autofluorescence of samples, and the signal from DAPI labelled cells was used to eliminate 
dead cells, dead cells being the brightest for DAPI. The forward scatter (FSC) represents the 
size of the event, whilst the side scatter (SSC) indicates the cell granularity. Prior to the 
selection of pericyte populations, a side versus forward-scatter plot (SSC vs. FSC) was used 
to remove the debris (small-sized cells to the extreme left), followed by a height versus width 
plot (SSC-H vs. FSC-W) to eliminate the doublets from the selected pericyte population. 
Excitation of fluorophores used a 633 nm laser with detection from 660/20 filter and 407 nm 
laser and detection from 450/40 filter (DAPI). The live cells from a DAPI negative population 
and positive for pericyte marker (PDGFR-β/CD140b, NG2) were directly collected live into 
pericyte specific growth medium (Figure 2.5) (Kikuchi et al., 2015). The percentage of the 






Figure 2.5 Schematic representation of imaging three fields of view from a 13mm diameter 
coverslip.  
The enriched pericytes were processed and labelled using the CD140b antibody. The labelled cells 
were live sorted based upon the marker expression on the cells. The CD140b+ pericytes were collected 
















Host species Dilution Source/Catalog 




Abcam – ab32570 





LA Jolla, CA 










Scientific - A31364 





Scientific – A21435 





Scientific – A21247 
 
2.5.3 Culturing FACSorted pericytes in PM 
Samples containing the sorted pericytes were then suspended at a ratio of 104 cells per 1 µL of 
pericyte medium (PM) in a 24-well plate and were cultured by repeated passaging once 
confluent to enrich for the pure population of pericytes. The cells were then incubated at 37 




and then T25-flasks. After the desired number of cells was achieved, the cells were 
transduced to express Red Fluorescent Protein (iRFP) using lentivirus prepared as below. 
2.6 Lentiviral Transduction 
2.6.1 Lentiviral production 
Lentivirus was prepared by Dr. Alison Clare (Department of Biochemistry), and three 
components required to generate lentivirus were transfected into a HEK293FT cell as three 
individual plasmids. The 293FT Cell line is ideal for generating high-titer lentivirus. The 
293FT Cell Line is a fast-growing, highly transfectable clonal isolate derived from human 
embryonal kidney cells transformed with the SV40 large T antigen. The first one was the 
packaging vector (psPAX2) that expresses the required genes gag (capsid) and pol (protease, 
reverse transcription, and integrase). The second one was the envelope vector that expresses 
the envelope glycoprotein of choice, which binds to the target cell. Vesicular stomatis virus 
glycoprotein (VSVg) was used in this production due to its broad tropism. The third 
component was the transgene vector that expresses the desired transgene (Figure 2.6). 
Transducing viral units were produced within the 293FT cells and released into the media. 





Figure 2.6 Schematic representation of vector packaging for Lentiviral production. 
The three components required to generate lentivirus are transfected into a HEK293FT cell as three 
individual plasmids: 1) The packaging vector (psPAX2) expresses the required genes gag (capsid) and 
pol (protease, reverse transcriptase and integrase), 2) The envelope vector expresses the envelope 
glycoprotein of choice which binds to the target cell. In this case the vesicular stomatis virus 
glycoprotein (VSVg) was used due to its broad tropism (Finkelshtein et al., 2013), 3) The transgene 
vector that expresses the desired transgene. Transducing viral units are produced within the 293FT 
cells and released into the media. The virus is harvested from the media 48 hours after the transfection 







2.6.2 Lentiviral transgene construct 
The infra-Red Fluorescent Protein (iRFP) encoding sequence was cloned into a lentiviral 
plasmid backbone with one of three constitutively expressed promoters. Two of the promoters 
were synthetic promoters created from a combination of sequences. The first promoter was 
the CAG promoter, which is a CMV early enhancer/chicken β actin. The second promoter 
was MND, which is a U3 region of a modified MoMuLV LTR with myeloproliferative 
sarcoma virus enhancer. The third promoter was the constitutively expressed EF1α promoter 
derived from the human elongation factor 1 alpha (Figure 2.7). All cloning work was carried 
out by Dr. Alison Clare. 
 
 
Figure 2.7 Schematic representation of different promoters attached to the plasmid backbone.  
The iRFP encoding sequence (Filonov et al., 2011) was cloned into a lentiviral plasmid backbone with 
one of three different constitutively expressed promoters. Two of the promoters are synthetic 
promoters created from a combination of sequences a) CAG promoter (CMV early enhancer/chicken β 
actin;(Qin et al., 2010) and b) MND (U3 region of a modified MoMuLV LTR with myeloproliferative 
sarcoma virus enhancer;(Li et al., 2010), c) The third promoter is the constitutively expressed EF1α 
promoter (derived from the human elongation factor 1 alpha promoter;(Qin et al., 2010). LTR; long 









2.6.3 Lentivirus titer- information – provided by Dr. Alison Clare 
Functional titer: Virus was added to HT1080 cells, and the total transduced cells were 
averaged from three frames (20 x magnification). HT1080 is a fibrosarcoma cell line that 
carries an IDH1 mutation and an activated N-ras oncogene. To calculate the number of 
transducing units per mL, the number of transduced cells, the fraction of the total area of the 
well, and the dilution factor of the virus were considered (Table 2.4).  
Genomic titer: Absolute quantitative PCR was used to determine the number of genomic 
ssRNA molecules, using a standard curve of the transgenic plasmid used in the generation of 
the virus (Table 2.4).  
 
Table 2.4 Functional and genomic titer of viruses containing the three different 
promoters  
Lentivirus (transgene) Functional titer Genomic titer 
CAG-iRFP 3.62 x 108 6.62 x 1010 
MND-iRFP 3.65 x 108 3.23 x 1011 






2.6.4 Lentiviral transduction of pericytes to express iRFP and enrichment prior to 
stereotaxic injection 
FACSorted pericytes (Section 2.4.2) were seeded in a 24-well plate as described above. On 
the next day, the medium was replaced by PM containing LV expressing one of the 
promoters. Two days post-transduction (48 h), the media with the virus was discarded in 1% 
Virkon. The transduced cells were trypsinized as previously described and suspended in 1 mL 
PM. 
2.6.5 FACSorting and collecting the transduced cells 
The transduced cells expressing iRFP along with the controls (untransduced cells and cells 
with DAPI) were prepared for FACSorting. The FACSAria with BDFACSDiva software (BD 
biosciences, AU) and a 70 µm nozzle was used to sort cells, with assistance from the 
University of Otago flow cytometry suite technician Michelle Wilson. Prior to sorting, the 
fluorescence compensation settings were optimized using negative controls (Appendix 2). 
Untransduced cells were used to account for the autofluorescence of samples, and DAPI was 
used to eliminate dead cells. Prior to the selection of the iRFP+ population, a side versus 
forward-scatter plot (SSC vs. FSC) was used to remove the debris (small-sized cells to the 
extreme left), followed by a height versus width plot (SSC-H vs. FSC-W) to eliminate the 
doublets from the selected pericyte population. Excitation of fluorophores used a 633 nm laser 
with detection from 660/20 filter and 407 nm laser and detection from 450/40 filter (DAPI). 
The live cells positive for iRFP were directly collected in pericyte specific growth medium 
(Kikuchi et al., 2015). The sorted iRFP+ pericytes were centrifuged at 300rpm for 5 min at 4 




2.7 Stereotaxic surgery 
All surgical tools were sterilised in an autoclave before surgery. The stereotaxic equipment 
was disinfected with 70% (v/v) ethanol and covered with a sterile surgical drape. A sterile 10 
µL Nanofil syringe and 33 G needle assembly (World Precision Instruments, US, FL) were 
loaded with either 6 – 7 µL (50,000 cells / µL) of pure sorted iRFP+ pericytes dissolved in 
HBSS or HBSS alone. 
Mice (3 – 4 months old) were anaesthetised by subcutaneous injection of 150 mg/kg 
ketamine, 1.5 mg/kg domitor, and 0.05 mg/kg atropine. Breathing and pedal withdrawal 
reflex were checked throughout the surgery after this point. Once sedated, the mouse was 
shaved at the surface of the head, and the area swabbed with 70% (v/v) ethanol and iodine 
solution. Lopaine (2 mg/kg) was injected at the surgical site, and 5 mg/kg carprieve was then 
delivered subcutaneously, as it is an analgesic non-steroidal anti-inflammatory agent that 
helps in reducing the pain. Tricin (Jurox, AU) applied to the eyes prevented corneal drying. 
After checking the pedal reflex, the animal was fixed securely on the stereotaxic equipment 
using the 45⁰ non-rupture ear bars and inserting the nose clamp gently into the mouth 
(310037R, Köpf Instruments). The ear bars and nose clamp were adjusted to ensure the skull 
was levelled, and the mouse covered with a sterile drape, leaving the head exposed. Before 
making an incision, the pedal reflexes were checked, and surgery did not proceed until 
reflexes were absent.  
A midline incision was made in the scalp using a sterile scalpel blade, and the exposed skull 
was swabbed with 70% (v/v) ethanol to clear subcutaneous tissue. The coordinates for bregma 
were located using the tip of the Nanofil syringe needle, and the coordinates for the injection 
site was identified in mm from the bregma, anterior +0.9, lateral +1.5 and depth -0.5. A small 




from the needle to ensure no blockage before lowering the needle to the surface of the brain 
tissue. The depth of the incision was measured from this point, where the syringe was allowed 
to sit inside the tissue for 10 min before the injection (unilateral). Either 1 µL of iRFP+ 
pericytes or 1 µL of HBSS was infused slowly, driven at a rate of 75 nl/min using an 
UltraMicroPump microinjector operated by a remote digital SYS-Micro4 Controller (World 
Precision Instruments, US, NJ). To avoid any backflow to the brain surface, the needle was 
allowed to sit for 5 min post-injection before slowly retracting from the tissue. The injections 
were unilateral and always on the left-brain hemisphere for all the animals. 
The surgical area was cleaned with sterile saline before closing the wound with wax coated 
silk sutures. Sterile saline (200 µL) was delivered subcutaneously to aid post-surgery recovery 
followed by injection of antisedan to reverse anaesthesia. Animals were monitored according 
to the animal welfare guidelines of the University of Otago to observe the water intake and 
any signs of pain. The monitoring was done every hour for the first three hours after surgery 
and every day for four days post-surgery. 
2.8 Post grafting Detection in the Motor Cortex 
2.8.1 Fixing mouse brain tissue 
Mice were anaesthetised 96h post grafting by intraperitoneal (IP) injection with 150 mg/kg 
ketamine and 2mg/kg domitor, and the absence of pedal reflexes checked before making an 
incision. The thoracic wall and upper abdominal cavity were exposed by making a 5 - 6 cm 
incision along the midline through the skin and abdominal wall.  The liver was separated from 
the overlying diaphragm, and an incision was made along the entire diaphragm to visualise 
the base of the lungs and heart. The ribcage was cut open to expose the thoracic cavity, and 




blunt needle was pierced into the left ventricle at the apex of the heart. The right atrium was 
snipped with a fine pair of 70% (v/v) ethanol sterilised scissors where the blood was flushed 
out with PBS and the animal was immediately perfused with 25ml of 4% (w/v) 
paraformaldehyde (PFA) fixative solution.  
2.8.2 Post perfusion fixation and storage 
The brain was then removed using blunt tweezers and post-fixed for 24 hours in 4% PFA at 4 
⁰C, before cryoprotecting in 30% (w/v) sucrose for 2 days at 4 ⁰C. The sucrose infiltrated 
brains were frozen in dry ice and stored at -80 ⁰C for weeks to months. 
2.8.3 Preparation of cortical slices  
Coronal sections, 30 µm thick, were cut using a sledge microtome (Leica SM2400, Germany), 
where the specimen cutting stage was cooled by dry ice. Once the specimen stage was cooled, 
a small mound was made with PBS. A previously sectioned motor cortex chunk incorporating 
the injection site was placed over the PBS mound and covered with a few drops of PBS 
oriented coronally to the cutting blade. Coronal cortical slices were cut by sliding the stage 
under the blade and were transferred to 24-well plates using a small brush. The plates were 
filled with an antifreeze solution and stored at -20⁰C for long-term storage. The mouse brain 
atlas (Franklin and Paxinos, 2008) was used as a reference to identify the injected regions in 
the mouse motor cortex. The analysis was done on six cortical sections with intervals of 90 
µm choosing from  1.72 mm anterior to bregma to 0.10 mm posterior to bregma. 
2.8.4 Immunohistochemistry  
For IHC experiments, 30 µm coronal mouse cortical tissues were used. Free-floating sections 
were washed in PBS thrice for 10 min and permeabilized in 0.3%  (v/v) Triton X-100 twice 




Scientific Inc., USA). The slices were then blocked in 0.2 mL of blocking solution containing 
PBS, 0.3% (v/v) Triton X-100 and 10% normal goat serum for 1 h at room temperature. 
Primary antibodies were diluted in antibody solution containing PBS with 0.3% (v/v) Triton 
X-100 and 10% normal goat serum, according to the dilution factors listed (Table 2.5). The 
slices were incubated in 0.2 mL of primary antibody solution overnight at 4 ⁰C. The primary 
antibody solution was removed, and cortical tissue slices were washed in PBS – Triton X-100 
3 times for 10 min in order to remove any unbound primary antibody. The secondary antibody 
was diluted in antibody solution containing PBS with 0.3% (v/v) Triton X-100 and 10% goat 
serum, according to the dilution factors listed (Table 2.6). The slices were incubated in 0.2 
mL of secondary antibody solution for 90 min, in the dark. A further 3 PBS – Triton X-100 
washes were carried out in order to remove any unbound secondary antibody. The slices were 
then mounted on a glass slide and were coverslipped with aqueous anti-fade mounting 
medium containing DAPI before the slices were completely airdried.  





Host species Dilution Source/catalog 
GFAP Astrocytes Rat polyclonal 1:1000 ThermoFisher Scientific – 13-
0300 
Iba1 Microglia Rabbit 
polyclonal 
1:100 ThermoFisher Scientific – 
PA5-21274 
PDGFR-β Pericytes Rabbit 
monoclonal 




α-SMA Pericytes Mouse 
monoclonal 
1:100 ThermoFisher Scientific – 
MA5-11547 
 
Table 2.6 List of secondary antibodies used for IHC 
Secondary 
antibody 
Host species Dilution Source/catalog 
Alexa Fluor 647 
Goat anti-rabbit 
Rabbit monoclonal 1:1000 ThermoFisher Scientific – A27040 
Alexa Fluor 555 
Goat anti-mouse 
Mouse monoclonal 1:1000 ThermoFisher Scientific – A21422 
Alexa Fluor 488 
Donkey anti-rat 
Rat polyclonal 1:1000 ThermoFisher Scientific – A21208 
 
2.8.5 Image acquisition 
Images were acquired using a Zeiss LSM 710 upright fixed stage confocal microscope. Laser 
lines 448 nm, 507 nm, 561 nm, and 638 nm were used to excite and visualize fluorescence 
emitted by Alexa Flour 405, 488, 555, and 647, respectively. The images were scanned at ¼ 




single optical plane or a Z stack with a thickness of 0.8 µm using a 63x magnification. The 
images across all groups were taken with identical image acquisition settings and exposure 
times. Three fields of view around the injection site were imaged from each slice, and a mean 
value generated for each animal (n=each animal). The analysis was done on six cortical 
sections with intervals of 90 µm choosing from 1.72 mm anterior to bregma to 0.10 mm 
posterior to bregma (Franklin and Paxinos, 2008). 
2.8.5.1 Quantification of the number of exogenous pericytes 
The number of exogenous pericytes on the PDGFR-β and α-SMA expressing vasculature 
were quantified using the automated cell counting with ImageJ. The two-color stack image of 
α-SMA, PDGFR-β and iRFP was converted to a Z projection by choosing a stack option from 
the Image menu, and the images were split according to the respective channels (Figure 
2.8a). Using the polygon selection tool, the area of the vasculature was selected (PDGFR-
β+/α-SMA+), and the region of interest (ROI) was added by choosing the add 't' option in the 
ROI manager followed by thresholding the image (Figure 2.8b). The thresholding was done 
manually and no algorithm was used. The threshold setting that was used for the vehicle-
injected tissue was used as a control setting and the same setting was used for all the iRFP 
grafted tissues making sure the level of the threshold used was consistent between all the 
images.  
Next, the image was converted into a binary (mask-like) image and watershed analysis was 
used to isolate the cells to be counted. Then the analyze particle function was executed by 
choosing the size of 10 µm2-infinity and circularity of 0.0-0.8. The highlighted cells in light 
blue are the number of PDGFR-β+ cells in this case (Figure 2.8c). Similar steps were 
followed for analysing the exogenous iRFP+ pericytes on the vasculature (Figure 2.8d-f) 




individually for PDGFR-β, α-SMA, iRFP and then averaged across image sets for each 
mouse. The total number of overlapping PDGFR-β+ cells highlighted in light blue (Figure 
2.8c) with the DAPI+ cells highlighted in light blue (Figure 2.8i) were considered. Similarly, 
the total number of  PDGFR-β+ expressing (Figure 2.8c) DAPI+ (Figure 2.8i) and exogenous 
iRFP+ (Figure 2.8f) were considered to be co-labelled cells. The results designated as the 
number of iRFP+ (exogenous pericytes) compared with the number of PDGFR-β+/α-SMA+ 





Figure 2.8 Quantification of cell number using watershed analysis in ImageJ.  
Representative images show the pre-processing data for cell area quantification of PDGFR-β. (a) z-
stack of PDGFR-β. (b) choosing the PDGFR-β region of interest (ROI) and thresholding and clearing 
background. (c) conversion to a binary image using watershed segmentation and the total number of 
cells was analysed in light blue by choosing the size. (d) z-stack of iRFP+ cells. (e) Choosing ROI for 
iRFP image (f) Thresholding and conversion to a binary image using watershed segmentation and the 
total number of cells were analysed in blue. (g) z-stack of DAPI. (h) choosing the DAPI region of 
interest using ROI on the PDGFR-β vasculature. (i) Thresholding and conversion to a binary image 
using watershed segmentation and the total number of DAPI+ cells were analysed in light blue. The 




2.8.5.2 Quantification of the percentage area of the vasculature occupied by exogenous 
pericytes 
The area covered by the iRFP+ grafted pericytes on α-SMA positive vasculature was analysed 
using ImageJ. Here, α-SMA is shown as an example (Figure 2.9). The stack image of α-
SMA, along with the DAPI (Figure 2.9a), was converted to a Z project by choosing a stack 
option from the Image menu, and the images were split according to the respective channels 
(Figure 2.9b, c). Using the polygon selection tool, the area of the vasculature was selected, 
and the region of interest (ROI) was added by choosing the add 't' option in the ROI manager 
(Figure 2.9d). The area outside the selected vasculature was cleared using the clear outside 
tool from the edit menu (Figure 2.9e), and the image was thresholded (Figure 2.9f). The 
thresholding was done manually, and no algorithm was used. The threshold setting that was 
used for the vehicle-injected tissue was used as a control setting and the same setting was 
used for all the iRFP grafted tissues making sure the level of the threshold used was consistent 
between all the images. By choosing the create selection option from the edit menu, the area 
of the threshold vasculature was selected (green) and added to the ROI manager (Figure 
2.9g). The second step is to open the iRFP stacked image and select the area of the 
thresholded vasculature saved in the ROI manager (Figure 2.9h), and later the area selected 
in the iRFP stack (light blue) was thresholded (Figure 2.9i). The percentage area of the 
grafted iRFP+ pericytes on the vasculature was finally analysed (Figure 2.9j) by considering 






Figure 2.9 Quantification of percentage area of the vasculature occupied by exogenous pericytes. 
Representative images of the pre-processing data for co-labelling of exogenous pericytes with α-SMA 
on the vasculature. The data obtained is the percentage of exogenous iRFP+ pericytes on α-SMA 
expressing vasculature (green). (a) Stack image of α-SMA and DAPI. (b,c) Split images of iRFP and 
α-SMA, respectively. (d,e) choosing α-SMA region of interest (ROI) and clearing background. (f,g) 
thresholding the selected ROI. (h) applying α-SMA ROI on the iRFP image. (i,j) thresholding the 




2.8.5.3 Microglia cell number quantification 
The stack images of Iba1 and DAPI were collapsed into single split images (Figure 2.10a) 
and merged (Figure 2.10b). The number of Iba1+ cells was counted by quantifying the 
number of DAPI-stained nuclei that also expressed Iba1. Each arrow represents a single 
microglia (Figure 2.10b). 
 
Figure 2.10 Quantification of the number of microglia cells in a field of view.  
Representative confocal images of (a) Iba-1 expressing microglia in green; (b) merge image of Iba1+ 
microglia and DAPI+ nucleus. Arrows show the presence of activated microglia that were counted 
using a cell counter.  
 
2.8.5.4 Semi quantification of the area covered by microglia 
In order to analyse the area covered by microglia, the image was processed in a systematic 
way to obtain a filled image and its counterpart outlined shape. For this purpose, a series of 
steps were performed using Image J (FIJI) software. The image was filtered to soften the 
background and enhance the contrast (Figure 2.11a). The image was then transformed into 8-
bit grayscale and binarized to obtain a black and white image by thresholding (Figure 2.11b). 




was used for the vehicle-injected tissue was used as a control setting and the same setting was 
used for all the iRFP grafted tissues making sure the level of the threshold used was consistent 
between all the images. Each image was manually edited with the aim to obtain the cell image 
formed by a single and continuous set of pixels (Fernández-Arjona et al., 2017). Some pixels 
were cleared to separate ramifications of neighboring cells, while some pixels were added to 
join the processes (Figure 2.11c, d). This step was performed under the view of the original 
raw image of the cells as a reference image to avoid bias (compare the red circled area in c 
with d). Using the shape filter plugin, the area was set accordingly, keeping in mind not to 
exclude the tiny ramifications (Figure 2.11e), and the measurements collated. The red box 





Figure 2.11 Pre-processing steps for microglia cell area quantification.  
(a) Raw image of the microglia; (b) the image was changed to grayscale; (c) red circle shows the 
pixels joined together; (d) processed image of joint ramifications; (e) using shape filter plugin to 





2.8.5.5 Intensity quantification 
Raw stack images (GFAP) were imported into ImageJ software as a 16-bit image (Figure 
2.12a, b-i). The area to be quantified was selected, The threshold option was chosen from the 
Type dropdown menu, where the threshold was adjusted so that the positive staining would 
appear in white on a black background (Figure 2.12a, b-ii). The thresholding was done 
manually and no algorithm was used. The threshold setting that was used for the vehicle-
injected tissue was used as a control setting (Figure 2.12b-ii).  and the same setting was used 
for all the iRFP grafted tissues (Figure 2.12a-ii).  making sure the level of the threshold used 
was consistent between all the images. By choosing the option to analyze, the measurements 
were set by checking on mean gray value, area fraction, and limit to threshold. The area 
fraction gives the percentage of the image that was positively stained, and once the above 





Figure 2.12 Representative images of GFAP intensity calculation.  
(a) Astrogliosis in 96h post-graft tissues injected with exogenous pericytes and (b) astrocyte presence 
in 96h post graft vehicle-injected tissues. (i) represents a raw image of GFAP expressing astrocytes 
labelled in green. (ii) Threshold image of GFAP expressing astrocytes to calculate the intensity of 
GFAP staining in the given area or field of view.  
 
2.9 Behavioural analysis - Limb use asymmetry test (Cylinder test) 
The cylinder test was done to evaluate the effect of pericyte grafting on the basic motor 
performance of the mice. This test (Jimenez-Martin et al., 2015) was used to quantify the 
forelimb use of the animals receiving grafted pericytes or vehicle. Mice were habituated to the 
room before testing (1 hour). Each mouse was placed in a 20 cm wide transparent glass 
cylinder (Figure 2.13), and a minimum of 20 rearings of the forepaw with the wall of the 




forelimbs) were recorded by placing a camera under the glass table. The asymmetry index 
(AI) was calculated as AI = (right forelimb contacts – ½ both forelimb contacts) / (right 
forelimb contacts + left forelimb contacts + both forelimb contacts). 
 
Figure 2.13 Motor behaviour analysis using the Cylinder test.  
Image showing animal inside a glass cylinder with the forelimb rearing that is recorded by a camera 
under the glass table. 
 
2.10 Statistical Analysis: 
All data were tested for normal distribution (Shapiro-Wilk/Kolmogorov-Smirnov normality 
test), parametric statistical tests were used for data sets that passed normality (P < 0.05) and 
non-parametric statistical tests (Mann-Whitney test) were used for data sets that failed the 
normality test (P > 0.05). All values were expressed as the mean ± standard error of the mean 
(SEM). In Chapter 3, the statistical analysis was carried out using one-way ANOVA (Dunnett 
multiple comparison as a post-hoc test) to compare multiple timepoints where a Gaussian 
distribution of residuals was assumed. The mean values of all the groups were compared with 
the control group. In Chapter 5, the statistical analysis was carried out using one-way 




of PDGFR-β+/α-SMA+, iRFP+ and colabelled cells on the vasculature,  where a Gaussian 
distribution of residuals was assumed. The mean values of all the groups were compared 
without assuming any control group. Unpaired parametric t-test was used for comparing the 
area occupied by PDGFR-β+/α-SMA+ and colabelled cells (iRFP PDGFR-β++/iRFP α-SMA++) 
on the vasculature. In Chapter 6, an unpaired t-test and Wilcoxon signed-rank test was used to 
compare the theoretical value of symmetrical use of the forelimbs, where p ≥ 0.05 compared 
















3 CHAPTER 3: CHARACTERISATION OF A 













The identification of pericytes is critical for studying and understanding their function. One of 
the challenges in identifying the pericyte population is the lack of specific pan-pericyte 
marker due to the heterogeneity in their developmental origins and morphogenetic changes 
(Sims, 2000). Therefore, the identification of pericytes requires molecular characterisation in 
combination with anatomical and morphological characterisation. Due to heterogeneity in the 
expression of pericyte markers, unambiguous identification of pericytes has been a persistent 
issue (Stark et al., 2018). Therefore, more often than not, several pericyte markers are used in 
combination in order to identify and classify various pericyte populations. These markers 
include neural glial proteoglycan 2 (NG2), platelet-derived growth factor receptor β (PDGFR-
β) (Bergers and Song, 2005, Armulik et al., 2011a), alpha-smooth muscle actin (α-SMA) 
(Grant et al., 2017), CD13 (Armulik et al., 2010b) and Desmin (Bell et al., 2010). These 
markers are also expressed by other cell types including VSMCs (α-SMA, PDGFR-β), 
perivascular fibroblasts (α-SMA, FSP1), myeloid cells (Iba-1, CD45), oligodendrocyte 
progenitors (NG2, PDGFR-α), astroglia (SOX2, GFAP), and ependymal cells (GFAP, Nestin, 
S100β) (Bergers and Song, 2005, Daneman et al., 2010b, Winkler et al., 2011, Zhang et al., 
2014, Guimaraes-Camboa et al., 2017, Jung et al., 2018a). However, the expression of these 
markers varies depending on pathological situations, developmental stages, organs, and in 
vitro and in vivo conditions (Yamazaki and Mukouyama, 2018). Hence, morphological 
characterisation, combined with at least two molecular markers, is important for positive 
pericyte identification. Broadly speaking within the literature, α-SMA, NG2, and PDGFR-β 
(Grant et al., 2017) are considered as pericyte positive markers, whilst Glial Fibrillary Acidic 
Protein (GFAP) (Tigges et al., 2012a) is reported as being a pericyte negative marker. 
Although the PDGFR-β and α-SMA are not absolutely specific for pericytes, PDGFR-β is 




on capillary pericytes but is also detected on α-SMA+ vascular smooth muscle cells (Damisah 
et al., 2017a). Although Desmin is expressed by immature and mature pericytes, a 
subpopulation of smooth muscle cells associated with developing or mature arteries also 
expresses this marker (Hu et al., 2017). Therefore, PDGFR-β, α-SMA and NG2 were used in 
the current study. 
Distinct morphologies of α-SMA, NG2, and PDGFR-β positive pericytes have also been 
observed and classified in mouse brain in situ, surrounding blood vessels (Crisan et al., 2012). 
Specifically, based on their morphology and location, the pericytes are sub-categorized into 
two groups: Ensheathing and capillary pericytes (Grant et al., 2017). The ensheathing 
pericytes occupy pre-capillary arterioles and are α-SMA positive, covering nearly 100% of 
the vessel. In contrast, the capillary pericytes are α-SMA negative, longer in total cell length 
(~40 µm -150 µm) and only cover the vessel partially (40-80%) (Murfee et al., 2005, Grant et 
al., 2017). α-SMA expression, a protein necessary for cell contraction, correlates with vessel 
vasoconstriction and has been used to determine activation state (Nehls and Drenckhahn, 
1991, Dore-Duffy et al., 2011). Therefore, two distinct populations of pericytes exist on the 
vasculature, i.e., ensheathing pericytes (α-SMA+) and capillary pericytes (α-SMA-). 
In this chapter, mixed pericyte cultures from mouse brains were characterised using single-
labelling of pericyte positive markers and colabelling of pericyte positive and negative 
markers. Pericyte enrichment depended upon the co-expression of selected positive markers 
by growing in Dulbecco’s modified eagle medium (DMEM) and pericyte-specific growth 
medium (PM) and eliminating the unwanted astrocyte (GFAP+) glial population. Pericytes 
grow well alone provided they are supplemented with the necessary medium. For example, 
the growth pattern of pericytes in the context of proliferation and differentiation is dependent 




cultures were grown in two different media and a comparison was made to understand the 
type of media that enriches pericyte cultures.  
Table 3.1 Antibodies used in combination for characterisation and enrichment of 
pericytes 
CHARACTERISATION 
Single-labelled cell expression 
Negative marker Positive marker Secondary control 
GFAP PDGFR- β DAPI + Alexa Fluor 647 Goat anti-rabbit 
 NG2 DAPI + Alexa Fluor 555 Goat anti-guineapig 
 α-SMA DAPI + Alexa Fluor 555 Goat anti-mouse 
 
ENRICHMENT (Co-expression of positive markers) 
Double labelled cell expression Triple labelled cell expression 








• Validating the pericyte positive and negative markers in situ. 
• Characterising the mouse brain pericytes by culturing in DMEM and PM for 7 and 14 
days till passage 3 (P3) using the validated markers. 


















The current chapter aimed to establish a protocol for culturing pericytes in our laboratory. As 
there are many protocols and different media that other laboratories use, it was important to 
test 1) both normal DMEM (Dulbecco’s modified eagle medium) media in addition to the 
commercially available PM (pericyte-specific media); and 2) the number of passaging of the 
cultures in order to characterise the pericytes. In order to characterise the expression profile of 
the cultured pericytes in our hands, the heterogeneous pericyte population was labelled with 
three pericyte-positive and one pericyte-negative antibodies. The main goal of this chapter 
was to develop a pericyte culture system that enriches mouse pericytes for future grafting 
experiments. 
3.3.1 Antibody validation on mouse cortex tissue slices 
While PDGFR-β, NG2, and α-SMA were used as pericyte positive marker, GFAP (an 
astrocyte-specific marker) was used as a pericyte negative marker (Table 3.1). In order to 
validate each of the antibodies, PFA fixed mouse brain cortical sections were used and stained 
with antibodies as described in (Chapter 2 section 2.8.1). Whereas α-SMA staining was 
present only on large vessels (Figure 3.1A), PDGFR-β stained most of the vascular tree 
(Figure 3.1B). NG2 staining was also observed on large vessels (Figure 3.1C). The presence 
of astrocyte end-feet (GFAP) in a proportion of vessels was noteworthy (Figure 3.1D). A 
secondary control was included, where the tissue was stained with secondary antibody in the 
absence of primary antibody (Table 3.1). Assessment of all secondary controls revealed no 
non-specific IgG labelling. Therefore, it was concluded that the validation of all the pericyte 







Figure 3.1 Validation of pericyte positive and negative markers in brain sections obtained from 
the naïve mouse motor cortex.  
Representative confocal images of mouse brain cortical sections that were positively stained with 
antibodies against (A) α-SMA, (B) PDGFR-β, (C) NG2, and (D) GFAP along with their respective 
secondary controls. DAPI was used to detect the nuclei of intact cells (blue). The dotted box on the left 
panel (10X, scale bar = 100 µm) represents the magnified images on the right panel (40X, scale bar = 




3.3.2 Characterization of 7-day (7P0) mouse cortical brain pericyte cultures.  
3.3.2.1 Characterisation of early passage cultures (7P0) by Immunocytochemistry 
(ICC) 
The validated pericyte positive and negative markers in section 3.3.1, were used to 
characterise the mouse cortical pericyte cultures by immunocytochemistry. The 
immunocytochemical analysis of mouse cortex-derived, 7-day (7P0) DMEM cultures, 
revealed a mixed population of single labelled pericyte negative and positive markers (Figure 
3.2A). The pericytes isolated from the mouse cortex when plated and grown for 7 days by 
supplementing with DMEM invitro, are called 7P0 (passage-0) DMEM pericyte cultures. 
After one passage (replating in a new dish), they are called 7P1 (passage-1) cultures. The 
percentage of single, double, and triple labelled cell expressions within the DMEM cultures 
was quantified (Figure 3.2B). The cultures composed of 20% PDGFR-β+ (Figure 3.2A-ii, 
arrowhead), 4% NG2+ (Figure 3.2A-ii, arrow), and 7% α-SMA+ (Figure 3.2A-ii, star). As 
low as 7%  were GFAP expressing cells (Figure 3.2A-iii). While there were 37% of PDGFR-
β NG2++ cells (yellow) (Figure 3.2A-ii, dotted circle), the culture also expressed 25% of 
PDGFR-β NG2 α-SMA+++ pericytes (Figure 3.2A-ii, dotted box). Therefore, From the 
results obtained by characterisation and cell quantification, it was observed that the 7P0 








Figure 3.2 Characterisation and quantification of pericyte cultures.  
(A) Representative confocal images of a heterogeneous cell population of 7-day (7P0) DMEM 
cultures. Immunocytochemical characterisation revealed a mixed population (i) secondary control 
against the primary antibody with DAPI labelling the intact nuclei (blue); (ii) PDGFR-β+ (red labelled 
cells, arrowhead), NG2+ (green labelled cells, arrow), α-SMA+ (pink labelled cells, star), double 
labelled cells in yellow (PDGFR-β, NG2, dotted circle) and triple labelled cells in white (PDGFR-β, 
NG2, α-SMA, dotted box). The mixed population also consisted of (iii) GFAP+ cells (purple labelled 
cells). (B) Quantification of the heterogeneous cell population within the 7-day (7P0) DMEM cultures. 
Data were analysed using one-way ANOVA (n=3 separate cultures) as described in Section 2.10. 






3.3.2.2 Gene expression analysis of pericyte positive and negative markers in a 
heterogeneous population 
The above ICC characterisation confirmed the protein expression of pericyte positive and 
negative markers in the 7-day (7P0) DMEM cultures. Additionally, the gene expression 
profile of all the above markers was confirmed using PCR. GAPDH was used as an 
endogenous control. As shown in Figure 3.3, the cells of 7P0 DMEM cultures positively 
expressed the genes of all the pericyte positive and negative markers, which further supports 
the protein quantification data by indicating that the 7P0 DMEM cultures indeed consist of a 
mixed population of cells.  
 
Figure 3.3 PCR revealed the heterogeneous gene expression of pericyte positive and negative 
markers.  
The gene expression of pericyte positive markers (PDGFR-β (850 bp), NG2 (850 bp), α-SMA (850 
bp)) and negative marker (GFAP (650 bp)) was observed in 7-day DMEM (7P0) cultures. GAPDH 
(1000 bp) was used as an endogenous control. 
 
3.3.3 Enrichment of pericytes 
From the above protein and gene expression analysis, it was evident that the mixed population 
of cells harboured not only the pericyte population but also GFAP expressing astrocytes. 
Since the long-term goal of the current study was to graft a pure pericyte population, it was 
necessary to eliminate unwanted non-pericyte populations from the culture and enrich the 




DMEM for 7/14-days. Subsequently, the P0 (both 7 and 14-day old) cultures were passaged 
three times (P1-3) by supplementing with either DMEM and PM in parallel (Figure 2.2). The 
reason for culturing cells in both types of media was to compare the percentage and type of 
pericytes enriched in DMEM and PM. The switching of the media from DMEM to PM after 
7/14 days not only helped in identifying putative pericyte markers but also helped enrich the 
pericyte population. Switching from DMEM medium to PM has selectively increased the 
percentage of single labelled (PDGFR-β+, NG2+) and double labelled (PDGFR-β NG2++). 
However, the media switch decreased the percentage of α-SMA single labelled as well as 
triple labelled pericytes. Importantly, the media switch has significantly downregulated the 
percentage of GFAP+ astrocytes. Therefore, the media switch from DMEM to PM has helped 
identify an expression pattern consistent with the enrichment of pericytes in the cultures. 
3.3.3.1 Passaging and Pericyte Medium are critical for GFAP+ astrocyte elimination 
While the elimination of GFAP expressing cells was a crucial step in enriching for pericyte 
population, identifying the right media (DMEM/PM) that eliminates the astrocytes early (P0-
P3) from the culture was important. Figure 3.4A-i shows the representative confocal images 
of the 7-day cultures expressing GFAP+ astrocytes (pink labelled cells) when supplemented 
with DMEM and PM. The 7-day DMEM cultures (7P0) consisted of a high percentage (8%) 
of GFAP+ astrocytes (Figure 3.4B-i). Their subsequent passages showed a reduction in the 
percentage of GFAP+ population (2-3%) when supplemented with DMEM. While the 
reduction in the GFAP+ population was observed, their complete elimination was not 
achieved. Critically there was a significant decrease in the GFAP+ population (0.5%) when 





Figure 3.4A-ii shows the representative confocal images of the 14-day cultures expressing 
GFAP+ astrocytes when supplemented with DMEM or PM. The 14-day (14P0) DMEM 
cultures initially consisted of 2% of the GFAP+ population. Interestingly, a subsequent 
passaging (P1-P2) of the cells resulted in an increased population (5-3%) of astrocytes in the 
culture, followed by a reduction (Figure 3.4B-iii). Overall, passaging in DMEM could not 
reduce or eliminate the astrocyte population. Furthermore, switching of the growth media 
from DMEM to PM reduced GFAP+ astrocytes, but not completely (Figure 3.4B-iv).  
Based on the above results, a media switch from DMEM to PM was critical to significantly 












Figure 3.4 Characterisation and quantification of GFAP+ astrocytes in DMEM and PM.  
7 and 14-day cultures were immunocytochemically analysed for GFAP expression (pink cells) 
supplemented with DMEM and PM. (A) Representative confocal images of 7 and 14-day DMEM and 
PM cultures at different passages. (i) 7-day DMEM cultures (7P0) were subsequently passaged and 
cultured parallelly in DMEM (left panel) and PM (right panel) till P3. (ii) 14-day DMEM cultures 
were subsequently passaged and cultured in DMEM (left panel) and PM (right panel) parallelly till P3. 
(B) Quantification of GFAP+ astrocytes in the culture medium. The percentage of GFAP+ astrocytes in 
(i) (ii) 7-day DMEM and PM cultures by repeated passaging. (iii) (iv) 14-day DMEM and PM 
cultures. All points represent the mean ± SEM of 3 separate cultures. Statistical analysis was carried 
out using one-way ANOVA (Tukey’s multiple comparison test) to compare multiple timepoints. The 
mean values of all the groups were compared with the control group (7P0/14P0-DMEM). Statistical 





3.3.3.2 Maintenance of triple labelled pericyte population when supplemented with  
DMEM and PM 
To investigate the role of PM in enriching the pericyte population, the expression of the triple 
labelled pericytes (PDGFR-β NG2 α-SMA+++) was monitored in cultures supplemented with 
DMEM and PM. Figure 3.5A shows the representative confocal images of 7- and 14-day 
cultures containing triple labelled pericytes (white labelled cells, dotted box) supplemented 
with DMEM and PM. The 7-day DMEM cultures (7P0) demonstrated a significant increase 
(82%) in the triple-positive cells at P1, but this was not maintained and decreased (42%) by 
the third passage, P3 (Figure 3.5B-i). Although a media switch to PM increased the triple 
labelled cell population in 7P1 (Figure 3.5B-ii), it was surprising to observe a significant 
decrease in triple labelled pericytes on further passages (7P2, P3). 
The 14-day DMEM cultures also showed a similar trend, where there was an initial increase 
in the percentage of triple labelled cells at P1 but the subsequent decreasing trend at P2 and  
P3 irrespective of media switch  (Figure 3.5B-iii&iv).  
In summary, the cells cultured in both DMEM and PM exhibited a similar pattern in the 
expression of triple labelled pericytes. There was an increase in the percentage of triple 
labelled pericytes at P1, but this decreased with passage number P2 and P3. It was not clear if 
repeated passaging was causing the triple-positive pericytes to dedifferentiate and lose their 
molecular signature, but passaging was not enriching the number of triple-positive pericytes 
in the cultures. Hence, in the subsequent sections, the enrichment of single labelled pericytes 









Figure 3.5 Pericyte medium does not enrich the triple labelled (PDGFR-β+NG2+α-SMA) cell 
population.  
7 and 14-day cultures were immunocytochemically analysed for the triple labelled expression of 
pericyte positive markers (dotted box, white labelled cells) supplemented with DMEM and PM. (A) 
Representative confocal images of 7 and 14-day DMEM and PM cultures at different passages. (i) 7-
day DMEM cultures (7P0) were subsequently passaged and cultured parallelly in DMEM (left panel) 
and PM (right panel) till P3. (ii) 14-day DMEM cultures were subsequently passaged and cultured in 
DMEM (left panel) and PM (right panel) parallelly till P3. (B) Quantification of triple labelled cells in 
the culture medium. The percentage of triple labelled cells in (i) (ii) 7-day DMEM and PM cultures by 
repeated passaging. (iii) (iv) 14-day DMEM and PM cultures. All points represent the mean ± SEM of 
3 experiments. Statistical analysis was carried out using one-way ANOVA (Tukey’s multiple 
comparison test) to compare multiple timepoints. Statistical significance was set as *p < 0.05, **p < 





3.3.3.3 PM increases the expression of NG2+ single labelled cells 
The enrichment of NG2+ pericytes was characterised and quantified in the cultures 
supplemented with DMEM and PM. Figure 3.6A shows the representative confocal images 
of 7-day (i) and 14 -day (ii) NG2+ cells (green labelled cells) cultured in DMEM and PM. The 
7-day (7P0) DMEM cultures (8% of NG2) demonstrated a significant downregulation in NG2 
expression when supplemented with DMEM up to P3 (Figure 3.6B-i). Although initial 
switching of media from DMEM to PM resulted in a decrease in NG2+ population (7P1), 
repeated passaging did show an increasing trend (7P2, P3). (Figure 3.6B-ii),  
While the 14-day (14P0) DMEM cultures did not show a significant increase in the 
percentage of NG2+ cells until P3 (Figure 3.6B-iii), switching to PM resulted in a pattern 
similar to 7-day PM cultures (Figure 3.6B-iv). 
In summary, the 7-day cultures displayed an increasing percentage of NG2+ pericytes when 
switched to PM. However, the 14-day cultures showed an increasing trend when passaged in 
DMEM as well as PM.  Although the actual reason for the decrease in the NG2+ pericytes 
(Figure 3.6B-i) could not be deciphered, the current section importantly highlights that the 
decrease in triple-positive pericytes (section 3.2.3.2) was not associated with the expression 









Figure 3.6 Characterisation and quantification of NG2+ single labelled cells.  
7 and 14-day cultures were immunocytochemically analysed for the expression of NG2 pericyte 
positive marker (green labelled cells) supplemented with DMEM and PM. (A) Representative 
confocal images of 7and 14-day DMEM and PM cultures at different passages. (i) 7-day DMEM 
cultures (7P0) were subsequently passaged and cultured parallelly in DMEM (left panel) and PM 
(right panel) till P3. (ii) 14-day DMEM cultures were subsequently passaged and cultured in DMEM 
(left panel) and PM (right panel) parallelly till P3.(B) Quantification of NG2+ cells in the culture 
medium. The percentage population of NG2+ cells in (i) (ii) 7-day DMEM and PM cultures by 
repeated passaging. (iii) (iv) 14-day DMEM and PM cultures. All points represent the mean ± SEM of 
3 experiments. Statistical analysis was carried out using one-way ANOVA (Tukey’s multiple 
comparison test) to compare multiple timepoints. The mean values of all the groups were compared 
with the control group (7P0/14P0-DMEM). Statistical significance was set as **p < 0.01, ns represents 





3.3.3.4 DMEM and PM increases the PDGFR-β+ single labelled cell population 
One of the important markers for pericyte identification is PDGFR-β (Tigges et al., 2012a). 
Investigating the expression of single labelled PDGFR-β+ cells within the DMEM and PM 
cultures was essential to understand the reason for the decrease in the triple labelled pericyte 
population in Section 3.3.3.2. The representative confocal images of 7- and 14-day PDGFR-
β+ cells (red labelled cells) cultured in DMEM and PM are shown in Figure 3.7A. The 7-day 
DMEM (7P0) cultures exhibited an increase in the percentage of PDGFR-β+ pericytes by P3, 
irrespective of the media switch (Figure 3.7B-i&ii). The 14-day cultures demonstrated a 
similar change in single labelled PDGFR-β+ cells as the 7-day cultures irrespective of media 
switch (Figure 3.7B-iii&iv). In summary, both the 7- and 14-day cultures demonstrated an 










Figure 3.7 Increasing trend of PDGFR-β+ single labelled cells in DMEM and PM.  
7 and 14-day cultures were immunocytochemically analysed for the expression of PDGFR-β pericyte 
positive marker (red labelled cells) supplemented with DMEM and PM. (A) Representative confocal 
images of 7 and 14-day DMEM and PM cultures at different passages. (i) 7-day DMEM cultures (7P0) 
were subsequently passaged and cultured parallelly in DMEM (left panel) and PM (right panel) till P3. 
(ii) 14-day DMEM cultures were subsequently passaged and cultured in DMEM (left panel) and PM 
(right panel) parallelly till P3. (B) Quantification of PDGFR-β+ cells in the culture medium. The 
percentage population of PDGFR-β+ cells in (i) (ii) 7-day DMEM and PM cultures by repeated 
passaging. (iii) (iv) 14-day DMEM and PM cultures. All points represent the mean ± SEM of 3 
experiments. Statistical analysis was carried out using one-way ANOVA (Tukey’s multiple 
comparison test) to compare multiple timepoints. The mean values of all the groups were compared 
with the control group (7P0/14P0-DMEM). Statistical significance was set as ns represents p > 0.05. 





3.3.3.5 Higher passages in PM lead to the downregulation of α-SMA+ cells. 
Characterisation and quantification of α-SMA+ cells within the DMEM and PM cultures were 
carried out in order to identify capillary and ensheathing pericytes. Figure 3.8A shows the 
representative confocal images of 7- and 14-day α-SMA+ cells (pink labelled cells) cultured in 
DMEM and PM. The 7-day DMEM cultures (7P0)  expressed 13% of α-SMA+ cells, and their 
subsequent passaging (P1-P3) demonstrated a decrease in α-SMA expression (Figure 3.8B-i). 
Interestingly, switching the media to PM lead to a significant decline in α-SMA+ expression 
from P1-P3 (Figure 3.8B-ii). 
While the 14-day DMEM cultures (14P0) did not exhibit a significant change in the α-SMA+ 
population(Figure 3.8B-iii), switching the media to PM and their subsequent passaging (P3) 
lead to a significant decrease in the population of α-SMA+ cells (Figure 3.8B-iv).  
These results conclude that culturing cells in DMEM allowed the expression of the α-SMA+ 
cell population along with cells expressing other pericyte positive markers (NG2 and PDGFR-
β). Whereas subsequent passaging in PM decreased the population of α-SMA+ cells, as also 
seen from a decrease in the population of triple labelled pericytes with passaging as observed 









Figure 3.8 Switching of culture media from DMEM to PM decreases α-SMA expression with 
increasing passages.  
7 and 14-day cultures supplemented with DMEM and PM were immunocytochemically analysed for 
the expression of α-SMA pericyte positive marker (pink labelled cells). (A) Representative confocal 
images of 7 and 14-day DMEM and PM cultures at different passages. (i) 7-day DMEM cultures (7P0) 
were subsequently passaged and cultured parallelly in DMEM (left panel) and PM (right panel) till P3. 
(ii) 14-day DMEM cultures were subsequently passaged and cultured in DMEM (left panel) and PM 
(right panel) parallelly till P3. (B) Quantification of α-SMA+ cells in the culture medium. The 
percentage population of α-SMA+ cells in (i) (ii) 7-day DMEM and PM cultures by repeated 
passaging. (iii) (iv) 14-day DMEM and PM cultures. All points represent the mean ± SEM of 3 
experiments. Statistical analysis was carried out using one-way ANOVA (Tukey’s multiple 
comparison test) to compare multiple timepoints. The mean values of all the groups were compared 
with the control group (7P0/14P0-DMEM). Statistical significance was set as *p < 0.05, **p < 0.01, 





3.3.3.6 Pericyte medium enriches early pericyte markers 
As the culturing of cells in PM lead to an increase in NG2 (section 3.3.3.3) and PDGFR-β 
(section 3.3.3.4) positive cells and a decrease in α-SMA+ (section 3.3.3.5), it was interesting 
to study the expression pattern of PDGFR-β+NG2 double labelled pericyte population. 
Figure 3.9A shows the representative confocal images of 7- and 14-day cultures expressing 
double-positive pericytes (yellow labelled cells) supplemented in DMEM (left panel) and PM 
(right panel). The 7-day DMEM (7P0) cultures showed a significant increase in the double-
positive cells at P1. However, repeated passaging until P3 showed a decreasing percentage of 
these double labelled cells (Figure 3.9B-i). However, successive passaging of 7P0 cells in 
PM significantly increased the population of double-positive pericytes, with 7P2  the highest 
percentage (Figure 3.9B-ii). 
The 14-day cultures, irrespective of their media supplementation, did not demonstrate any 
change in the percentage of double-positive cells (Figure 3.9B-iii&iv).  
In summary, PM selectively enriched the double-positive pericytes in 7P2 cultures. This 
observation emphasises the importance of PM in the enrichment of double-positive pericytes. 
It is also interesting to reiterate the fact that PM was specifically effective in enriching 











Figure 3.9 PM favours the expression of early pericyte markers.  
7 and 14-day cultures supplemented with DMEM and PM were immunocytochemically analysed for 
the expression of double-positive pericytes (yellow labelled cells). (A) Representative confocal images 
of 7 and 14-day DMEM and PM cultures at different passages. (i) 7-day DMEM cultures (7P0) were 
subsequently passaged and cultured parallelly in DMEM (left panel) and PM (right panel) till P3. (ii) 
14-day DMEM cultures were subsequently passaged and cultured in DMEM (left panel) and PM (right 
panel) parallelly till P3. (B) Quantification of double-positive pericytes in the culture medium. (i) (ii) 
7-day DMEM and PM cultures by repeated passaging. (iii) (iv) 14-day DMEM and PM cultures. All 
points represent the mean ± SEM of 3 experiments. Statistical analysis was carried out using one-way 
ANOVA (Tukey’s multiple comparison test) to compare multiple timepoints. The mean values of all 
the groups were compared with the control group (7P0/14P0-DMEM). Statistical significance was set 





3.3.4 Gene expression analysis of pericyte positive and negative markers at different 
passages 
Similar to P0 cultures (Section 3.3.2.2), the expression of pericyte positive and negative 
markers was further validated at the level of transcription. As depicted in Figure 3.10, 
pericyte markers PDGFR-β and NG2 displayed a constant expression throughout the cultures 
irrespective of media supplemented. Similar to its protein expression, α-SMA was 
conspicuously downregulated with increasing passages in PM. The gene expression of 
pericyte negative marker GFAP was significantly abrogated when cultured in DMEM and 
PM. GAPDH was used as endogenous control, and all the samples consistently expressed the 
control gene. The H2O negative controls were used as blank for all the samples. 
 
Figure 3.10 Gene expression studies by PCR.  
Representative images of PCR results depicting the gene expression of pericyte positive (PDGFR-β, 
NG2, and α-SMA) and pericyte negative (GFAP) markers cultured in DMEM and PM. Water (H2O) 





3.4.1 Summary of the results 
The current chapter highlights a detailed procedure to characterise and enrich the cultured 
brain cortical pericytes. The brain pericytes isolated from the mouse motor cortex (detailed in 
chapter 2, section 2.2.1) harbours a heterogeneous population of cells, including pericyte and 
non-pericyte population. To selectively graft brain pericytes, it was a prerequisite step to 
enrich the pure population of pericytes and eliminate the non-pericyte population. Therefore, 
the heterogeneous mixture of isolated brain pericytes was taken through a series of the 
passaging procedure (P0 to P3) and further characterised to monitor the expression of pericyte 
positive and negative markers. The enrichment procedure compared the efficiency of two 
different growth media, i.e., DMEM and PM. This approach facilitated the elimination of 
unwanted GFAP+ astrocytes and α-SMA+ cell populations by enriching the population of 
PDGFR-β+ and NG2+ pericytes. PM is used for the enrichment of pericyte positive cells only. 
The characterisation experiments have proven that the cells grown in PM downregulate the 
expression of α-SMA and increase the expression of PDGFR-β and NG2. From the literature, 
it is understood that the capillary pericytes are the population with therapeutic potential. 
Moreover, there is a possibility that injecting pericytes with increased α-SMA could lead to 
tissue fibrosis due to increased secretion of cytokines like TGF-β (Rustenhoven et al., 2017, 
Caja et al., 2018). Hence, considering the therapeutic potential of capillary pericytes as well 
as deleterious effects of α-SMA pericytes, we wanted to enrich our cultures for α-SMA 





3.4.2 Culture media-based enrichment of pericytes 
Most of the existing pericyte isolation protocols use the DMEM growth medium. Since our 
approach was to obtain a large number of enriched pericytes, a commercially available PM 
was tested and compared along with the conventional DMEM. While the PM was designed to 
support the growth of pericytes, DMEM was unbiased in facilitating the growth of a wide 
variety of cell types, leading to increased numbers of astrocytes. The pericyte basal medium 
consisted of pericyte growth supplements (provided with the pericyte media) that enhanced 
the growth of the pericyte population by decreasing the expression of glial cells.   
3.4.3 PM facilitated the elimination of astrocytes by repeated passaging of early 
pericyte (7-day) cultures 
The cultures grown in DMEM did not show a significant reduction of GFAP+ astrocytes at 
any given passage number (P0-P3). Contrastingly, the cultures supplemented with PM 
demonstrated a complete absence of GFAP expression with repeated passaging (section 
3.3.3.1). The PM selectively exhibited the ability to eliminate the astrocyte population. Since 
DMEM also facilitates the growth of glial and fibroblast cells, repeated passaging did not help 
in the elimination of astrocytes. Switching the media from DMEM to PM remarkably reduced 
the percentage of GFAP+ astrocytes, leading to their elimination by P3 (Figure 3.4B-iii, iv). 
Therefore, a combination of pericyte-specific growth medium (PM) and repeated passaging 
indeed helped in the enrichment of pericytes by the elimination of astrocytes. 
3.4.4 PM enriches capillary pericytes (PDGFR-β+ and NG2+) by downregulating the α-
SMA+ cells 
One of the essential pericyte markers, NG2, is expressed by mature pericytes during the early 




identification is PDGFR-β, which is essential for the formation of new vessels or angiogenesis 
(Hellstrom et al., 1999, Lindblom et al., 2003). While α-SMA has also been used as one of the 
positive markers for pericyte identification and their contraction, their expression was also 
reported in vascular smooth muscle cells (vSMCs) and myofibroblasts (Hill et al., 2015). The 
expression of all the above markers was monitored and analysed at each passage of the 
enrichment procedure. Throughout the enrichment, PDGFR-β and NG2 ubiquitously 
expressed within the pericyte population (7 and 14-day) irrespective of the growth media 
(Figure 3.6B and 3.7B). However, it was interesting to observe a noticeable reduction in the 
percentage of α-SMA expressing cells when supplemented with PM (Figure 3.8B-iii, iv). The 
decline in α-SMA was also well supported by previous studies (Rustenhoven et al., 2018a). 
The decreased expression of α-SMA in PM-supplemented cultures provides compelling 
evidence to speculate that the PM specifically enriches the population of α-SMA--capillary 
pericytes. The ability of PM to enrich α-SMA--capillary pericytes has also been supported by 
some of the previous studies (Balabanov and Dore-Duffy, 1998, Dore-Duffy, 2008, Grant et 
al., 2017). Contrasting to PM, the DMEM-supplemented cultures could be enriching α-SMA+-
ensheathing pericytes, which could be a result of continuous passaging in DMEM.  A study 
by Balabanov and Dore-Duffy reported that the pericytes cultured for more extended periods, 
in a basal media, had completely acquired α-SMA expression (Balabanov and Dore-Duffy, 
1998). My results show that the commercially available PM selectively enriches the 
population of α-SMA- capillary pericytes by reducing the number of α-SMA+ cells. While the 
7-day DMEM cultures demonstrated an increase in double-positive cells at P1 (Figure 3.9B-
i), a media switch to PM showed a significant increase, not until P2 (Figure 3.9B-ii). This is 
an interesting observation, where the delay in the increased double-positive population until 
P2 could be attributed to the time taken by the cells to acclimatize to the media switch at P1. I 




stain and image, although sampling can under/ overestimate cell populations the ICC 
approach did enable me to replicate identification of single double and triple labelled cells 
across several different cultures and passages. FACS would have allowed for the detection of 
multiple markers if a multi-color FACS sorter had been available, although FACS can require 
larger amounts of cells.  
3.5 Conclusion 
The current chapter shows how to enrich a population of pericytes and subsequently to 
validate their purity by analysing the expression of pericyte positive and negative markers. 
Although several protocols exist to enrich pericytes, obtaining a large number of 
undifferentiated pericytes as well as their definitive identification was a challenging effort. 
The adopted phenotype and functional responses of cultured cells in vitro can be influenced 
by the growth conditions. The pericytes cultured in PM retained their expression of the 
pericyte markers PDGFR-β and NG2 by image-based analysis and PCR analysis. The key 
benefit of growing in PM was to reduce the numbers of α-SMA expressing cells as increased 
α-SMA population can lead to tissue scarring. Therefore, the presence of limited amounts of 
α-SMA can be beneficial rather than having high α-SMA+ cells prior to grafting. A summary 
of all the findings of this chapter was given in Table 3.2. The combined data proves that 
cultures supplemented with PM completely abrogated the GFAP+ astrocytes and were 
assumed to enrich the capillary pericytes. These capillary pericytes with a low α-SMA 
population are most likely to differentiate into other types of cells and can also act as 
macrophages in the brain to demonstrate phagocytic ability, aiding the cerebral clearance of 
foreign matter (Rustenhoven et al., 2018b). In contrast, it is likely that the DMEM-
supplemented cultures enriched the population of α-SMA+-ensheathing pericytes. This result 




vascular niche. Importantly, a high proportion (88%) of double-labelled pericyte populations 
were observed at 7P2 in PM-supplemented cultures, with further passaging leading to fewer 
of these cells. Hence, 7P2 was selected as an ideal passage number for further purification and 
labelling of pericytes for the grafting procedure (Chapter 4). 
 
Table 3.2 Summary of the expression pattern of pericyte positive and negative markers 
 DMEM PM 
GFAP ↓ ↓ 
Triple positive cells 
(NG2+PDGFR-β+α-SMA) 
Stable expression (no 
change) 
↓ 
NG2 ↑ ↑ 
PDGFR-β Stable expression (no 
change) 
↑ 
α-SMA Stable expression (no 
change) 
↓ 
Double positive cells 
(NG2+PDGFR-β) 
Stable expression (no 
change) 







3.6 Key findings 
The enriched pericytes from PM-supplemented cultures (7P2) were selected for the successive 
purification experiments due to  
• Low percentage expression of α-SMA+ cells. 
• A higher percentage of double-positive pericytes (PDGFR-β NG2++). 
• Elimination of GFAP+ astrocytes. 
The  pericytes from 14-day PM cultures were ruled out due to 
• A relatively higher population of α-SMA+ and GFAP+ cells in the culture. 




















4 CHAPTER 4: PURIFICATION OF ENRICHED 
PERICYTES AND LENTIVIRAL 












For the translation of cell-based therapies to the clinical level, cell purification steps are 
crucial for safety and reproducibility reasons, and Fluorescent-activated cell sorting (FACS) 
purification provides an excellent platform to isolate highly purified cell populations (Pruszak 
et al., 2007). FACS is a technique that allows the isolation of defined populations of cells 
based on their surface marker expression (Crouch and Doetsch, 2018b) and to purify cells 
based on known phenotype. There are other methods of purification, including 
immunopanning (Zhang et al., 2014), complement depletion, and magnetic bead separation. 
However, these techniques require large amounts of starting material, are time-consuming, 
and use harsh dissociation and digestion conditions. Hence, FACS is the most preferred 
method when a high purity of the desired population is required (Basu et al., 2010a). 
Pericyte purification by FACS involves labelling the enriched pericytes (Chapter 3) with 
antibodies against pericyte positive markers (Chapter 2 Table 2.3). These purified pericytes 
will further be used in transplantation studies. However, identification of the transplanted 
cells among the complex organization of the central nervous system (CNS) requires an 
additional sophisticated approach. In order to study neurogenesis, recombinant retroviruses 
were used to drive the expression of GFP fluorescent proteins that provided the basis to study 
migration and differentiation of newly generated neurons and glia in the cortex. A similar 
approach was used in this study using iRFP to track the exogenous pericytes even if they 
differentiated or proliferated (Gomez-Nicola et al., 2014).  
Here we used lentiviral vectors (Chapter 2 Section 2.6) to express a single fluorescent 
protein, infra-Red Fluorescent Protein (iRFP), in the cultured pericytes. Lentiviruses amplify 
and package their genetic material by using the host cellular machinery and delivers the 




method produces high efficiency by rapidly establishing a stable integration into the genome 
of the host cell, allowing persistent expression of the gene of interest (Elegheert et al., 2018). 
Lentiviral vectors have been successfully used for the transduction of various stem/progenitor 
cells (Logan et al., 2002, van Hooijdonk et al., 2009) and target most cell types within the 
CNS including astrocytes, oligodendrocytes, neurons. They have emerged as efficient 
vehicles for transgene delivery in both dividing and non-dividing cells (Parr-Brownlie et al., 
2015, Maes et al., 2019), making the recombinant lentiviral vectors highly applicable for 
stable, and long-term gene delivery (Sakuma et al., 2012). In this study, the lentiviral 
transduction of our cultured pericytes to express iRFP facilitates tracking over a long period 

















Given the above background, the current chapter aims to  
• Purify enriched cultured pericytes by FACS using the pericyte-specific marker, 
CD140b/PDGFR-β. 
• Lentivirally transduce pure pericyte population with iRFP to differentiate between 

















4.3.1 FACS analysis  
Before live-sorting the bulk of cell samples, 25,000 events were recorded to determine the 
sorting criteria that include a selection of cell bodies and exclusion of non-specific labelling 
of antibodies. When the cells pass through the laser beam, the light passes through the sample 
and emits light in forward scatter (FSC), representing the size of an event, and in side-scatter 
(SSC), representing the granularity of the event that helps to eliminate the doublets. Each dot 
represents one event when the cell crosses the laser path. Events with high granularity and 
small in size were considered as debris and were gated out (Guez-Barber et al., 2012).  
4.3.2 Unsuccessful FACSorting of enriched 7P2 PM cultures using PDGFR-β and NG2 
antibodies 
The cells were co-labelled with antibodies against the surface proteins PDGFR-β and NG2, 
and DAPI was used for the nuclear staining of intact cells. Only 0.36% (Figure 4.3) of the 
total cell population (Figure 4.2A) displayed double labelling against PDGFR-β and NG2 






Figure 4.1 Representative image of the total live cells by haemocytometer.  
The accurate percentage of live and dead cells is obtained from an automated cell counter. A total of 
approximately 7.23 x 106 cells was used as a starting population for live sorting. 
 
 
After evaluating the percentage of double staining cells, the percentage of  PDGFR-β+ cells 
and NG2+ cells were analysed and plotted individually. The total labelled cells are cells that 
express both PDGFR-β and NG2++ cells. Out of which only 0.47% were NG2+, and 0.64% 
were PDGFR-β+ (Figure 4.3A-i). The reason for the low percentage of the NG2 population 
was unknown. However, it was known from the supplier (Sanford Burnham, LA Jolla, CA) 
that the NG2 antibody was tested for IHC and ICC but not for applications in FACS. Since 
the NG2 antibody was used for validating, characterizing, and enriching pericytes, the goal 
was to use the same antibody for live sorting. Although several concentrations of the NG2 
antibody (Figure 4.3A-ii, iii middle panels) were tested for FACS, the desired result could 
not be achieved. Another antibody used for sorting was against PDGFR-β, which has been 




recommended concentrations of antibody (Figure 4.3A-ii, iii right panel), the latter 
displayed non-specific staining and did not work in the tested experiments, resulting in a low 
yield of PDGFR-β+ cells. Thus, the above antibodies were ruled out for live sorting of 
enriched pericytes, and a new FACS-specific anti-PDGFR-β antibody was sourced and used, 











Figure 4.2 Unsuccessful Sorting of enriched pericytes labelled with PDGFR-β and NG2.  
Each dot represents one event or one cell. The antibodies were tested at three different concentrations 
for live sorting to obtain the desired number of population for further experiments. Fluorescence plot 
showing colabelling of enriched pericytes with PDGFR-β and NG2 antibodies (left panel), individual 
plot graph for antibodies NG2 (middle panel), and PDGFR-β (right panel). The antibodies were tested 
at a concentration of (i) 1:100 and 1:200 (ii) 1:50 and 1:100 (iii) 1:20 and 1:50  for NG2 and PDGFR-β 





4.3.3 Increase in sorted pericyte positive population using the FACS specific antibody 
(CD140b) 
After three experimental trials, the enriched pericytes were further purified using 
CD140b/PDGFR-β antibody (eBioscience™ from Thermo Fisher Scientific, catalog # 17-
1402-82, RRID AB_1548743), which is a FACS specific (tested for FACS application) 
antibody against PDGFR-β antibody that is supplied under the name CD140b and a putative 
marker for the identification of pericytes (Eilken et al., 2017). CD140b antibody was used 
because: 
• PDGFR-β antibody was unable to label live cells for sorting. 
• NG2 antibody failed to stain for FACS (Section 4.1.2). 
• α-SMA is an intracellular marker and, therefore, unsuitable for FACS, and our 







Figure 4.3 Percentage of sorted CD140b positive cells with the corresponding controls.  
(A) Representative image of the total cells used as a starting population for live sorting. (B) The left 
panel shows the % of the unstained cell sample, and the middle panel shows the secondary control 
against the positively expressing population. Right panel shows 55.8% population of CD140b+ 
pericytes (n=2). The experiments were carried out twice. This is one of the two examples and no 
statistical analysis was performed.  
 
4.3.4 CD140b+ sorted pericytes expressed a low percentage of α-SMA 
The CD140b+ sorted pericytes were replated and supplemented with PM for 3 – 4 days until 
they achieved ~80% confluency. Once confluent, a small population of sorted pericytes was 
processed for ICC by the methods described in Chapter 2.3, to test if the sorted pericytes 
were maintaining their purity during proliferation. The ICC analysis thus revealed that the 
sorted pericyte cultures were PDGFR-β positive and largely α-SMA negative (2.7%) with a 






Figure 4.4 Characterising the α-SMA expression in CD140b FACS sorted cells.  
(A) Represents ICC of CD140b positive sorted cultures that express a majority of PDGFR-β, and a 
very low percentage of α-SMA only cells. The yellow labelled cells are double-positive cells for 
PDGFR-β and α-SMA. The secondary controls for the respective antibodies were used to negate their 
non-specificity in the positive cells. DAPI detected the nuclei of intact cells. (B) Data shows the 
percentage of the sorted pericyte population. Images were taken under 20 X magnification with a scale 







4.3.5 Testing different promoters for efficient lentiviral transduction of iRFP 
The PM enriched pericytes were used to test different promoters for efficient LV transduction 
of the gene for iRFP reporter using an expression system described in methods (Chapter2 
Section 2.6.1. To achieve successful transduction, three different promoters (MND, EF1, and 
CAG) were tested for their efficiency (Section 2.6.1 Figure 2.5). The viral particles 
containing different promoters were used at different concentrations to transduce the sorted 
pericytes. Different volumes (2.5 μL, 1 μL, 0.3 μL, 0.1 μL, 0.03 μL ) of their corresponding 
concentrations of LV were added to the media containing the sorted cells and were treated for 
48hrs (Chapter2 Table 2.4).  
Immunocytochemical analysis of transduced pericytes demonstrated successful transduction 
by CAG-iRFP LV promoter compared to the other two promoters even at a lower 
concentration (1.09 x 104 functional units) (Figure 4.6A left panel). However, all the three 
promoters efficiently transduced (40% of transduction efficiency) at higher concentration 
(1.44 x105 functional units) (Figure 4.6A middle panel). Therefore, to achieve a maximum 
transduction efficiency for the successive grafting experiments (chapter 5), the CAG 
promoter was preferred and selected for LV transduction among the three tested promoters. A 
volume of   2.5 µL of CAG-iRFP LV achieved around 40% transduction efficiency (Figure 
4.6B). Untransduced cells and cells treated with polybrene were used as controls for cells 








Figure 4.5 Efficiency of LV transduction of pericytes using three different promoters.  
(A) Representative images of transduced pericytes at lowest volume 0.03 µL of LV (Left panel), 
highest volume 2.5 µL of LV (Middle panel), and control image of untransduced pericytes (Right 
panel). (B) The above graph shows the percentage of pericytes transduced when different volumes of 
LV was used (n=1). CAG promoter shows the stable, efficient transduction of pericytes when 






4.3.6 LV transduction of CD140b sorted pericytes 
Live sorted pericytes grown in PM were transduced with LV to express iRFP, allowing us to 
distinguish between the grafted (exogenous) and endogenous pericytes in vivo. Once the 
promoter was chosen, CD140b+ pericytes were successfully transduced with LV to express 
iRFP. It is to be remembered that an antibody to PDGFR-β was used for ICC experiments 
whereas CD140b has been used in replacement for an antibody to PDGFR-β for FACSorting. 
The iRFP transduced pericytes display the red color, PDGFR-β in green and DAPI in blue. 
Immunocytochemical analysis revealed the successful transduction of pericytes by colabelling 
for PDGFR-β and iRFP (Figure 4.7A-i). Untransduced cells were used as a negative control 
(Figure 4.7A-ii). Further quantification determining the percentage of CD140b sorted 
pericytes transduced by LV expressing iRFP. Similar to the results mentioned in section 
4.4.5, the sorted CD140b+ pericytes resulted in 40% of transduced pericytes that express 
iRFP. The transduction efficiency was only 40% at higher concentrations (1.44 x105 
functional units). The efficiency could be higher if higher concentrations are used but an 
increase in the concentration further can be toxic and result in cell death. Only the pericytes 







Figure 4.6 Representative images of sorted CD140b+ transduced pericytes.  
(A) ICC of sorted pericytes after transduction by LV (2.5 µL) to express iRFP. (i) The cultures were 
positive for PDGFR-β and iRFP. The yellow cells are transduced pericytes that express iRFP. (ii) 
Untransduced cells are used as a negative control that does not express iRFP and is positive for 
PDGFR-β.  (B) The percentage of sorted pericytes transduced was 40% that express iRFP. Results 
were represented from two batches that used Cd140b for FACSorting (n=2). Images were taken under 





4.3.7 FACSorting the iRFP transduced pericytes 
Before grafting, the iRFP-transduced CD140b+ pericytes were again FACS sorted by 
identifying the cells based on iRFP expression. Figure 4.8 depicts a representative dot plot of 
FACSorted iRFP+ pericytes. 
 
Figure 4.7 Representative dot plot depicting the percentage iRFP+ pericytes.  













4.4.1 Summary of the FACS sorting and purification of enriched cultured pericytes 
The current chapter highlights the importance of pericyte purification and further transducing 
the purified populations to express iRFP. A FACS specific CD140b antibody successfully 
sorted PDGFR-β/ CD140b+ pericytes. The sorted pericytes were further Lentiviral transduced 
to express iRFP reporter to identify and differentiate them from endogenous pericytes at the 
time of grafting. The iRFP+ pure pericytes were then live sorted prior to grafting to ensure that 
every grafted (exogenous) pericyte expressed iRFP.  
4.4.2 FACS – an important step for purification 
Protocols for the isolation of brain vascular cells often require the whole brain, or large 
regions, because of the difficulty of obtaining adequate yields of vascular cells (Crouch and 
Doetsch, 2018a). FACS allows the isolation of defined populations of cells based on their 
expression of surface markers or fluorescent reporters (Wang et al., 2018). In this study, 
initially, PDGFR-β and NG2 colabelled cells were processed for the sorting procedure. As a 
co-labelled population, the percentage of the cells was low (Figure 4.2i) but as a single 
labelled population, the PDGFR-β expressed a higher percentage of expression than the NG2 
which was identified as a weakly expressed surface marker (Figure 4.2iii). Therefore, when a 
cell population needs to be purified based on a weakly expressed surface marker or when two 
populations that have different levels of expression of the same surface marker needs to be 
purified, FACS is advantageous over other available methods of purification (Basu et al., 
2010b). Fluorescent proteins that are genetically expressed or cells that are tagged with a 
fluorescent reporter are also commonly sorted using FACS. Similarly, in this study FACS has 
been used to sort iRFP tagged enriched pericytes successfully (Figure 4.7). This type of 




essential step in the case of grafting experiments.  An important consideration in FACS is that 
the final cell yield depends on the amount of starting material, as well as the dissociation and 
digestion conditions that must be established to preserve epitopes of interest (Cossarizza et 
al., 2017). To achieve a larger number of cells, cells should be pooled from multiple sorts and 
multiple flasks.  
4.4.3 Choosing an appropriate promoter and viral titration influences the transgene 
expression 
The majority of basic studies are conducted with transformed cells, due to difficulties in 
achieving stable and efficient levels of gene expression in normal cells (Winiarska et al., 
2017).  Lentivirus has demonstrated to remain within a contained area and not to spread 
around the body, thus providing high selectivity for the target tissue. Including a cell-type-
specific promoter within the lentivector plasmid sequence, the genetic material can be 
engineered to express only in specific target cell types (Liu et al., 2006). In this study, we 
evaluated three different viral promoters in the context of lentiviral vectors for their 
transduction efficiency. We observed an increase in the transduction efficiency with an 
increase in the lentiviral volume (Section 4.3.5). CAG promoter was the promoter chosen for 
transduction as we did not observe much difference in the transduction efficiency between 
low volume and highest volume of LV particles used when compared to the other two 
promoters (Figure 4.5b). Therefore, it was important to optimize the usage of different 
promoters at different titre concentrations as it influences the levels of transgene expression. 
In addition to the choice of the promoter, titration of the virus is also important. Virus titration 
determines the success of the lentivirus production and helps to troubleshoot if the viral 
transduction fails. Therefore, viral titration is an important step. The functional and genomic 
titre in this study has been evaluated for the three different promoters which helped to 




4.4.4 Purification of enriched pericytes using CD140b/PDGFR-β as a putative pericyte-
specific marker.   
From the results of chapter 3, it was evident that supplementing the heterogeneous 
population of pericytes with PM led to the enrichment of PDGFR-β NG2++ pericytes. Hence, 
the enriched pericytes were initially live sorted by using the cell-surface expressing PDGFR-β 
and NG2 protein markers. However, FACS yielded a meagre percentage of PDGFR-β-NG2++ 
pericytes in contrast to the ICC results observed in chapter 3.3.3.6. The antibodies used in the 
FACS were the same as the ones used for ICC in chapter 3.3.2. Further, the FACS yielded a 
low percentage of PDGFR-β NG2++ pericytes as well as fewer single positive PDGFR-β+ and 
NG2+ pericytes. The low yield by FACS could be due to the non-specificity of the antibodies 
as they were not previously tested for FACS assay. Moreover, in the brain, it has been 
especially challenging to obtain pure populations of pericytes because widely used markers, 
such as NG2, PDGFR-β, and Nestin, are also expressed by oligodendrocyte progenitors, adult 
neural stem cells and progenitors, and astrocytes and/or ependymal cells (Crouch and 
Doetsch, 2018a). Hence, in order to reduce the ambiguity from the plethora of existing 
perivascular markers, the enriched pericytes were sorted by staining with a FACS tested 
antibody that binds to the pericyte-specific cell surface expressing PDGFR-β protein (Eilken 
et al., 2017). For multicolour staining, choosing fluorochrome that has no spectral overlap is 
extremely difficult and hence compensation is performed in such cases. An unstained control 
and single positive controls for each fluorochrome used for a multicolour or single staining 
are required for compensation calculations. Besides, the use of antibody concentration is very 
important in the experiment. Using three different concentrations of antibodies resulted in 
different percentages of a cell population in this study (Figure 4.2). The use of suboptimal 
concentrations of antibodies can result in poor separation of the desired cell population from 




chance for antigen non-specificity. Therefore, a FACS tested an antibody that has been 
titrated should be highly preferred for cell sorting as it gives the maximum brightness of the 
positive population and minimal background staining.  
4.4.5 Expression of α-SMA in pure pericyte population 
The important reason for purification was to eliminate unwanted cells from the enriched, but 
not pure pericyte culture developed in Chapter 3. In Chapter 3, Section 3.3.3.5, the PM 
cultures downregulated the expression of α-SMA+ cells, whereas DMEM cultures exhibited a 
stable expression of α-SMA. Since the presence of α-SMA might confer fibrosis when 
grafted, eliminating α-SMA expressing cells by enriching and purifying CD140b+ pericytes 
was crucial. Therefore, the enriched cells were processed further for purification to eliminate 
the remaining α-SMA+ cells from the culture. Interestingly, the sorted purified population also 
exhibited low levels of α-SMA, concluding that the pericyte population is never devoid of α-
SMA to confer the contractile ability to the pericytes. Also, the presence of serum (10%) in 
culture media might have induced the activation of α-SMA expression in pericytes, as has 
been shown previously (Tigges et al., 2012b). The CD140b purified pericytes were efficiently 
transduced with an iRFP reporter that helps in differentiating exogenous and endogenous 
pericytes. The transduced pericytes were further FACSorted by identifying iRFP+ pericytes 








Analytically, FACSorting was successfully used to sort the pure populations of pericytes, and 
the necessity for increasing the percentage of the pure population was exemplified by the 
heterogeneity observed in this study. Using the FACS-specific antibody against the CD140b 
epitope helped select the pericytes from the culture population. The CD140b+ pericyte 
population was successfully cultured and shown to be positive for PDGFR-β. These cells 
were then transduced with LV to stably express iRFP, helping to distinguish exogenous from 
endogenous host pericytes. The iRFP transduced pericytes were further FACSorted so that all 
cells grafted into the motor cortex were iRFP positive (see Chapter 5). 
4.6 Key Findings 
Table 4.1 Key findings summarizing the results of Chapter 4 
PDGFR-β antibody identified a small number of pure pericytes (>1%) 
NG2 antibody Non-specific  
CD140b antibody Pericyte population were purified by FACSorting based on 
CD140b staining 
CAG promoter 40% of transduction efficiency when the higher volume (2.5 
µL) of LV was used. 
Stable expression was observed. 
CD140b+ sorted pericytes iRFP was LV transduced with 40% efficiency. 












5 CHAPTER 5: GRAFTING TRANSDUCED 











5.1.1 Pericyte transplantation in motor cortex as a future therapeutic strategy 
Pericytes are multipotent stem cells that have the therapeutic potential to repair cerebral 
vasculature by promoting angiogenesis (Brown et al., 2019). It is their property of 
multipotency that make pericytes the cells of therapeutic interest to help repair brain 
vasculature and regeneration by replacing the lost cells. Damage to the rodent adult motor 
cortex leads to deficits in motor function and loss of coordination. One approach for 
overcoming the generally limited capacity of the mature CNS to regenerate in response to cell 
loss is the transplantation of pericytes. Based on recent findings, it has been proposed that 
transplantation of stem cells is a potential novel treatment for stroke (Baker et al., 2019). 
Several studies have used the transplantation technique as a mechanism of improvement such 
as modulation of inflammation and stimulation of plasticity (Kokaia et al., 2012). In the case 
of stroke, the patient’s functional loss is caused by the ischemic lesion extending into the 
cerebral cortex (Delavaran et al., 2013). For recovery, cortical neuronal implantation would 
be required to replace the lost neurons. A study has previously shown that transplantation of 
human cortical neural progenitors derived from induced pluripotent stem cells (iPSCs), into 
the cerebral cortex adjacent to the ischemic lesion induced by MCAO leads to improvement 
of sensorimotor deficits (Tornero et al., 2013). Recent advances in stem cell transplantation 
research have revealed the remarkable ability of engrafted neurons to specifically integrate 
into the injured nervous system, highlighting the potential for reconstruction of complete 
neuronal circuits that can support the recovery of complex neurological functions (Fischer et 
al., 2020). Several studies have shown that the new neurons generated following NPC 
transplantation in animal models anatomically and functionally integrate with host neural 




et al., 2012, Lee et al., 2014, Yokota et al., 2015). Therefore, stem cells like pericytes that can 
differentiate into multiple cell types like neurons and glia have to be transplanted into the 
motor cortex to improve connectivity in sensory, motor systems as well as to promote the 
formation of neuronal connections and improve vasculogenesis. Thus, pericyte transplantation 
in the motor cortex can be considered a potentially powerful therapy.  
Peripheral pericytes from dental pulp could be differentiated into glial and neuronal cell types 
(Farahani et al., 2019). Pericyte administration to the injured brain regions could improve the 
repair process by promoting neurogenesis and vasculogenesis (Cheng et al., 2018). Pericytes 
grafted in an animal model of Alzheimer's disease, improved vascularization and reduced 
amyloid-β pathology (Tachibana et al., 2018). Therefore, to understand the vasculogenic and 
differentiation potential of the pericytes after grafting into the brain in vivo, it was necessary 
to start with as pure a pericyte population as possible and to stably label these cells (Chapter 
3&4). In this chapter, we analysed the phenotype and hence the fate of the purified iRFP+ 
pericytes after they were grafted into the mouse cortex. 
5.1.2 Efficiency of transplantation 
There are controversies regarding the efficiency of exogenous stem cell transplantation due to 
the low grafting efficiency in the brain, which is usually less than 5% (Zhang et al., 2019). 
For example, studies with bone marrow stromal cell (BMSC) transplantation used a 
therapeutic dose range of 40,000 to 200,000 cells to exert therapeutic effects in a rat model of 
chronic ischemic stroke (Yasuhara et al., 2009). Another study with international stem cell 
corporation human parthenogenetic neural stem cell (ISC-hpNSC) grafts used a dose range of 
50,000 cells for low dose, 100,000 cells for the moderate dose and 200,000 cells for the high 
dose. The dosage range of 100,000 and 200,000 NSC grafts had shown improvements in TBI-




(Lee et al., 2019). These results showed dose-response efficacy readouts for different types of 
stem cells. There were not many studies available that could provide information on the initial 
number of pericytes to be transplanted in the mouse cortex. Grafting low numbers may reduce 
the efficiency of cell homing in the brain tissue, whereas a high number may induce scar 
formation. Hence, based on the available literature (Lee et al., 2019), an initial number of 
50,000 pericytes were grafted into the mouse cortex. Most of the literature is based upon 
grafting non-pericyte cells. Hence, a starting of only 25000 cells/µL was used initially to test 
if the grafted iRFP+ pericytes survive or not, but since I could not identify any RFP positive 
grafted cells with this dosage, I increased the dosage to 50000 cells. Grafting 50000 cells 
confirmed the presence of exogenous iRFP+ pericytes and hence the experiments were 
continued with the same dosage number. Although the literature suggests that a dosage of 
100000 cells would be recommended to observe any difference in pathology (Lee et al., 
2019), since pericytes are bigger than neural stem cells injecting high dosage numbers would 
block the syringe during injection. A study by Jackson et al., has shown the presence of 
transplanted neural crest stem cells localized in the corpus collosum and the transplanted cells 
migrated toward the lesion site by differentiating into glial phenotype when only 50,000 cells 
in a volume of 5 µL was injected (Jackson et al., 2010). When the neural stem cells derived 
from human iPSCs were injected at a volume of 250,000 cells/5 µL into the focal cerebral 
ischemia induced rats, the graft cells doubled the amount of transplanted cells one month 
later. The cells proliferated expressing neuronal marker and no signs of tumor formation were 
observed (Jensen et al., 2013). Therefore, depending upon the cell type used, the dosages have 
to be adjusted for a successful grafting experiment. 
5.1.3 Astrocyte response post-grafting 
Transplanting cells into the brain could initiate inflammatory responses such as activation of 




beneficial effects depending upon the severity of the damage (Karve et al., 2016). Reactive 
astrocytes have both pro-repair and pro-damage phenotypes depending upon their stimulus, 
for example, inducing middle cerebral artery occlusion (MCAO) upregulates the astrocyte-
specific markers like GFAP, vimentin and nestin (Zamanian et al., 2012). Astrocytes are 
essential for the integrity of the BBB and play a key role in several homeostatic and 
neuroprotective functions (Oksanen et al., 2019). An increase in GFAP expression has been 
considered one of the essential characteristics of astrocyte activation in neurodegenerative 
disorders (Millington et al., 2014), and it is essential to understand the astrocytic response by 
observing their morphological behaviour post-pericyte grafting in the mouse cortex.  
5.1.4 Role of microglia post-grafting 
In addition to astrocytes, microglia can display beneficial characteristics (tissue repair) by 
producing various neurotrophic growth factors, remove endogenous and exogenous 
neurotoxins and eliminate unwanted inflammatory cells (Gomes-Leal, 2012). They have been 
considered the resident immune cells of the brain and makeup 5%-10% of the cells in the 
brain (Frost and Schafer, 2016). A recent study has reported that pericytes constitute an 
unknown source of microglial cells in stroke and play an important role in the pathogenesis of 
tissue damage after ischemic stroke. In this study, the activated pericytes (RGS5) leave the 
blood vessel wall, proliferate and give rise to microglial cells in the infarct area after ischemic 
brain injury  (Ozen et al., 2014). During any brain lesion or dysfunction, microglial cells 
acquire an activated state displaying pro-inflammatory or phagocytic features (Nimmerjahn et 
al., 2005, Kettenmann et al., 2011, Kettenmann et al., 2013, Gomez-Nicola and Perry, 2015).  
Microglia have been characterised into three distinct subtypes depending upon their 
morphology or activation state in the situations of neuroinflammation. The first type is the 




microglia is the activated microglia characterised by a swollen cell body with shorter, thicker 
processes (Davis et al., 1994). These activated microglia can also be harmful by aggravating 
CNS injury by producing gliotoxins like ROS, NO and enzymes, causing subsequent 
secondary neural damage (Tambuyzer et al., 2009). Amoeboid microglia, the third type of 
microglia, are small spherical cells with one or no processes helping in phagocytosis and these 
microglia are usually observed during pathological situations (Streit et al., 1999). The positive 
characteristics of the microglia cells could protect the CNS in a gentle and neuron-friendly 
manner during cell transplantation. Therefore, it is important to understand the microglial 
response to pericyte grafting.  
5.2 Aim 
In the previous chapter, enriched and purified pericytes were transduced with iRFP reporter 
and FACSorted. These FACSorted iRFP+ pericytes were ready to be grafted into a mouse 
cortex. Considering pericyte transplantation as a possible future therapeutic strategy for brain 
regeneration, it is imperative to understand the fate of transplanted pericytes. To achieve this, 
the current chapter aims to understand  
• The fate of iRFP+ grafted pericytes (exogenous pericytes).  
• The astrocytic and microglial response to pericyte grafting. 
5.3 Methods 
The iRFP+ pericytes were grafted into the mouse motor cortex that was processed as detailed 
in chapter 2, section 2.7 alongside HBSS to serve as vehicle control. Each animal received 
unilateral injections of 1 µL cell suspension that contained 50,000 cells, or vehicle and was 
analysed 96h post graft. The fate of the grafted iRFP+ pericytes (exogenous pericytes) was 




the grafted mouse motor cortex was labelled with antibodies PDGFR-β, α-SMA to identify 
pericytes, Iba-1 to identify microglia, and GFAP to identify glia. The coronal sections were 





















5.4.1 Grafted pericytes survive and integrate into the vasculature 
To examine the role of grafted exogenous pericytes in the mouse cortex, the 96h post-graft 
motor cortex was labelled with PDGFR-β marker to validate the co-labelling of exogenous 
pericytes (iRFP+) along with PDGFR-β+ endogenous pericytes. The animals that received 
vehicle injections did not show iRFP expression (Figure 5.1a-i), but the presence of 
endogenous pericytes (green) could be seen (Figure 5.1b-i, ii). Animals grafted with 
exogenous pericytes displayed positive iRFP expression (Figure 5.1a-ii). A 'bump on a log' 
(as mentioned in Section 1.4)  (Attwell et al., 2016) morphology (arrowhead) of an iRFP 
positive grafted pericyte was observed on the PDGFR-β+ vasculature labelled in green 
(Figure 5.1b-ii). Results presented in Figure 5.1c show the vascular integration by the 
exogenous iRFP+ pericytes on the endogenous PDGFR-β+ vasculature in the 96h post-graft 
tissues.  
Similarly, the co-labelling of exogenous iRFP+ pericytes along with the PDGFR-β+ 
endogenous pericytes was validated on the capillaries. The vascular diameter of the capillary 
was shown to be 8.30 µm (>10 µm) and assumed to be a capillary. The grafted iRFP+ 
pericytes were seen in red (Figure 5.2a) and the endogenous PDGFR-β+ pericytes on the pre-
capillary arteriole (dotted box, Figure 5.2b-i) and capillary (Figure 5.2b-ii) were labelled in 
green. A 'bump on a log' morphology was also seen on the capillary labelled by endogenous 
PDGFR-β (arrowhead). A few iRFP+ pericytes were found lining the  PDGFR-β+ vasculature 





Figure 5.1 PDGFR-β co-labels with the grafted pericytes on the arteriole and pre-
capillary arteriole.  
Representative confocal images of 96h post-graft tissues. (a) (i) HBSS injected (ii) iRFP+ pericyte 
grafted tissues. (b) PDGFR-β+ labelling on the vasculature; (ii) The arrowhead shows the 'bump on a 
log' morphology of a pericyte on the vasculature; (c) Co-labelling of PDGFR-β and exogenous iRFP+ 
pericytes. DAPI labels the intact nucleus (blue). The arrow shows the place of exogenous pericyte 





Figure 5.2 PDGFR-β co-labels with the grafted pericytes on the capillary.  
Representative confocal images of 96h post-graft tissues  (a) (i) HBSS injected (ii) iRFP+ pericyte 
grafted tissues. (b) PDGFR-β+ labelling on the vasculature. The dotted box shows the presence of 
PDGFR-β on the pre-capillary arteriole. The arrowhead shows the 'bump on a log' morphology of a 
pericyte on the vasculature – arrowhead is in (ii)  (c) Co-labelling of PDGFR-β and exogenous iRFP+ 
pericytes. (ii) A magnified image shows the vascular diameter of the capillary to be 8.30 µm. DAPI 
labels the intact nucleus (blue). The arrow shows the place of exogenous pericyte integration along the 





To quantify the co-labelling of exogenous iRFP+ pericytes along with the endogenous 
PDGFR-β+ pericytes, the number of exogenous iRFP+ pericytes on the PDGFR-β expressing 
vasculature (96h post-graft tissues) were analysed using the methods detailed in Chapter 2, 
section 2.8.5.1. The average number of PDGFR-β+ cells was ~14 cells per µ2, and the total 
exogenous iRFP+ pericytes on the vasculature were ~3 cells per µ2 (Figure 5.3a). We did not 
observe a significant difference between the number of colabelled cells (PDGFR-β+ and 
iRFP+) and iRFP+ pericytes (ns Figure 5.3a). The comparison between iRFP PDGFR-β++  
rules out the possibility that the quantified PDGFR-β expression was not from endogenous 
pericytes. The quantification of iRFP PDGFR-β++ and iRFP+ cells was done in order to not 
overestimate the PDGFR-β expression of exogenous pericytes. Considering the fact that the 
host vasculature also contains endogenous pericytes, this particular quantification helped in 
differentiating the PDGFR-β expression of endogenous and exogenous iRFP+ pericytes. As 
evident from Figure 5.3a, there was no significant difference in the percentage of iRFP+ cells 
and iRFP PDGFR-β++ cells. 
The percentage area of exogenous pericytes was determined and compared with the area 
occupied by PDGFR-β+ endogenous pericytes using the methods detailed in section 2.8.5.2. 
There was a significant difference in the area covered by PDGFR-β and iRFP+ cells on the 





Figure 5.3 Quantification of exogenous iRFP+ pericytes on the PDGFR-β+ vasculature.  
(a) The number of PDGFR-β+ cells and exogenous iRFP+ pericytes on the PDGFR-β expressing 
vasculature 96h after grafting. Statistical analysis used a one-way ANOVA (n = 6 mice). (b) area of 
vasculature covered by the endogenous PDGFR-β was compared with PDGFR-β iRFP++ cells on the 
vasculature showed a significant difference in the area covered. Statistical analysis was done using an 
unpaired t-test for 96h (n = 6 mice). Statistical significance was set as **p < 0.01, ns represents p > 
0.05. 
 
5.4.2 Grafted pericytes integrate into the α-SMA expressing vasculature 
The CD140b FACSorted pericytes contained 2.7% of α-SMA+ cells only that were PDGFR-β- 
cells (Chapter 4, section 4.4.4). Therefore, to observe the post-grafting status of α-SMA 
expression in the grafted iRFP+ pericytes, the motor cortex was labelled with an antibody 
against α-SMA. While the pericyte-grafted tissues successfully expressed iRFP, as expected, 
the HBSS-injected vehicle did not show iRFP expression (Figure 5.4a). Both the vehicle-
injected and pericyte-injected cortex demonstrated α-SMA expression along the vasculature 
(Figure 5.4b). The analysis of 96h post-graft tissues revealed the colabelling of the 
vasculature by exogenous iRFP+ pericytes along with the endogenous α-SMA expressing 




Similarly, the co-labelling of exogenous iRFP+ pericytes along with the α-SMA+ endogenous 
pericytes was validated on the pre-capillary arteriole. The vascular diameter of the vasculature 
was shown to be 12.1 µm (<10 µm) and assumed to be a pre-capillary arteriole. The grafted 
iRFP+ pericytes were seen in red (Figure 5.5a) and the endogenous α-SMA+ pericytes on the 
pre-capillary arteriole were labelled in green. The dotted box represents the pre-capillary 
arteriole branching from the arteriole (Figure 5.5b-i).  A few iRFP+ pericytes were found 
lining the  α-SMA+ vasculature and the magnified image shows the co-labelling of the same 







Figure 5.4 α-SMA co-labels the grafted exogenous pericytes on the arteriole.  
Representative confocal images of 96h post-graft tissues (a) (i) HBSS injected (ii) iRFP+ pericyte 
grafted tissues. (b) α-SMA+ labelling on the vasculature. The dotted box shows the presence of α-SMA 
on the pre-capillary arteriole.  (c) Co-labelling of α-SMA and exogenous iRFP+ pericytes. DAPI labels 
the intact nucleus (blue). The arrow shows the place of exogenous pericyte integration along the 





Figure 5.5 α-SMA co-labels the grafted exogenous pericytes on the vasculature.  
Representative confocal images of 96h post-graft tissues (a) (i) HBSS injected (ii) iRFP+ pericyte 
grafted tissues. (b) α-SMA+ labelling on the vasculature. The dotted box shows the presence of α-SMA 
on the pre-capillary arteriole. (c) Co-labelling of α-SMA and exogenous iRFP+ pericytes. (ii) A 
magnified image shows the vascular diameter of the capillary to be 12.1 µm. DAPI labels the intact 
nucleus (blue). The arrow shows the place of exogenous pericyte integration along the vasculature. 





To understand the number of α-SMA+ cells and iRFP+ pericytes lining the vasculature, the 
total number of positive cells was determined using the methods detailed in Chapter 2, 
section 2.8.5.1. The number of grafted iRFP+ cells (red) and iRFP SMA++ cells (yellow) was 
significantly lower than the total number of α-SMA+ cells (green) on the vasculature. 
However, there was no significant difference between the number of iRFP+ cells (red) and 
iRFP SMA++ cells (yellow) (Figure 5.6a). The number of cells was calculated by choosing 
the light blue highlighted cells as described in Section 2.8.5.1, Figure 2.8.  The percentage 
area covered by the exogenous pericytes on the α-SMA expressing vasculature was also 
quantified, as discussed in Chapter 2, section 2.8.5.2. The area covered by the light blue 
highlighted cells was taken into account as described in Section 2.8.5.2, Figure 2.9. The 
results presented in Figure 5.6b show a significant difference between the percentage area 
positive for endogenous α-SMA compared to the area positive for exogenous α-SMA 
expressing pericytes on the vasculature.  
 
Figure 5.6 Quantification of exogenous iRFP+ pericytes on the α-SMA+ vasculature.  
(a) The number of α-SMA+ cells and exogenous iRFP+ pericytes on the α-SMA expressing vasculature 
96h after grafting. Statistical analysis used one-way ANOVA (n=6). (b) area of vasculature covered by 
the endogenous α-SMA was compared with α-SMA iRFP++ cells on the vasculature showed a 
significant difference in the area covered. Statistical analysis was done using an unpaired t-test for 96h 






When the total percentage of iRFP PDGFR-β++ cells and iRFP α-SMA++ cells that were 
integrated into vasculature were compared, there was no statistical significance observed 
(Figure 5.7a). However, the area of the vessel covered by the iRFP PDGFR-β++ cells was 
significantly larger than the area covered by iRFP α-SMA++ cells (Figure 5.7b). The latter 
phenomenon could be due to the migratory potential conferred by the PDGFR-β expression 
upon iRFP PDGFR-β++ cells, unlike the iRFP α-SMA++ cells concentrated in a relatively 
smaller area. 
 
Figure 5.7 Comparative analysis of iRFP-PDGFR-β++ and iRFP-α-SMA++ expression integrated 
into the vasculature.  
(a) Comparing the vascular integration of the number of iRFP-PDGFR-β++ and iRFP-α-SMA++ cells  
(b) Comparing the vascular integration of iRFP-PDGFR-β++ and iRFP-α-SMA++ cells in terms of the 
area covered. Statistical analysis was done using an unpaired t-test for 96h (n=6). Statistical 
significance was set as *p < 0.05, ns represents p > 0.05. 
  
In summary, the fate of the grafted iRFP+ pericytes colabelled with  PDGFR-β and α-SMA 
revealed that the population of exogenous pericytes was integrating into the vasculature. Their 
coexpression has resulted in three important observations: 
1. The exogenous pericytes have survived the grafting procedure in the mouse brains and 




2. Considering that less than 10% of the grafted exogenous pericytes expressed α-SMA, 
at the time of the grafting, it is remarkable that more than 60% of the α-SMA+ 
vasculature was iRFP+. 
3. Despite the presence of a similar percentage of iRFP-PDGFR-β++ and iRFP-α-SMA++ 
cells integrated, the former occupied a larger vessel area compared to the latter.  
 
5.4.3 Grafted pericytes do not acquire a microglial phenotype 
The 96h post-graft tissues were immunostained with Iba-1, a marker for microglia and the 
exogenous pericytes were observed expressing iRFP (Figure 5.8a). The endogenous Iba-1+ 
microglia were observed around the injection site (Figure 5.8b, green). The grafted 
exogenous pericytes were negative for the microglial marker Iba-1 at 96h (Figure 5.8c ii) as 






Figure 5.8 Exogenous pericytes do not acquire microglial phenotype 96h post-grafting. 
Representative confocal images of 96h post-graft tissues (a) (i) HBSS injected (ii) iRFP+ pericyte 
grafted tissues. (b) Iba-1+ labelling for microglia in green. (c) Co-labelling of Iba-1 and exogenous 
pericytes. Images show activated (arrowhead), ramified (arrow),  and amoeboid (star) microglia. DAPI 




5.4.4 Pericyte grafting and the microglial population 
Morphologically, the endogenous Iba-1+ cells displayed the traits of activated (arrow), 
ramified (arrowhead) and amoeboid (star) microglia (Figure 5.8b) and were quantified using 
the ImageJ cell counter tool, as mentioned in Chapter2, Section 2.8.5.3. Since exogenous 
pericytes are foreign bodies that could act as an immunogen in the host tissues, the effect of 
pericyte grafting on the microglial numbers were quantified, signifying their inflammatory 
response. The total number of microglia around the grafted area was quantified and estimated 
to be ~12 cells/field of view in both vehicle-injected and pericyte grafted tissues (Figure 
5.9a). While the number of ramified microglia was ~6 cells out of the total Iba1+ cells (Figure 
5.9b), the number of activated microglia was ~4 cells in the vehicle-injected cortex, 
respectively (Figure 5.9c). When the pericyte grafted tissues were analysed, there was no 
significant difference within the total number of ramified and activated microglia cells when 
compared with vehicle-injected. It was interesting to observe a non-significant change in the 
population of amoeboid microglia within the vehicle-injected and pericyte grafted tissues 
(Figure 5.9d), indicating the possible presence of dead cells/dead exogenous pericytes within 
the injection area independent of the presence of pericytes, and likely a result of damage from 





Figure 5.9 Quantification of activated, ramified and amoeboid microglia.  
There was no significant difference in the numbers of total Iba1+, ramified, activated and amoeboid 
microglia within the vehicle and iRFP grafted tissues. Statistical analysis was done using an unpaired 
t-test for 96h post-graft tissues (n=6 mice). Statistical significance was set as ns represents p > 0.05. 




After comparing the number of microglia, the effect of pericyte grafting on the size (area) of 
microglia between the groups was analysed using the shape filter in ImageJ (Chapter 2, 
section 2.8.5.4). Similar to the result observed in the microglia numbers, there was no 
significant increase in microglial cell size in 96h pericyte grafted tissues compared to the 
vehicle (Figure 5.10).  
 
Figure 5.10 Area of total microglia within the vehicle-injected and pericyte grafted tissues.  
There was no significant difference within the area occupied by the Iba1+ microglia when compared 
with vehicle and iRFP grafted tissues. Statistical analysis was done using an unpaired t-test for 96h 
post-graft tissues (n=6). Statistical significance was set as ns represents p > 0.05. 
 
5.4.5 Activation of endogenous astrocytes 
Although the exogenous grafted pericytes in this study were purified to be negative for GFAP 
expressing astrocytes (Chapter 3, Section 3.3.3.1), a recent study has shown that grafted 
neuronal cells actively induce astrogliosis surrounding the graft (Tomov et al., 2018a). All the 
animal groups that received the exogenous pericytes expressed iRFP (Figure 5.11a). While 
the 96h vehicle-injected tissue did not show extensive morphological changes (Figure 5.11b-
i), the astrocytes surrounding the graft in the pericyte grafted tissues formed an optically 




morphology. Individual cells exhibited small cell bodies with increased branching and thick 
processes that could signify the process of astrogliosis (Figure 5.11c-iii). There was no 
astrogliosis observed distal to the injection site (Appendix 4). Although not quantified, 
interestingly, a few GFAP+ astrocytes displayed colabelling with iRFP+ in 96h pericyte 
grafted tissues (Figure 5.11c-iii).  
 
Figure 5.11 Grafting iRFP+ pericytes into the motor cortex activated endogenous astrocytes. 
Representative confocal images of 96h post-graft tissues  (a) (i) HBSS injected tissues; (ii) iRFP+ 
pericyte grafted tissues shows. (b) GFAP+ labelling for astrocytes in green shows the presence of 
astrocytes in the vehicle-injected tissue(i) and astrogliosis in the iRFP grafted tissue (ii). (c) Co-





We also observed a significant difference in the number of GFAP+ astrocytes after grafting 
(Figure 5.12a). The vehicle-injected cortex expressed ~5-8 cells/ mm2, while the pericyte 
grafted tissues showed the presence of ~6-12 cells/ mm2. To evaluate astrogliosis after 
grafting exogenous pericytes, we measured the intensity of GFAP expression surrounding the 
grafts (Figure 5.12b) described in Chapter 2, Section 2.8.5.5. The increase in the number of 
GFAP+ activated astrocytes means that the astrocytes have thick processes, with long/ 
increased branching. These thick processes and increased branching increase the intensity of 
the GFAP marker expression. The intensity of GFAP expression was significantly higher in 
96h pericyte grafted tissues compared to vehicle-injected controls (Figure 5.12b). Therefore, 
the observed increase in the GFAP cell number and intensity in pericyte grafted tissues 
corresponds to an increase in the activated astrocyte population. 
 
Figure 5.12 Quantification of GFAP expressing astrocytes.  
There was a significant increase in the number of GFAP+ astrocytes as well as an increase in the 
GFAP intensity in the iRFP grafted tissues compared to the vehicle-injected tissues. (a) The total 
number of GFAP+ astrocytes; (b). The intensity of GFAP increased double-fold in 96h pericyte grafted 
tissue compared to the vehicle-injected tissue. Statistical analysis used an unpaired t-test (n=6). 








The results of this chapter demonstrate that the iRFP labelled exogenous pericytes grafted into 
the mouse cortex survive and integrate into the vasculature in 96h post-graft tissues. The 
grafted pericytes did not differentiate into glial phenotype. However, the injection of 
exogenous pericytes resulted in astrogliosis and a non-significant activation of microglia 
surrounding the site of injection. 
5.5.1 Exogenous pericytes specifically integrate into the vasculature and may confer 
vascular stability 
Our results demonstrate that 96h post grafting, the exogenous PDGFR-β+ pericytes were 
successfully lining the pre-capillary and capillary network (Figure 5.1, 5.2). This property of 
vascular integration could indicate that exogenous grafted pericytes behave similarly to 
endogenous pericytes by wrapping the blood vessel with their projections extending from the 
soma (Figure 5.1a, arrow). Since the enriched and purified pericytes were low in the α-SMA 
population, we assumed that the cells were capillary pericytes (Chapter 3, 4). It was also not 
surprising to find the exogenous iRFP+ pericytes lining the endogenous PDGFR-β expressing 
capillaries (Figure 5.2). The specificity of exogenous pericytes to line the vasculature 
suggests one of two hypotheses: 1) The pericytes were attracted towards the vasculature on 
account of endogenously available chemokine PDGF-BB, secreted by endothelial cells 
(Heldin, 2013); or 2) The surface receptor PDGFR-β of the exogenous pericytes stimulated 
endothelial cells to secrete PDGF-BB. Either way, there seems to be a chemotactic interaction 
between the exogenous PDGFR-β receptor and the chemokine PDGF-BB, leading to the 
specific lining of exogenous pericytes (Winkler et al., 2010c). Understanding the factors 
responsible for promoting endothelial-pericyte integration post grafting will help in enhancing 




Failure to recruit pericytes during development in a diseased model leads to vascular 
instability and regression (Lindahl et al., 1997a, Armulik et al., 2010b). Hence, the integration 
of grafted pericytes on the endogenous vasculature could be one of the useful properties for 
maintaining the vessel stability and development of new vasculature in the events of stroke or 
in any diseased condition. Observing the vascular integration by exogenous pericytes in the 
pre-capillary arteriole  (Figure 5.1) and capillary (Figure 5.2) indicates that the exogenous 
pericytes need no more than 96h to attach to the vasculature. Overall, our results demonstrate 
that exogenous pericytes integrating into pre-capillary and capillary is an important step and 
may enhance vascular stability.  
5.5.2 Exogenous pericytes integrating into α-SMA vasculature possess the contractile 
function 
In this chapter, we demonstrate that the exogenous pericytes grafted into the mouse cortex 
were positive for α-SMA (lining of α-SMA vasculature, section 5.4.2). Before grafting, the 
purified pericyte population consisted of only 2.7% α-SMA+ cells (Chapter 4, section 4.4.4). 
However, the grafted iRFP+ pericytes integrated into the α-SMA+ vasculature, as observed in 
the 96h post-graft tissues. The iRFP+ pericytes covered ~67% of the total area of α-SMA 
expressing vasculature, signifying that the grafted pericytes acquired SMA expression 96h 
post grafting (Figure 5.4b). We also observed the lining of the exogenous iRFP+ pericytes on 
the α-SMA expressing pre-capillary arteriole (Figure 5.5). This can be due to the presence of 
a low population of α-SMA (2.7%) in the grafted iRFP population. This observation could be 
supported by further validation experiments as the α-SMA staining along the vasculature 
could be from endogenous VSMCs lining the large vessels, not pericytes (Alarcon-Martinez 
et al., 2019). This could be achieved by staining the post-grafted tissues with an antibody that 
exclusively labels VSMCs but not pericytes. Calponin-1 is a calcium-binding protein that is 




Colabelling the post graft tissues with anti-calponin-1 and anti-SMA antibodies could clearly 
demarcate the endogenous VSMCs and the integrated exogenous pericytes. 
Studies have shown that most capillary pericytes in the CNS contained little or no α-SMA, 
and this protein was only present on pre-capillary arterioles and postcapillary venules (Nehls 
and Drenckhahn, 1991, Bandopadhyay et al., 2001, Armulik et al., 2011a).  Similar to this 
study, we also observed a partial lining of the pre-capillary arteriole expressing α-SMA along 
with a few exogenous iRFP+ pericytes (Figure 5.5). A couple of studies also showed that the 
presence of α-SMA is dependent on the state of differentiation and treatment conditions, as 
well as the location on capillaries (Nehls and Drenckhahn, 1991, Dore-Duffy et al., 2011). 
Most importantly, the presence of α-SMA on pericytes helps to support the blood vessel wall 
structurally (Nehls and Drenckhahn, 1991). Therefore, the lining along the vasculature at 96h 
leads to an interesting hypothesis that the grafted iRFP+ pericytes might be acquiring an α-
SMA positive phenotype in this comparatively short time in order to promote vascular 
stability and contractility. Several plausible explanations could support this hypothesis as the 
availability of growth factors and the environment within the tissue plays an important role in 
cellular behaviour (Fernandez-Klett and Priller, 2014). Besides conferring the contractile 
ability to the pericytes, large amounts of α-SMA can also lead to fibrosis or fibrotic scar in the 
injured tissues (Fernandez-Klett and Priller, 2014). Hence, tracing the exogenous pericytes for 
longer periods by observing the percentage of exogenous pericyte proliferation and 
differentiation within the grafted tissue, could give an idea of whether these grafted α-SMA+ 
pericytes were destined to proliferate further to form an unwanted scar. 
In conclusion, based upon our findings, the exogenous iRFP+ pericytes were integrating into 
the vasculature and colabelled with PDGFR-β and α-SMA in both pre-capillary and capillary 
network. It is well known in the previous literature that PDGFR-β+ pericytes are known to 




α-SMA+ pericytes are more advanced in chemokine secretion and providing contraction (Park 
et al., 2016).  
5.5.3 Grafted pericytes initiate an inflammatory response by activating microglia  
Microglia play crucial roles in inflammation-mediated pathological conditions such as 
ischemic stroke (Sakuma et al., 2016). They arise as a result of divergent stimuli they receive 
from the surrounding environment and can also depend on the nature and severity of the 
injury (Karve et al., 2016). A recent report demonstrated that the multipotent brain pericytes 
could acquire a microglial phenotype post-ischemia (Ozen et al., 2014). Here, grafted 
exogenous pericytes did not appear to colocalise with Iba-1 positive cells and hence, 
acquisition of a microglial phenotype by the grafted pericytes can be ruled out. (Figure 5.8).  
A study investigating pathological changes in injured post-mortem human brains showed 
prolonged activation of microglia even years after injury (Johnson et al., 2013). Here, we saw 
evidence of some changes in activated microglia within 96h of grafting (Figure 5.8). A 
degree of heterogeneity in microglia structure occurs, depending upon their activation state 
(Figure 5.9). Although pericyte grafting did not show a significant effect on the overall 
number of all types of microglia, there was a significant increase in the size of microglia in 
the pericyte grafted tissues compared to the vehicle, leading to the possibility that pericyte 
grafting might be inducing phagocytic behaviour of endogenous microglia. This was further 
supported by a non-significant increase in the number of amoeboid microglia (figure 5.8d). 
Further analysis would benefit from using CD68 as a marker of macrophage (phagocytic) 
phenotype of microglia in the grafted cortex. CD68 is a transmembrane glycoprotein 
expressed by human monocytes and tissue macrophages that indicates phagocytic activity, 
suggesting that phagocytic microglia are likely to be involved in the removal of degraded 




HLA-DR class II molecules of the human major histocompatibility complex (MHC) present 
processed extracellular antigens to CD4+ helper T lymphocytes. Microglia upregulate HLA-
DR in response to interferon-γ stimulation and different pathological conditions including 
multiple sclerosis (Heppner et al., 2015).  Therefore, analysing the increase in both the above-
mentioned markers could help determine if the microglia are phagocytosing. Further analysis 
could also examine the phagocytic nature of the microglia from their outgrowth length and 
branching patterns of the different types of microglia.  
5.5.4 Grafted exogenous pericytes lead to reactive astrogliosis in the motor cortex 
Astrocytes are specialized glial cells that respond to all forms of CNS insults through a 
process called reactive astrogliosis (Sofroniew and Vinters, 2010). These responses involve 
changes in morphology, heightened proliferation, increased expression of GFAP and secretion 
of pro-inflammatory cytokines and growth factors (Pekny et al., 1999, Gorina et al., 2011, 
Zamanian et al., 2012, Paintlia et al., 2013). A similar change has been observed in our study 
that showed changes in morphology and heightened proliferation and increased GFAP 
expression (Figure 5.11) independent of damage caused by the process of injection.  
A recent study has reported the presence of hypertrophic astrocytes in the lesional and peri-
lesional area 72h after TBI in the mouse CCI model (Villapol et al., 2014). Another study 
observed a massive astroglial response in the lesion core from 4h to 24h post-ischemia that 
reaches a peak around day 4 (Nowicka et al., 2008). Similarly, we observed hypertrophic 
astrocytes/astroglia intertwined with the neighbouring astrocytes at 96h post-graft pericyte 
graft (Figure 5.11, c-iii). These highly branched, hypertrophic astrocytes also expressed 
greater levels of GFAP (Figure 5.12). Grafting of exogenous pericytes and the resultant low-
level microglial activation could have indirectly induced astrocyte activation by the release of 




cortex (Figure 5.12b) indicates that the reactive astrocytes could be modulating BBB 
formation, secretion of inflammatory factors, and also glial scar formation as occurs after 
injury (Alvarez et al., 2013). The other crucial function of astrogliosis surrounding the grafted 
site could be the necessary vascularization of the transplanted cells, as reported in a recent 
study (Tomov et al., 2018b). Astrocytes were reported to directly provide nutrition to the 
transplanted cells, in the form of glucose, by the process of glycogenolysis.  (Forno et al., 
1992). Integration and the successive nourishment of the transplanted pericytes rely on the 
formation of the vasculature, which in turn requires the active participation of astrocytes. 
Reactive astrocytes are capable of degrading the extracellular matrix that causes BBB 
disruption (Carpentier et al., 2005, Kim et al., 2005), and produce factors to support repair and 
regeneration after CNS damage (Kim et al., 2010, Madathil et al., 2013). Therefore, astrocytes 
can elicit both protective and deleterious actions, which influences the extent of brain damage 
or repair after injury; it would be very interesting to note if grafting of purified pericytes 













In this chapter, the exogenous pericytes, successfully integrated into the vasculature and 
colabelled with PDGFR-β and α-SMA in 96h post-graft tissues. The 96h post-graft tissues 
showed no significant difference in the number of ramified, activated, or amoeboid microglia. 
However, we observed more amoeboid microglia and a significantly increased size in the 
microglial area; thus, the grafted pericytes might be stimulating the microglia to become 
phagocytic (Sakuma et al., 2016). Grafted Pericytes also lead to astrogliosis observed as an 
increased expression of GFAP+. Reactive astrocytes have both pro-repair and pro-damage 
phenotypes depending upon their stimulus, for example, inducing middle cerebral artery 
occlusion (MCAO) upregulates the astrocyte-specific markers like GFAP, vimentin and 
nestin (Zamanian et al., 2012). Astrocytes are essential for the integrity of the BBB and play a 
key role in several homeostatic and neuroprotective functions (Oksanen et al., 2019). An 
increase in GFAP expression is one of the essential characteristics of astrocyte activation in 
neurodegenerative disorders (Millington et al., 2014), and alongside their altered morphology 
strongly supports an astrocytic response post-pericyte grafting in the mouse cortex. These 
pieces of evidence suggest that grafting pericytes could represent an interesting therapeutic 
opportunity due to its property of vascular integration and changes in the inflammatory 













6 CHAPTER 6: ASSESSMENT OF MOTOR 
BEHAVIOUR OF PERICYTE GRAFTED MICE 













To determine the motor function outcomes of central nervous system (CNS) diseases in 
rodent models, several behavioural tests have been developed (Hua et al., 2002, Belayev et 
al., 2003). These tests have been used for assessing acute and chronic changes in sensorimotor 
function and plasticity for unilateral brain injury such as cerebral ischemia (Schallert et al., 
2000) and also to assess the efficacy of behavioural or pharmacological interventions. One of 
the tests is the forelimb use asymmetry test or cylinder behaviour test (Schallert et al., 2000), 
which is a sensitive test that can assess the degree of damage and impairment caused by 
unilateral CNS disorders and the process of recovery. In vivo experiments show increased cell 
proliferation, the formation of new neurons and decreased gliosis, suggesting decreased 
inflammation after MSC treatment of ischemic brain injury. These EdU- or BrdU-labeled 
cells probably originate from the SVZ and migrated toward the injured area, where they 
potentially contribute to repair of the injured tissue and decreased lesion volume that was 
observed after MSC transplantation. After chronic cuprizone (CPZ), iNSC transplantation 
promoted recovery as detected using the Miss-step wheel running task. Miss-step wheels have 
a non-uniform pattern of missing rungs. This Miss-step wheel running may also work as a 
targeted exercise enrichment, acting in conjunction with iNSC transplantation to promote 
recovery (Sullivan et al., 2020). Testing the effect of grafted cells on naïve animals prior to 
experimenting with stroke mice would be beneficial. Most of the literature mentioned above 
did not show any motor deficits but only showed improvement post grafting stem cells. 
When placed in the cylinder, animals explore by rearing and touching the walls of the 
cylinder with their forelimb paws for postural support. Following ischemic injury or any 
damage to the cortex, animals rely more heavily on their unaffected forelimb paw for support 




test is easy to perform and sensitive to detect motor impairments that the other behaviour tests 
fail to detect (Schallert and Woodlee, 2005).  
6.2 Aim 
In my study, the cylinder test has been used to determine if unilateral grafting of pericytes into 
the motor cortex was sufficient to influence a bilateral forelimb specific behaviour. Given the 
above background, the current chapter aims to investigate the motor behaviour of mice post 
grafting to confirm no deleterious effects. As the long-term goal of this project was to graft 















6.3.1 Injecting cells in the motor cortex did not cause motor deficits/impairment  
Figure 6.1 summarizes the behavioural data from pre and post graft animals, and there were 
no differences between the groups. Regardless of the control (HBSS) injection or iRFP+ 
pericyte injection, all the animals showed normal rearing behaviour and forelimb use on the 
cylinder test pre and post graft. In this test, the animals were assessed for any asymmetry to 
their use of forelimbs for vertical exploration by the method described in Section 2.9. The 
asymmetry index (AI) was around the theoretical value of 0.5, indicating symmetrical use of 
forelimbs in both the experimental groups (Wilcoxon signed-rank test; p ≥ 0.05 compared to 
0.5) where 0.5 is the theoretical value if the mouse uses its forelimbs symmetrically against 
the side of the cylinder wall during the rearing.  The motor assessment was carried out in the 
same animals both before and after (96h) grafting. All the animals were in good health and no 
neurological symptoms were observed pre and post grafting. The health parameters taken into 
consideration were: 
• Surgical site  
• Bodyweight change 
• Hydration state (water bottle weight) 
• BAR (Bright, Alert, Responsive) 
• General activity 
• Signs of pain 
Out of the above-mentioned parameters, change in BAR is considered to indicate a 
neurological defect in the animal. These results confirm that the grafted cells do not affect the 









Figure 6.1 Grafted pericytes Injections into the motor cortex did not alter motor behaviour.  
Behaviour deficits measured by the cylinder test did not show any changes in their motor performance 
(96h post-graft). (A) The asymmetry index is shown for pre-op (before the graft) and HBSS injected 
post-graft vehicle animals. (B) The asymmetry index is shown for pre-op (before the graft), and iRFP+ 
pericyte injected post-graft animals. The analysis used a Wilcoxon signed-rank test; p ≥ 0.05 







6.4 Discussion and Conclusion 
The cylinder task is objective, easy to use and score, and requires no pre-training of the 
animal and reliably tests if the mouse uses one forepaw more than the other (Glajch et al., 
2012). Although the current study has not been studied in stroke mice, the functional recovery 
in the events of stroke is typically evaluated with behavioural tests like the cylinder test that 
measure functional deficits. It is worthwhile, therefore, to explore and compare the effects of 
these newly enriched pure pericyte populations on the behaviour of rodent stroke models 
following transplantation of iRFP+ pericytes into the motor cortex. Vehicle HBSS and iRFP+ 
pericytes treated mice performed similarly in the cylinder test (Figure 6.1). Our results 
indicate that the injection of iRFP+ pericytes in the motor cortex did not affect forelimb use 
during vertical explorations. 
Pericytes from mice were chosen for allogeneic transplantation in order to avoid immune 
rejection between species. It has been shown that the motoric behaviour in the cylinder 
rearing test at 10 and 21 days after HI was significantly improved by MSC treatment 3 days 
after the insult. Moreover, even when treatment was started at 10 days after HI, there was a 
significant reduction in lesion size and improvement of behavioral outcome (van Velthoven et 
al., 2010). Therefore, there is a possibility of a greater effect after 96h post grafting in stroke 
mice. 
The cylinder test is considered to be an important test for impairments in the bilateral limb 
movement in response to a unilateral lesion. A study where rats were subjected to transient 
MCAO showed a severe and long-lasting impairment when sensitive sensorimotor test like 
cylinder test was applied (Parkkinen et al., 2013). Since the cylinder test can only be used to 
study the spontaneous exploratory forelimb use, another behaviour test should be studied in 




quantitative gait analysis tool (CatWalk system). This test represents a rapid way to 
objectively quantify several gait parameters such as position, pressure and surface area of 
each paw, which are used to calculate spatial paw statistics, the relative positions between 
paws, temporal parameters of gait and interlimb coordination (Parkkinen et al., 2013). Using a 
cylinder test can confirm the deficits in gait and CatWalk analysis provides more sensitive 
and detailed information on specific gait parameters. Therefore, Cylinder and CatWalk tests 
can be a useful tool to study both motor impairment and recovery associated with various 







































Stem-cell based approaches hold much promise as potential novel treatments for stroke, 
which may help prevent further damage and repair the injured brain (Sakata et al., 2012). A 
variety of cell types have been tested such as neural stem/progenitor cells (NSPCs), 
immortalized cell lines, hematopoietic/ endothelial progenitors and stromal cells isolated from 
bone marrow, peripheral blood, and umbilical cord blood (Bliss et al., 2007). NSPCs, have the 
potential to differentiate to neurons, oligodendrocytes and astrocytes, which are the most 
affected by stroke (Bliss et al., 2010). Similar to NSPCs, pericytes are multipotent in 
differentiating into different cell types (Ozen et al., 2014, Nakagomi et al., 2015), which make 
them a useful target for therapeutic interventions in different kinds of diseases (Brown et al., 
2019).  
As components of NVU, pericytes attracted considerable interest for their ability to regulate 
physiological and pathological processes of the CNS (Geranmayeh et al., 2019a). Pericytes 
play an important role in maintaining the blood vessel homeostasis in the brain. Their secreted 
soluble factors regulate vascular development and their integration within the vasculature 
(Nakagawa et al., 2009). Pericytes provoke immune cells to regulate neuroinflammatory 
conditions during brain acute and chronic diseases (Yang et al., 2015). There have been 
reports where pericytes are important in provoking an immune response to regulate 
neuroinflammatory conditions (Geranmayeh et al., 2019b). They are also directly involved in 
supporting the vascular integrity by themselves acquiring a microglial like phenotype 
(Haruwaka et al., 2019). A subset of pericytes possess multipotentiality and exhibit trans-
differentiation capacity in the context of damaged tissue (Guimaraes-Camboa et al., 2017). 
Given their above spectrum of functions, pericytes could be identified as one of the potential 




7.1 Summary of main findings 
The focus of this thesis has been to determine what happens to a distinct set of purified 
pericytes grafted into the mouse motor cortex. Mouse brain pericytes were isolated, 
characterised, enriched and purified in order to graft a pure population of pericytes as possible 
in the mouse cortex. Prior to pericyte isolation, pericyte markers were characterized on naïve 
mouse cortex tissues as there is no single specific marker to identify pericytes. When 
characterised, the pericytes were heterogeneous in nature (Chapter 3). To obtain a pure 
population of pericytes, the heterogeneous population of cells was cultured in a pericyte-
specific growth medium (PM), resulting in an enriched pericyte population (capillary 
pericytes), which was further purified by FACS (Chapter 4). The purified pericytes were then 
grafted into the mouse cortex leading to their integration into the vasculature, microglial 
activation and astrogliosis (Chapter 5). Additionally, behavioural studies by cylinder analysis 
revealed that the grafted pericytes have no apparent deleterious effects on the motor behaviour 
of healthy mice (Chapter 6). The studies have to be extended beyond 96h along with the 
increase in the cell dosage to observe any changes resulting due to the grafting of exogenous 
iRFP+ pericytes in the mouse motor cortex.   
7.2 Pericyte medium (PM) enriches capillary pericytes 
The heterogeneous cortical cultures were enriched by supplementing two different growth 
media, DMEM and PM. The cells were cultured for 7 as well as 14 days and were passaged 
until P3 (Passage-3), monitoring for the elimination of unwanted cells like astrocytes and 
enriching a pure population of pericytes (Chapter 3, Section 3.3). Additionally, cells cultured 
in PM demonstrated downregulation of α-SMA expression, unlike the cells cultured in 
DMEM (Chapter 3, Section 3.3.3.5). Previously published approaches have reported similar 




increased expression of α-SMA, decreased growth rate and cell enlargement, signifying 
pericyte differentiation (Dellavalle et al., 2007). In contrast, the mouse brain pericyte cultures 
in PM expressed low levels of α-SMA, consistent with previous studies showing no signs of 
pericyte differentiation into α-SMA or any other types of cells up to 40 passages (Tigges et 
al., 2012b). These results could reflect different pericyte phenotypes at different 
developmental time points and should be an important consideration for this study, which 
involves examining the pure population of pericytes. As there are different types of pericytes 
depending upon their location on the vessels, downregulation of α-SMA and upregulation of 
PDGFR-β and NG2 is a molecular signature that is specifically considered to indicate 
capillary pericytes (Grant et al., 2017, Alarcon-Martinez et al., 2019). Based on the obtained 
results, 7P2-PM cultures were chosen for further purification process as they displayed a low 
percentage of α-SMA and a high percentage of PDGFR-β and NG2 compared to DMEM 
cultures (Chapter 3, Section 3.3.3.6). Therefore, PM enriches capillary pericytes by showing 
a significant reduction in α-SMA expression, similar to a study (Rustenhoven et al., 2018a). 
These findings provide a strong understanding of the nature of pericytes and regulation of 
molecular signature when cultured in different growth conditions as well as the type of 
growth medium. 
7.3 FACS results in a high percentage of CD140b+/PDGFR-β+ pericytes 
Although pericytes are positive for PDGFR-β, NG2 and α-SMA, the latter could not be used 
to sort a pure population of pericytes due to its intracellular expression. Since FACS isolation 
is based on the surface marker expression of cells, in this study, PDGFR-β and NG2 markers 
were initially used to sort a pure population of pericytes (Chapter 4, Section 4.4.2). The 
antibodies used for the first phase of sorting did not yield enough pericytes to be grafted due 




expressed in the neuronal-glial population and is not restricted to pericytes (Ishii et al., 2008, 
Dimou and Gallo, 2015, Guimaraes-Camboa et al., 2017). Hence, a FACS-specific PDGFR-β 
(anti-CD140b) antibody (Ozen et al., 2014) was used to sort as pure a population of pericytes 
as possible (Chapter 4, Section 4.4.4). 
7.4 The density of the injected pericyte population determines the 
efficiency of grafting 
Successful grafting of cells requires large numbers of cells (Chapter 5, Section 5.1.2). 
Previous studies in the mouse brain reported that injecting high numbers of human embryonic 
stem cell-derived NPCs lead to the formation of tumors (Carson et al., 2006). Another study 
reported that 1x105 cells/3.0 µL of human mesenchymal stem cells (hMSC) could not be 
detected long-term after injection into the mouse brain after stroke (Mora-Lee et al., 2012). 
Therefore, it is to be considered that injecting (grafting) optimum number of cells determines 
the efficiency of transplantation, where low numbers affect the homing of transplanted cells, 
and high numbers could have a deleterious effect on the host like the formation of tumors or 
scarring. In my study, Increasing the cell density to 50,000 cells/µL resulted in successful 
grafting of pericytes, which could be visualised by their iRFP expression (Chapter 5, Section 
5.4). It would have been interesting to compare the results of pericyte grafting with increased 
cell density (100,000-200,000cells/ µL), However, in a study using NSCs (Lee et al., 2019), 
transplantation at moderate (40,000 cells/µL) and high doses (200,000 cells/µL) had no 
significant difference in the resulting therapeutic effects on cognition.  
7.5  Integration of grafted cells into host vasculature 
The integration of pericytes is crucial for the maintenance of vessel stability (Mazzoni et al., 




vasculature, positive for PDGFR-β and α-SMA expression (Chapter 5, Section 5.4.1&5.4.2). 
Although the molecular mechanism by which pericytes mediate vessel stability is not clearly 
understood, a few studies have demonstrated the critical importance of pericytes for vessel 
stabilization by analysing pericyte-deficient states of various PDGF-BB and PDGFR-β 
mutants and in PDGFR-β antibody-injected mice (Betsholtz et al., 2005). The integration of 
grafted pericytes to the PDGFR-β expressing vasculature is due to the presence of PDGF-BB, 
known to be a key regulator of vascular pericytes. When PDGF-BB is genetically deleted, 
microvascular pericytes are lost, and capillary microaneurysms occur (Lindahl et al., 1997a). 
Hence, PDGF-BB is required for the recruitment of pericytes to nascent blood vessels 
(Hellstrom et al., 1999) and this is the likely mechanism for the grafted pericytes to integrate 
into the vasculature. Moreover, in the mouse fibrosarcoma model, the overexpression of 
PDGF-BB or its receptor PDGFR-β increased the pericyte recruitment to tumor blood vessels 
(Abramsson et al., 2003). These studies also support the need to graft low, but efficient 
numbers of pericyte positive cells as increased numbers could lead to tumor formation. The 
PDGF signalling pathways, as mentioned in the introduction section (Chapter 1, Section 
1.5.2.1), interact with other signalling pathways that induce the recruitment of pericytes to 
neovessels. Besides, EC-derived PDGF-BB and heparin-binding EGF-like growth factors are 
crucial for pericyte regulation, proliferation, motility and recruitment to EC-lined capillaries 
(Stratman et al., 2010). To understand the proliferative and angiogenic properties of purified 
pericytes,  in vitro assays like a scratch assay, migration assay, or matrigel assay could be 
performed in the presence of the above-mentioned growth factors like PDGF-BB, EGF or 
VEGF. 
In addition to PDGFR-β, the grafted pericytes integrated into the vasculature have also 
displayed α-SMA expression, as observed in the 96h post graft tissues (Chapter 5, Section 




expression of α-SMA. The increase in α-SMA expression in the grafted pericytes could either 
be due to their increased proliferation post-grafting or their ability to differentiate into a 
contractile phenotype by acquiring α-SMA expression. There is no evidence on proliferation 
as the grafted tissues were not validated for BrdU or Ki67 staining. Based on the results, it 
can be assumed that there could be proliferation due to an increase in α-SMA iRFP++ cells. As 
the α-SMA cells are highly proliferative in nature, a small percentage of the grafted cells can 
lead to increased proliferation within the grafted niche. Double labelling of the grafted tissue 
with PDGFR-β and α-SMA would have further validated their co-expression. Though α-SMA 
will induce contractile phenotype, we did not carry out functional studies to test this. Future 
studies could assess the calcium dynamics of the grafted pericytes in response to a 
depolarising stimulation in vitro as a first step. A recent study in the ischemic model has 
shown that the pericytes located near the microvascular constrictions exhibited significant 
calcium increase post-ischemia (Alarcon-Martinez et al., 2019).   
7.6  Activation of glial cells in the pericyte grafted tissues 
Microglia and astrocytes are considered to be the key players in initiating the inflammatory 
response after any brain injury. Hence, the effect of pericyte grafting on glial and astrocyte 
behaviour was studied (Chapter 5, Section 5.4.3&5.4.5). In the current study, grafting 
pericytes into the mouse cortex did initiate an inflammatory response 96h post-grafting 
resulted in the phenomenon of astrogliosis (Chapter 5, Section 5.4.5) as well as an 
indication, but not significant, increase in microglial activation (Chapter 5, Section 5.4.3).  
During a brain injury, microglia are the first population that is instrumental in mounting an 
immune response (Karve et al., 2016).  This could be due to their ability to compensate for the 
injury-associated cortical cell loss with a potential neuroprotective response (Beschorner et 




several neurotrophic factors and growth factors post-injury (Lai and Todd, 2006). Microglia 
produces an important cytokine IL-6 after injury, which, in combination with other 
neurotrophic factors, decrease neuronal death during events of brain injury (Suzuki et al., 
1999). Post-ischemic microglia produce two neurotrophic factors (PDGF and a glial cell line-
derived neurotrophic factor) that promote neuronal survival (Lu et al., 2005). From the above 
literature, it could be inferred that the microglial activation, induced by pericyte grafting, 
could act as an indirect mechanism to promote neuroprotection. 
Moreover, the mechanism of neuroprotection may involve the presence of cytokines such as 
PDGF-BB (a PDGFR-β agonist) and IL-6 (secreted by microglia). Although it was beyond 
the limit of the current study, future in vitro studies involving pericytes, endothelial cells, and 
microglia can help in validating their neuroprotective potential in rescuing physiological 
stress-induced neurons (Future directions, Section 7.8.3 ).  
Here, along with activated microglia, a few amoeboid and ramified microglia within the 
analysed grafted tissues were observed in comparison to the vehicle (Chapter 5, Section 
5.4.4). The presence of amoeboid and ramified microglia suggests that they were maintaining 
a healthy environment by phagocytosing the dead or unwanted cells.  
Astrocytes interact with NVU by forming astrocytic end-feet around endothelial cells and 
maintain BBB integrity (Abbott, 2002). During astrogliosis, reactive astrocytes demonstrate a 
change in morphology, increased expression of GFAP and heightened proliferation, all of 
which were clearly observed in 96h post-graft tissues (Chapter 5, Figure 5.9). Human 
studies have shown that astrocytic downregulation after TBI promotes the accumulation of 
glutamate that contributes to excitotoxicity leading to neurodegeneration (Karve et al., 2016). 
On the contrary, the presence of large numbers of activated astrocytes leads to glial scarring 
that is mediated by TGF-β1 and TGF-2, IFN-γ, FGF and fibrinogen (Schachtrup et al., 2010). 




On the other hand, it was thought to act as a physical barrier to encapsulate damaged tissue to 
prevent toxic molecules from entering into healthy tissue and to prevent access to invading 
cell types after injury (Ribotta et al., 2004, Silver and Miller, 2004b). Therefore, considering 
the above contrasting effects of astrogliosis, it is too early to confirm the functional effect of 
astrogliosis (acute) from the results of 96h post graft analysis. A long-term observation (up to 
7 days) of post graft tissues may help determine the long term effects of pericyte-induced 
astrogliosis and whether a scar developed. 
In summary, the current study developed a methodology for grafting as pure a population of 
pericytes as possible into the naïve brain.  This is the first study to highlight the importance of 
enriching and purifying the pericyte population by dissecting the optimum time point during 
in vitro culture (7P2) and then follow them in the mouse motor cortex in vivo with a 
lentivirally-transduced iRFP reporter. Together, the findings from the current work indicated 
that the grafted pericytes integrate into host vasculature as a means to ensure vascular 
stability. The grafted pericytes also seem to activate the inflammatory machinery, i.e., 












7.7 Limitations in study design 
7.7.1 Colabelling for endothelial cells and pericytes 
One of the major limitations of this study is the failure to analyse the colabelling of CD31 and 
PDGFR- β in the grafted tissue. CD31 (PECAM-1) labels for endothelial cells, and a study 
has proven that some pericyte markers overlapped with CD31 during development and under 
pathological conditions (Nakano-Doi and Nakagomi, 2016). Unfortunately, the CD31 
antibody failed to work even after several attempts to validate the antibody. CD31 staining is 
also important to study sprouting angiogenesis, which is the formation of new capillary 
branches from the already existing blood vessels. Isolectin B4 staining can also be used to 
analyse the microvessel diameter, and the lectin binds to an extracellular site on endothelial 
cells of blood vessels in the brain. Therefore, Isolectin B4 can be used to label blood vessels 
in both living and PFA-fixed slices (Leung and Jensen, 2013). Hence, analysing the grafted 
tissues for colabelled CD31/Isolectin and other pericyte markers would have been helpful in 
this study and would be useful in future studies such as stroke or many other neurological 
diseases where angiogenesis is altered (Potente et al., 2011).   
7.7.2 Analysis of migration property of pericytes by scratch assay 
Pericyte migration occurs in response to stress and injury in the brain (Dore-Duffy et al., 
2000), retina (Chen et al., 2011) and heart (O'Farrell and Attwell, 2014) and could be an early 
sign of brain hypoxia. Pericyte migration is one of the important properties to consider in our 
grafting studies and has remained one of the limitations. We have shown that grafted pericytes 
integrated into the host vasculature surrounding the injected area (Chapter 5, Section 5.4), 
and it is plausible that the pericyte integration into vasculature could be a result of their 
migration property. PM cultured pericytes were shown to efficiently migrate into the gap area 




Performing a migration assay (Boyden chamber technique) with the FACS sorted pericytes 
could specifically demonstrate their migration properties in response to the cytokines secreted 
by ECs, explaining their propensity for vascular integration. 
7.7.3 Studying the role of inflammatory cytokines and the possibility of graft-induced 
scar formation 
There are several papers discussing glial scarring by increased activation of microglia and 
astrocytes (Anderson et al., 2016, Gautam and Yao, 2018). The 96h post graft tissues 
demonstrated an increasing trend in the activation of microglia and astrocyte activation 
(Chapter 5, Sections 5.4.3 & 5.4.5). But another limitation in our study is that we did not 
follow the fate of the grafted tissue for longer, and thus cannot say if the graft would result in 
long term scarring. In the future, this could be done by studying the levels of two 
inflammatory cytokines IFNγ, and fibroblast growth factor 2 (FGF2) both elevated after 
induction of glial scar (Silver and Miller, 2004a). Additional members of the scar-inducing 
family of proteins include interleukin-1 (Hewett et al., 2012, Murray et al., 2015) and TGFβ1, 
2 (Moon and Fawcett, 2001, Buisson et al., 2003)  and their expression should also be 









7.8 Future directions 
There are several important implications of this experiment in the future.  
7.8.1 Comparing the grafting experiments between naïve and stroke mice models  
The current work demonstrates grafting experiments in naïve mouse models, where the 
grafted pericytes integrated into the vasculature and also resulted in glial cell activation. 
However, it is not known how the grafted pericytes would respond to the hostile environment 
(increased inflammation and fibrosis) promoted by the events of stroke. The pro-
inflammatory environment could either reduce graft survival or could enhance as a 
neuroprotective mechanism. A study involving neural progenitor cell (NPC) transplantation 
has demonstrated that there was a remarkable reversal in the decrease of NPC survival at day 
14 in immunocompetent ischemic mice than the non-ischemic group (Kim et al., 2006). 
Contrastingly, another study has reported a decrease in graft survival in both ischemic and 
non-ischemic groups after 7days of NPC transplantation (Boehm-Sturm et al., 2014). 
Although pericytes are a subtype of MSCs and considered to be non-immunogenic in 
immunocompetent animals, it is important to validate the same by comparing the grafting 
experiments between naïve and stroke-induced mice. Also, the post graft experiments in the 
current study were limited up to 96h (4d), unlike the transplantation studies involving NPCs. 
Therefore, long-term monitoring (1-4weeks) of the grafted pericytes will reveal the survival, 
integrity, and behaviour of the grafted cells. 
7.8.2 Maximising grafting efficiency with different pericyte densities at different time 
points 
As mentioned earlier, the pericytes were grafted with a cell density of 50,000 cells/µL. The 




was not feasible to determine if the injected cell density was the optimum dosage as there was 
no reference to compare its efficiency with a spectrum of dosages. Hence, it will be beneficial 
to perform pericyte grafting at different cell densities and compare their relative efficiency in 
terms of graft survival, homing, and consequent functional effects. Although the literature 
suggests that 100000 cells are recommended to observe any difference in pathology (Lee et 
al., 2019), since pericytes are bigger than neural stem cells, injecting such high numbers 
risked blocking the syringe during the injection. A recent study shows that injecting a low 
dosage of 6.25x104 cells/µL of human neural stem cells did not demonstrate long-term 
cognitive impairment (TBI) using a non-spatial memory task (Haus et al., 2016). Therefore, 
depending upon the cell type used, the cell numbers have to be adjusted for a successful 
grafting experiment.  
After a successful grafting, it is important to understand the timepoint for observing the 
grafted tissues. In the current study, the post graft tissues were analysed 96h post grafting. It 
would also be beneficial to observe the post graft tissues for 7 days as it might help determine 
the long-term effects of pericyte induced astrogliosis and whether a scar developed. A recent 
study shows that the brain microcirculation in the pericyte-injected hemisphere of the mice 
increased 3 weeks after implantation (Tachibana et al., 2018). Therefore, a long-term 
observation of up to 3 weeks post graft in this study could be beneficial to understand if there 
is a development of new vasculature or angiogenesis post pericyte grafting.  
7.8.3 Coculture in vitro experiments to validate the neuroprotective effect of 
inflammatory glial cells 
As mentioned in section 7.6, conducting in vitro co-culture experiments will determine if 
pericyte induced microglial activation could act as a neuroprotective mechanism by 




to secrete neurotrophic factors like PDGF-BB and IL-6 could be validated by adopting in 
vitro qualitative assays like enzyme-linked immunosorbent assay (ELISA). Subsequently, the 
neuroprotective potential of these factors could be measured by assessing their ability to 
rescue the survival of neurons in vitro that are subjected to physiological stress (Nutrient 
deprivation/ hypoxia). Neuroprotection could involve mechanisms like decreased apoptosis 
(Robertson et al., 2000), increased autophagy (Young et al., 2009) and activation of 
PI3K/AKT signalling pathways (Sanchez-Alegria et al., 2018).  
7.8.4 Studying the calcium dynamics in post-graft pericytes in vivo 
The grafted pericytes lining the vasculature express a high percentage of α-SMA (Figure 
5.4b), which could be a sign of early differentiation to contractile phenotype. To validate the 
contractile phenotype, in vivo calcium imaging could be used to determine the functional 
phenotype (raised basal calcium levels and larger spontaneous calcium events) in the grafted 
pericytes. 
7.8.5 Pericytes as the potential therapeutic agents for brain regeneration and recovery 
7.8.5.1 Pericyte grafting in combination with pharmaceutical intervention 
Pericytes are susceptible to stress and injury, and multiple neurological diseases result in 
pericyte degeneration. Pericyte grafting in the stroke model could be an effective therapeutic 
strategy. There is an increased notion that pericyte plasticity and function may be improved or 
restored in an injury situation (Berthiaume et al., 2018). Stroke leads to damaged vasculature 
and BBB leakage; whose restoration is a priority.  BBB leakage is considered to occur 
through disturbed transcellular transport or the junctional breakage between endothelial cells, 
causing paracellular leakage. The former could be due to reduced N‐cadherin expression in 




pericyte deficiency or their reduced integrity covering endothelial cells. Pharmaceutical drugs 
like imatinib (Gleevec) and cilostazol/iloprost have been shown to improve BBB integrity 
caused by pericyte deficiency (Armulik et al., 2010a) and reduce pericyte detachment (Omote 
et al., 2014), respectively. Hence, pericyte transplantation, in combination with 
pharmaceutical interventions, could be more effective in alleviating vascular integrity and 
inhibiting BBB leakage.  
7.8.5.2 Transient pericyte inhibition in disease models 
Although pericyte contractility and function are crucial for restoration and homeostasis of 
BBB, pericyte transplantation could have differential effects in different disease situations. In 
a model of Alzheimer’s disease, transient inhibition of pericyte function was suggested as one 
of the effective ways to enhance BBB permeability to transport therapeutic agents from the 
blood to the brain effectively. Bivalent anti-Aβ antibodies were transported via transferrin 
receptor‐mediated transcytosis, and may also be considered to modulate pericyte function 
(Sevigny et al., 2016, Syvanen et al., 2018). Therefore, in the context of Alzheimer’s disease, 
the presence of a large number of pericytes could have deleterious effects. A recent study has 
shown that abnormal Aβ oligomer deposits constrict human and rodent capillaries by acting 
on pericytes by a mechanism involving ROS generation and ET release. Cortical capillaries 
are constricted by 30% at pericyte locations in rapidly fixed biopsies of living human patients 
with Aβ deposition and cognitive decline. This in turn is sufficient to produce a major 
reduction of cerebral blood flow (Nortley et al., 2019). The above evidence suggests that the 
pericyte replacement therapies may help restore normal pericyte function and BBB integrity.  
A recent study by Sun et al. observed low efficacy of engraftment of human pluripotent stem 
cells-cranial neural crest-derived pericyte-like cells (hPSC-CNC PCs) 7 days post-treatment 




capillaries were surrounded by the grafted cells in the penumbra area. The above study 
demonstrated that cranial neural crest-derived pericyte-like cells could promote neurological 
recovery and rescue BBB function in a tMCAO model (Sun et al., 2020). Therefore, 
comparative studies for the optimal delivery routes and factors such as cell size, cell dosage 
and delivery speed need to be ensured for the efficacy and safety of pericyte transplantation.  
7.8.6 Translation using larger animal models like pig, sheep, primates 
It is always important to think about translating this experiment into higher species. Using the 
rodent model for this study is not a limitation but a steppingstone to translation. If the present 
study were to be compared in the context of a clinical perspective, a rodent model is definitely 
not the best model. However, the present study was not conducted to directly model human 
transplantation studies but to understand the exclusive effect of transplanting pericytes to the 
brain motor cortex. Before translating the current work to higher species, it is of utmost 
importance to understand the basic grafting behaviour of pericytes in the host brain. Also, 
factors like isolation, purification, enrichment, upscaling the number of pericytes and 
standardising the dosage as well as the route of administration are very important before the 
current study could be translated to higher species. The success of stem cell transplantation 
has already been studied successfully in the fields of corneal (Parikumar et al., 2018) and 
heart transplantation (Katare et al., 2011). Only after considering the results of rodent models, 
further studies were carried out in higher species like sheep, swine and primate models. A 
study has transplanted human MSCs into fetal sheep, but not brain-specific, early in gestation 
which engrafted and persisted in multiple tissues for as long as 13 months after 
transplantation. The grafted cells underwent site-specific differentiation into chondrocytes, 





The current study provides a novel method for a thorough characterization, enrichment and 
purification of a pure population of mouse cortical pericytes. The pericyte enrichment resulted 
in the identification of markers of a novel phenotypic cluster in terms of increased expression 
of PDGFR-β and NG2, and decrease in α-SMA, signifying the enrichment of capillary 
pericytes. Reporter tagging the CD140b-purified pericytes with iRFP helped to identify the 
grafted pericytes. Graft survival is one of the preliminary yet major steps to represent a 
successful grafting, where the grafted pericytes successfully displayed homing and integration 
into the host vasculature within 96h of injection. Along with homing and integration, within 
96h, the grafted cells demonstrated an acute response in activating immunoregulatory 
microglia and astrocytes. Finally, these findings contribute to the growing body of knowledge 
that indicates that the capillary pericytes grafted in an immunocompetent naïve mice could 
stably integrate, contributing to maintaining vessel stability. Long term monitoring of the 
transplanted cells at different doses will help in understanding the functional significance of 
active glial response as a potential therapeutic target in repairing the damaged brain. Even 
though most of the neurodegenerative diseases are incurable at this point, the latest findings 
and technology bring us new hope by facilitating the development of stem cell-based 
therapies, especially pericytes that are more likely to protect and traverse the BBB keeping in 
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9.1 Appendix 1: Solutions and buffers 
1. Antibody solution 
X µL Primary/Secondary antibody 
200 µL Goat serum 
Made to 1 mL with PBS-T (0.1% v/v) 
 
2. Blocking solution 
200 µL Goat serum 
Made to 1 mL with PBS-T (0.1% v/v) 
 
3. Cryoprotectant solution 
300 g sucrose 
300 mL ethylene glycol 
Made to 500 mL with PBS 
 
4. DNA loading dye (6X) 
3 mL Glycerol 
25 mg Bromophenol blue 
Made to 10 mL with ddH2O 
 
5. Paraformaldehyde (4%) 
40 g paraformaldehyde (PFA) 
500 mL 0.1 M PB 




Make up to 1 L with 0.1 M PB 
Filter and PH to 7.4 with 37% (v/v) HCl 
 
6. Phosphate buffered saline (10X) 
2 g KH2PO4 
11.5 g Na2HPO4 
2 g KCl 
80 g NaCl 
800 mL ddH2O 
 
7. Phosphate buffer (0.4M) 
27.6 g sodium phosphate monobasic (NaH2PO4H2O) in 1 L dH2O 
53.6 g sodium phosphate dibasic (Na2HPO47H2O) in 1 L H2O 
Mix 220 mL of monobasic with 720 mL dibasic solution 
Adjust pH to 7.2 
Make to 2 L with ddH2O 
 
8. Sucrose (30%) 
30 g sucrose 
Made to 100 mL with 0.1 M PB 
 
9. TAE buffer (50X) 
484 g Tris 
114.2 mL acetic acid 
200 mL EDTA (0.5 M, pH 8.0) 
Make up to 2 L with ddH2O 






10. Complete Dulbecco’s modified eagle medium (C. DMEM) 
DMEM/F-12 media (ThermoFisher Scientific, C.No – 11330032) 
10% FBS 
1X Antibiotic-antimycotic (ThermoFisher Scientific, C.No – 15240062) 
 
11. Pericyte medium (PM) 
Commercial PM 
10% FBS 
1% pericyte growth supplement 
1% penicillin-streptavidin 
 
12. Agarose (15%) 
0.45 g of agarose  
30 mL TAE 1X buffer 
3 µL SYBR safe DNA gel stain 
 
13. Cryopreservation medium 
6 mL FBS 
3 mL growth media 










9.2 Appendix 2 
 
 
Figure 9.1 Representative flow cytometry dot plots depicting the gating of a cell population  
(A). Forward and side scatter gating is the first gating procedure to select a viable population of 
interest. (B). Doublet discrimination was done by gating forward scatter-width against forward scatter-













9.3 Appendix 3  
 
Figure 9.2 Representative image of the threshold setting for Iba-1 quantification.  
The same threshold setting that was used for the vehicle tissue was applied to the iRFP injected 
tissues. The noise below 18% was cut off and the above percentage was taken into consideration. (a) 
Threshold setting used on a vehicle tissue; (b) threshold setting used on an iRFP injected tissue. 
 
9.4 Appendix 4  
 
Figure 9.3 Low magnification image of astrogliosis.  
Representative image of the astrogliosis at the iRFP injected area and no astrogliosis distal to the 




9.5 Appendix 5 






α- SMA F-CATCTTTCATTGGGATGGAG 
R-TTAGCATAGAGATCCTTCCTG 
GFAP F-GGAAGATCTATGAGGAGGAAG 
R-CTGCAAACTTAGACCGATAC 
GAPDH 
F-ACCCAGAAGACTGTGGATGG 
R-CACATTGGGGGTAGGAACAC 
 
 
 
